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Abstract 
The spread of epileptic activity within the cortex is opposed by a powerful 
inhibitory restraint.  We hypothesized that the same inhibitory mechanisms are 
likely also to underlie the phenomenon of centre-surround suppression. In this 
thesis, I used different non-invasive visual psychophysical assays of surround 
suppression to answer whether they can be used as a measurement of network 
state in epilepsy and as a way of predicting seizures. 
We recruited 146 healthy volunteer controls and 54 patients with clinically 
confirmed epilepsy. Three different stimulus paradigms (motion 
direction discrimination, contrast detection and orientation discrimination 
tasks) were used to derive surround suppression indices which are believed to 
reflect the strength of cortical inhibition.  
Our results suggest that motion and contrast surround suppression phenomena 
are not related.  We found that suppression indices for the different tests in 
individual participants were not significantly correlated. In addition, multivariate 
regression analyses showed that motion suppression index was predicted 
strongly by age and seizure type, but not by seizure frequency.  Specifically, we 
found that patients with exclusively focal epilepsy, and no history of 
generalization, showed significantly stronger cortical inhibition as measured by 
the surround suppression index compared to all other groups, including controls. 
In contrast, patients with focal seizures evolving into generalised seizures, and 
patients with generalised genetic epilepsy, showed a similar level of cortical 
inhibition to controls. 
To answer whether psychophysical tests can be used as a way of predicting 
seizures, a longitudinal study was designed, deriving repeated measures of 
suppression indices in individuals. The results indicated no strong link between 
timing of seizures and suppression indices in patients. 
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In conclusion, visual psychophysics provides a simple and non-invasive means of 
assessing the state of inhibitory networks involved in the pathophysiology of 
epilepsy. The inability to increase activity in inhibitory networks in response to 
focal epileptic seizure may predict the risk of generalised seizures, which may in 
turn allow stratification of SUDEP risk.  
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Overview of the thesis 
 
This thesis is divided into the following chapters: 
• It begins with chapter 1 with a review of epilepsy, visual psychophysics 
and previous clinical studies using visual psychophysics.  
• Following the introduction, chapter 2 describes the materials and details 
of the experimental methods and analysis that were used to extract the 
results. It also describes participants’ recruitment policies and the rationale 
behind recruiting Indian participants.  
• Chapter 3 demonstrates the initial set of experiments and the results that 
were used for healthy controls to find the relationship between different 
visual psychophysical tests in one population. This chapter describes how the 
motion discrimination and the contrast detection tasks are related and what 
the relationship of the suppression indices is with age.  
• Chapter 4 and 5 show results of visual psychophysics in patients with 
epilepsy and the comparison between their suppression indices with the 
control group. Chapter 4 explores the relationship between seizure frequency 
and suppression indices. Moreover, I explain whether the differences are 
affected by anti-epileptic drugs or the type of epilepsy. Following the results 
found in this chapter, Chapter 5 further investigates the possibility of a link 
between the measured suppression indices and seizure susceptibility in 
patients. Here I also compare the variation in suppression indices among 
patients and controls in a longitudinal study.  
• Chapter 6 is a short chapter to present the results found in the India cohort 
and to explain whether the results support what was found in Newcastle.  
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• And finally, the discussion chapter will discuss the results and the practical 
issues regarding the use of visual psychophysics to predict seizures in epilepsy 
and what can be done in the future studies. 
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Chapter 1  Introduction 
 
The brain consists of massively interconnected networks made up of excitatory 
(principal cells) and inhibitory (inhibitory interneurons) cells. In the cerebral 
cortex, excitatory neurons comprise around 80% of the neuronal population, 
while inhibitory neurons take up the remaining 20% (Hendry et al., 1987). An 
important feature of cortical networks is the precise interplay between these 
two forces, the excitation and the inhibition (Isaacson and Scanziani, 2011, 
Moore et al., 2010). This endlessly changing flow of excitatory and inhibitory 
synaptic barrages has an important role in modulating the participation of 
neurons in local and large scale networks (Haider and McCormick, 2009). Neural 
networks optimise their function using complex homeostatic mechanisms to 
regulate this proper interaction (Turrigiano, 2011), however, when this precise 
interplay breaks, epileptic seizures can occur.  
Epilepsy is one of the most common neurological disorders and around 1% of 
the world’s population (about 50 million people) suffer from epileptic seizures 
(WHO, 2006). Epilepsy is characterised by epileptic seizures. The International 
League Against Epilepsy (ILAE) defines an epileptic seizure as a transient 
occurrence of signs and/or symptoms due to abnormal excessive or synchronous 
neuronal activity in the brain (Fisher et al., 2005).  According to their most recent 
report (Fisher et al., 2014) epilepsy is “a disorder of the brain characterized by 
an enduring predisposition to generate epileptic seizures, and by the 
neurobiological, cognitive, psychological and social consequences of this 
condition”. They defined three characteristics for epilepsy: “(1) At least two 
unprovoked seizures occurring 24 hours apart; (2) one unprovoked seizure and a 
probability of further seizures similar to the general recurrence risk (at least 60%) 
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after two unprovoked seizures, occurring over the next 10 years; (3) diagnosis of 
an epilepsy syndrome”.   
Epilepsy is defined as the occurrence of “paroxysmal events” which refer to 
intermittent and inherent unpredictability of these events. The underlying 
pathophysiology is of periods of neuronal hypersynchrony which can be 
observed as large amplitude discharges on the EEG (Electroencephalogram). The 
clinical manifestation ranges from almost nothing (subclinical seizures) to status 
epilepticus which is a life-threatening medical and neurologic emergency (Al-
Mufti and Claassen, 2014). 
Epilepsy is mainly treated by anti-epileptic drugs (AEDs) and in some cases by 
surgically removing the seizure focus. However considering side effects and the 
unexpected nature of seizures, epilepsy can significantly interrupt a patient’s life 
(plus social disadvantages, such as unemployment and stigma). Most patients 
respond to AEDs but some do not and continue to have seizures (Loscher et al., 
2013).  The unpredictability of seizures has a major effect on patients’ lives since 
it makes it almost impossible to mitigate against. Therefore, there has been a lot 
of effort in this area, from basic understanding of epilepsy to different ways of 
predicting seizures, to improving the living conditions of patients with epilepsy. 
Anything that allows patients in this group to predict their seizures would be 
hugely beneficial. The requirements of such a predictive tool are that it should 
be easy to use in the patient’s own home which means it does not need an EEG 
or other specialized equipment, it reliably predicts seizures without producing 
too many false alarms, and does it sufficiently far before the seizure to allow the 
patient to be able to manage it.  
Epilepsy is believed to stem from a lack of proper balance between inhibition 
and excitation. The mechanism of action of AEDs are still not exactly known. 
However, they are aimed to improve the relationship between inhibitory and 
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excitatory forces through reducing the excessive electrical activity in the brain 
and making inhibitory forces more effective. Of course, inhibition has many 
other functions within the brain beyond avoiding epilepsy. For example, it is 
believed to underlie many aspects of vision (Allman et al., 1985b, Jones et al., 
2002, Solomon et al., 2004). Recently, there has been considerable interest in 
exploiting this fact to use non-invasive visual psychophysical tests as an assay of 
cortical inhibition. The term psychophysics was first introduced by German 
physicist and psychologist Gustav Theodor Fechner in 1860 (Kingdom and Prins, 
2010). Gescheider (1997) in his classic book of “Psychophysics: the 
fundamentals” defines psychophysics as “the scientific study of the relation 
between stimulus and sensation”. Psychophysics can be applied to any sensory 
system from vision and hearing to taste, smell and touch (Kingdom and Prins, 
2010). In fact, psychophysics is a non-invasive way of analysing a subject’s 
response to systematically designed changes to the physical properties of a 
stimulus. This is done by extracting a “threshold” or “just noticeable difference” 
from a psychometric function (Equation 2.8) by relating a quantitative quality of 
a stimulus to the probability of a particular judgement (Read, 2015) when the 
probability of a correct judgement exceeds a pre-defined level. 
 Intriguing results have been found in several clinical groups with impairment in 
cortical levels of the inhibitory neurotransmitter GABA (Gamma-Aminobutyric 
acid). However, this has not so far been examined in the context of epilepsy and 
here we investigated visual psychophysics as a potential clinical tool for assessing 
seizure risk.   
This chapter will start with basic introduction of epilepsy and different types of 
seizures. I then explain surround suppression and visual psychophysics with 
example of previous clinical studies and their findings. I will also explain the 
4 
 
relevance of using visual psychophysics for epilepsy. And lastly, I explain the aims 
of my thesis which will be further elaborated in the following chapters. 
1.1 Epilepsy and timing of seizures 
1.1.1 Classification 
It is important to make a clear distinction between classification of epilepsy and 
classification of seizures. Seizures are a separate category to epilepsies, and 
epilepsies are a separate category to aetiologies. It is very difficult to classify 
epileptic seizures.  Because of the wide verity of seizure types, their underlying 
aetiology and the effect on patients (for example with or without impaired 
consciousness) finding a single classification system has proven challenging, and 
several systems have been proposed over the years. There are multiple different 
types of epilepsy which are far greater than variation in other neurological 
disorders such as migraine, schizophrenia and depression.  
In general, epilepsy can be categorised by the seizure localisation into two 
groups of generalised and focal. Generalised seizures include seizures that 
engage bilaterally distributed networks but do not necessarily mean 
involvement of the entire cortex (Berg et al., 2010). Examples of epilepsies with 
generalised seizures are genetic generalised epilepsies (GGE), childhood absence 
epilepsy (CAE), juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy 
(JME), and epilepsy with generalised tonic-conic seizures (EGTCS) (Scheffer et al., 
2016). Focal epileptic seizures are defined as seizures that start within networks 
in one hemisphere of the brain (Berg et al., 2010). Examples are different types 
of temporal lobe and frontal lobe epilepsy. According to the new terminology by 
the ILAE, description of focal seizures should include the degree of impairment 
of consciousness. For example, the term complex partial seizures that means 
impairment of consciousness in focal epilepsy is now replaced with the term 
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“dyscognitive”. Classification of seizures based on these two groups according to 
ILAE can be seen in Figure 1.1 (Berg et al., 2010). 
Seizures can have multiple different causes and can be classified as acute 
symptomatic and unprovoked. A symptomatic seizure is caused by a previously 
known or suspected disorder of central nervous system which is believed to have 
increased the risk of developing seizure, for example a seizure that is developed 
after a stroke, brain trauma, drug or alcohol withdrawal, an CNS infection or a 
toxic insult. On the other hand, an unprovoked seizure is a seizure of an unknown 
aetiology which is not associated with a previous CNS insult known to increase 
the risk of developing seizure.  
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Figure 1.1. Classification of seizures into generalized and focal seizures, 
reproduced from Berg et al. (2010). 
 
Many patients cannot be categorised into one group, mainly because of 
overlapping features with both generalised and focal seizures. Therefore, 
aetiology or the underlying cause of epilepsy needs to be taken into account. 
Berg et al. (2010) have recommended three categories: genetic, structural-
metabolic (with structural lesions and stroke, trauma, infection) and unknown 
causes. Details of aetiology of recruited patients can be found in Appendix 1 and 
Appendix 2. There are also updated documents of ILAE based on the proposals 
and feedbacks after the final Berg et al. (2010) paper on seizure classification, 
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and on epilepsy classification which are not yet finalised 
(http://www.ilae.org/visitors/centre/Class-Seizure.cfm). 
Our hypothesis was that if visual psychophysics is a non-invasive way of 
measuring cortical inhibition, then it may be possible to use it to assess patients 
in which inhibition is believed to be compromised. Specifically, we speculated 
that visual psychophysics could be used to assess patients with epilepsy, as a 
potential assay to show any deficit in surround suppression in the form of altered 
thresholds in comparison with controls.  
 
1.1.2 Surround suppression and the role of excitation and inhibition in 
epilepsy 
GABA is the main inhibitory neurotransmitter in the adult mammalian central 
nervous system (CNS). In the CNS, inhibition primarily occurs through GABAergic 
signalling onto ionotropic GABAA receptors, which results in an inward chloride 
(Cl-) conductance that hyperpolarizes the cell (Lee and Maguire, 2014, Farrant 
and Nusser, 2005). A lot of experimental and clinical evidence have 
demonstrated the role of GABA in epilepsy. GABA agonists such as Muscimol and 
Progabide have anticonvulsant effect, and GABA antagonists such as bicuculline 
and picrotoxin are pro-convulsants (Treiman, 2001). Drugs that inhibit GABA 
synthesis, such as 4-deoxypyridoxine are linked to epilepsy (Treiman, 2001) and 
drugs such as barbiturates that increase GABA-mediated inhibition have 
anticonvulsive effect.  
Experimental evidence of different brain regions (Nusser and Mody, 2002) show 
that GABAA receptors located at synapses generate a spatially and temporally 
distinctive type of inhibition than those found extrasynaptically (Kaneda et al., 
1995). Phasic (synaptic) inhibition is short intermittent bursts of inhibition 
mediated by receptors at the post synaptic neuron with low affinity for GABA 
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binding critical for information processing. Whereas, tonic (extra-synaptic) 
inhibition is a constant, long-lasting inhibition activated by GABA in the 
extracellular space (Mody, 2001, Farrant and Nusser, 2005) with an important 
role in neuronal excitability in the brain (Brickley et al., 1996).  In thalamocortical 
neurons of genetic models of epilepsy, phasic GABAA inhibition is either 
unchanged or increased, whereas tonic GABAA inhibition is increased both in 
genetic and pharmacological models (Crunelli et al., 2011). This enhanced tonic 
inhibition is required for absence seizure generation (Cope et al., 2009). Some 
studies have shown implication of malfunction in the astrocytic GABA 
transporter GAT-1 in genetic models (Crunelli et al., 2011). 
Inhibitory configuration of the brain as a network depends on how its excitatory 
and inhibitory elements are interconnected. These patterns of wiring are 
categorised as feedback, feed-forward and lateral inhibition. A feedback 
inhibitory circuit provides a regulatory mechanism in which increase in firing of 
a principle cell, increases the interneuron’s firing which in turn may decrease the 
principle cell’s overall output. In a feed-forward inhibitory circuit, increase in the 
firing of an interneuron results in reduction of the discharge in a principle cell. 
The term “lateral inhibition” or “surround suppression” refers to the fact that an 
excited neuron can reduce the activity of its surround or neighbouring area. An 
influential early study of unit recording of cortical neurons done by Mountcastle 
and Powell (1959) showed such inhibitory activity in the surrounding cortical 
area following focal stimulation. Similar surround inhibition was also seen 
around focal pathological lesions induced by penicillin injections in cat 
hippocampus (Dichter and Spencer (1969a), Dichter and Spencer (1969b),Prince 
and Wilder (1967)) and also observed in ferret cerebral cortex using optical 
imaging (Schwartz and Bonhoeffer (2001)). These studies showed inhibitory 
postsynaptic currents in the surrounding area of the excited focus, giving rise to 
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the idea of a protective “surround inhibition” (Prince and Wilder, 1967). More 
recently, a few studies used electrophysiology and in vitro imaging in artificially 
prepared brain slices of rodents (in vitro models of epileptiform discharges), to 
show that areas of hypersynchronous activity were engaging all neurons. 
However, when the activity was going to the surrounding territories, they were 
not immediately recruited and were opposed, for a period of time, by a strong 
feed-forward inhibitory response (Cammarota et al., 2013b, Trevelyan et al., 
2007, Trevelyan et al., 2006). It is believed that, in healthy brains, this inhibitory 
effect efficiently stops local areas of hypersynchronous activity developing into 
an epileptic seizure.  
There are a number of pathological reasons for seizure generation, such as 
neural reorganization and changes in the release of neurotransmitters. Neural 
reorganization can cause hyper-excitability which increases the likelihood of the 
generation of recurrent seizures (Olney et al., 1972, McNamara, 1994). 
Reduction in the levels of GABA results in less inhibition and elevated levels of 
glutamate neurotransmitter have been reported in human brain tissues and 
animal models of epilepsy (Cho, 2013). Glutamate induced excitotoxicity has 
been linked to neuronal death in epilepsy (Haglid et al., 1994, Cho, 2013) and a 
lot of studies have suggested a link between excessive extracellular glutamate in 
the hippocampus to the pathophysiology of seizures in patients with medically 
intractable mesial temporal love epilepsy (Eid et al., 2004, Cavus et al., 2005, 
Olney et al., 1986, Olney et al., 1972). Astrocytes, the largest subgroup of glia 
cells, have a crucial role in mostly regulating the extracellular levels of glutamate 
neurotransmitter (Coulter and Eid, 2012). A malfunction in the glutamate 
degrading enzyme, glutamine synthetase, has been reported in astrocytes of the 
epileptogenic hippocampus in a subset of patients with temporal lobe epilepsy 
(TLE) (Eid et al., 2004). This deficiency in astrocytes has been linked to 
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extracellular accumulation of glutamate and seizure generation in mesial 
temporal lobe epilepsy (Eid et al., 2008).There are several ways that the 
inhibitory effect might fail to stop the spread of a seizure (Trevelyan and 
Schevon, 2012). One possibility is mutations in interneuron-specific sodium 
channel Nav1.1 or in glial cells which causes fast spiking interneurons to be less 
excitable (Trevelyan and Schevon, 2012). Also, changes in gene expression might 
cause pyramidal neurons become more excitable and some less, and therefore 
break the interplay between inhibition and excitation (Sloviter, 1987). Another 
possibility is short term depression where interneurons stop firing due to 
depolarizing block which in turn causes a change in the GABAergic effect 
(Trevelyan and Schevon, 2012, Trevelyan et al., 2006, Ziburkus et al., 2006). 
Another crucial change is an increase in postsynaptic chloride levels due to 
intense neuronal firing that will shift the membrane potential to a more 
depolarized level (Staley et al., 1995, Trevelyan and Schevon, 2012).  
Reduction in inhibition is not the only instance of triggering a seizure. There is 
evidence of increasing inhibition that promotes seizure generation (Snodgrass, 
1992). For example, Tiagabine which increases the level of GABA by blocking 
GABA transporter 1 (GAT-1) (Brodie, 1995) has been shown to trigger non 
convulsive status epilepticus in some patients with lesional focal epilepsy (Vinton 
et al., 2005). Moreover, abnormalities of GABAergic function have been 
observed in genetic and acquired animal models of epilepsy suggesting that 
possible synchronization effects of GABA interneurons may result in paradoxical 
facilitation of some types of epileptic discharges in these animal models 
(Treiman, 2001). 
Of course all of these electrophysiological studies were done in animals, and so 
it is important to investigate whether the same spatial pattern of inhibition takes 
place in spontaneous (in opposed to pharmacologically induced seizures in 
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animal models of epilepsy) seizures in humans. A study done by Schevon et al. 
(2012) took advantage of recent development of multi-electrode arrays for use 
in humans to record temporal and spatial resolution of recorded seizures and 
showed that human seizure recordings have remarkable similarities with animal 
studies of an inhibitory restraint. In fact, these recording have demonstrated two 
separate spatial territories: the ictal core (the recruited area with increase in 
synaptic activity) and penumbral territories (restrained areas surrounding the 
focus of ictal activity with a fractional increase in unit activity) (Merricks et al., 
2015). 
As mentioned before, the underlying pathologies in epilepsy are very complex, 
but almost all involve GABAergic inhibitory mechanisms in some way. 
1.1.3 Drugs affecting inhibition 
Anti-epileptic drugs (AEDs) are a means of controlling symptoms of epilepsy and 
the modern use of them started from 1912 with the discovery of phenobarbital 
which was at first mainly used to induce sleep (Sills, 2011). Since then a lot of 
new drugs have emerged in the market, however the percentage of people who 
do not respond to AEDs has not been changed (between 20-30%) (Loscher et al., 
2013).  
There are three main mechanisms of AEDs that are known: actions on voltage-
gated ion channels (blockade of voltage-gated sodium and calcium channels, 
activation of voltage-gated potassium channels), enhancement of GABA-
mediated inhibitory mechanisms or decreases of glutamate-mediated excitatory 
mechanisms (Sills, 2011).  
As we are using visual psychophysics as a non-invasive way of measuring 
inhibition, it is necessary to consider the effect of AEDs on the measured 
surround suppression. In particular, some classes of AEDs including 
benzodiazepines, and barbiturates act on GABAA receptors resulting in rise in 
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response to released GABA. Each class however binds to a different site on the 
receptor and influences the chloride channel opening in a different way. 
Barbiturate AEDs increase the duration of chloride channel opening and 
benzodiazepines change the frequency of chloride channel opening (Sills, 2011).  
In addition, patients with prolonged use of AEDs are believed to have impaired 
visual performance such as mild diplopia, blurred vision and nystagmus (Roff 
Hilton et al., 2004, Verrotti et al., 2007). A study done by Nousiainen et al. (2000) 
compared contrast sensitivity in patients with epilepsy who were treated with 
Vigabatrin or Carbamazepine with healthy controls and reported a reduced 
contrast sensitivity in the patients group.  
In another study the influence of single oral dosages of Carbamazepine, Valproic 
Acid, Vigabatrin, Lamotrigine and Gabapentin on visual perception was 
investigated in healthy volunteers to only account for the effect of AEDs without 
the possible influences of epilepsy (Steinhoff et al., 1997a). They reported an 
increase in the critical flicker fusion frequency only after Vigabatrin and 
Gabapentin. However, the visual stimuli used here are all fairly low in temporal 
frequency and any change in the flicker fusion is highly unlikely to affect 
perception. 
1.2 Inhibition in the visual system 
Inhibitory mechanisms are a universal property of visual information processing. 
Inhibition in visual system was first described in details by Hartline and 
colleagues in 1956 where they used logarithmic equations to describe the 
interaction between excitatory and inhibitory mechanisms and surround 
suppression in the retina of the horseshoe crab (Limulus) (Hartline et al., 1956). 
Motion representation starts in the primary visual cortex (V1). The projections 
then go through middle temporal (MT, V5) and medial superior temporal area 
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(MST) and end at higher areas of the parietal and temporal lobes (Liu and 
Newsome, 2003). 
1.2.1 MT  
V5 or middle temporal area (MT) is a region of extrastriate visual cortex that 
receives direct projections from the primary visual cortex (V1) and V2. Extensive 
evidence of physiological studies demonstrated that most MT cells are highly 
sensitive to the direction of the moving stimulus meaning that each single 
neuron in MT selectively responds to a preferred direction of visual stimuli on 
the retina (Maunsell and Van Essen, 1983, Albright, 1984). This suggests that MT 
is involved in perceiving motion. In addition, Albright et al. (1984) demonstrated 
that MT neurons are grouped in cortical columns with similar preferred 
direction. DeAngelis and Newsome (1999) also showed that MT neurons play an 
important role in stereoscopic depth perception and are clustered according to 
their preferred disparity selectivity. In addition, studies have shown that many 
neurons in V1 of macaque monkey are also direction selective and therefore 
speculated that V1 is also involved in motion analysis (Maunsell and Van Essen, 
1983, Dow, 1974, Wang and Yao, 2011). The difference between MT and V1 in 
motion processing is that V1 has smaller number of direction selective neurons  
and smaller receptive fields than MT neurons (Maunsell and Van Essen, 1983). 
Another property of most neurons in MT is that they are sensitive to the speed 
of the visual stimuli (Maunsell and Van Essen, 1983, Albright, 1984, Okamoto et 
al., 1999, Perrone and Thiele, 2001, Perrone and Thiele, 2002) making each of 
them respond to a certain speed of stimulus movement independent of the 
spatial and temporal frequency of the stimulus. Evidence of primate research 
has shown that lesions in MT and MST can diminish performance on speed 
discrimination tasks (Liu and Newsome, 2003, Newsome et al., 1985, Dursteler 
and Wurtz, 1988). 
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1.2.2 Centre surround organization  
MT neurons have well defined classical receptive fields that are arranged in a 
topographic representation of the visual field (Baker et al., 1981, Allman and 
Kaas, 1971, Maunsell and Van Essen, 1983) to integrate spatial and temporal 
information. Allman et al. (1985a) for the first time demonstrated that receptive 
fields of neurons in the MT visual area extends beyond the classical receptive 
field with the surrounding area much larger than the area of the classical 
receptive field. The surrounding region is direction and speed sensitive and 
antagonistic to the response from the classical receptive field (CRF) (Allman et 
al., 1985a). In primates the antagonistic centre-surround receptive field 
organization is a ubiquitous property that can be found in V1 (Jones et al., 2001), 
medial superior temporal (MST) (Eifuku and Wurtz, 1998), superior colliculus 
(Davidson and Bender, 1991) and MT (Allman et al., 1985a, Tanaka et al., 1986, 
Born and Tootell, 1992, Bradley and Andersen, 1998). A typical MT neuron will 
respond well if the centre of its receptive field is stimulated in the preferred 
direction. However, in a centre-surround MT neuron if the moving stimulus 
extends beyond its centre receptive field and into the surround, then the 
response will be reduced (Tadin and Lappin, 2005, Allman et al., 1985a). 
Evidently, the response to a large background motion is a reduction in the 
number of spikes (Figure 1.2). Centre-surround organization increases the neural 
responses to spatially different parts of stimuli (for example edges) and 
suppresses responses to unvarying regions of the stimuli (Tadin, 2015). One 
theory is that spatially different regions of the stimuli have vital information for 
the visual motion processing, while uniform areas carry less revealing 
information (Nakayama and Loomis, 1974).  
15 
 
 
Figure 1.2. Figure is depicted from Allman et al. (1985a). Left: histogram shows 
responses of 42 neurons in MT of an owl monkey to random dots moving for a 2 
second period in preferred direction in their classical receptive field (CRF) with a 
static background. Right: histogram shows responses of the same neurons with 
continuous stimulation in the preferred direction within their CRFs and then with 
a 2 second test of the moving random dots in their preferred direction in the 
surround. 
 
A distinctive feature of the interaction between the centre and surround of the 
receptive field of cortical cells is its orientation specificity (Angelucci and Bullier, 
2003), meaning that the extent of facilitation or suppression of the centre 
response following a simultaneous stimulation of the surround and centre, 
depends on the relative orientation and direction of motion of stimuli in these 
two regions (Angelucci and Bullier, 2003, Jones et al., 2002, Sillito et al., 1995).  
When the stimuli in the centre and surround have similar orientation, the centre-
surround interactions are reported to be suppressive, however this interaction 
can be less suppressive or in fact facilitatory when the centre and surround have 
orthogonal orientations of motion (Albright, 1984, Blakemore and Tobin, 1972, 
DeAngelis et al., 1992, Angelucci and Bullier, 2003). The centre-surround 
interactions in retina or LGN neurons are non-orientation selective (Felisberti 
and Derrington, 2001). However, the orientation selectivity of cortical cells 
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points to the fact that intracortical processing plays an important role in the 
generation of cortical modulatory surrounds (Angelucci and Bullier, 2003). 
Horizontal or lateral connections and feedback connection from extrastriate 
cortex have an important role in eliciting inhibitory activity that mediates 
surround responses in V1 (Angelucci and Bullier, 2003). A similar delay to 
propagation of excitatory activation which is believed to be mediated by 
horizontal connections, has been reported in the orientation surround 
suppression relative to the response of the centre. Therefore, it is likely that 
some of the centre-surround interactions in V1 neurons are mediated by 
horizontal connections. However, for longer distances in the visual field, 
feedback connections are the most likely substrate for the surround suppression. 
A lot of studies have reported lack of surround suppression after inactivation of 
MT, suggesting that feedback connections from MT have strong effect on the 
centre-surround suppression of neurons in lower order areas in the visual system 
(Hupe et al., 1998, Bullier et al., 2001). In fact, feedback connections combined 
with horizontal connections act as a non-linear model to boost the gain of the 
centre mechanism and to generate the centre-surround interactions (Angelucci 
and Bullier, 2003, Bullier et al., 2001, Kim and Freeman, 2014).  
An interesting property of MT centre-surround neurons is that contrast plays an 
important role in their behaviour to motion (Figure 1.3).  Pack et al. (2005) 
showed that some MT neurons respond stronger to a large low contrast stimulus 
than to one in high contrast and argued that this behaviour is in line with the fact 
that visual system reduces redundancy at high contrast while preserving 
sensitivity at low contrast by changing suppression to facilitation (Tadin et al., 
2003, Tadin, 2015). Tadin et al 2003 argues that at high contrast, the 
computational benefits of surround suppression are more important than the 
necessary decrease in neuronal activity and reduced sensitivity. At low contrast 
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however, high sensitivity is crucial, therefore makes functional sense that 
receptive field organization shifts from surround suppression to spatial 
summation (Tadin, 2015, Tadin et al., 2003). 
Figure 1.3. Depicted from (Pack et al., 2005). Figure shows the dependency of 
the neural response to stimulus contrast. Here size tuning of one MT neuron at 
low (dashed line) and high (solid line) contrast is shown. Error bar represent 
standard error of the mean. 
 
Along with neurophysiological studies that showed the existence of surround 
suppression in the analysis of motion, there were a lot of psychophysical studies 
that reported results consistent with neurophysiological surround suppression. 
Motion discrimination of brief, large moving gratings improves for human 
observers with increasing contrast at low contrasts, however with further 
increases in contrast performance declines (Derrington and Goddard, 1989). 
Verghese and Stone (1996) showed that dividing a large moving stimulus into 
smaller parts improved speed discrimination and suggested suppressive 
mechanisms to be responsible. More recently, Tadin et al. (2003) showed that at 
low contrast motion discrimination, measured by duration thresholds, can be 
improved by increasing the size of the moving stimulus. Authors suggested this 
is the perceptual consequence of spatial summation where surround 
suppression shifts to facilitation at low contrast (Pack et al., 2005). Conversely, 
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at high contrast increasing the size of the stimuli worsens the motion 
discrimination duration thresholds. Authors have attributed these phenomena 
to the perceptual consequence of neurophysiological surround suppression and 
referred to it as “spatial suppression”. Tadin et al. (2003) demonstrated that 
spatial summation is a basic characteristic of motion processing, but only in low 
contrast conditions. In addition, they showed the transition between spatial 
summation and spatial suppression happens from contrast of 5.5% upwards 
(Tadin, 2015) and the biggest increase in duration threshold was for Gabor 
patches larger than 2.7° in width which made the authors to speculate the 
existence of a “critical size” (Tadin et al., 2003). This critical size is similar to 
foveal MT receptive fields of neurons in macaque monkey (Raiguel et al., 1995)  
and the contrast dependency of spatial suppression matches with a population 
of neurons in MT (Pack et al., 2005). In addition, as receptive field of motion 
sensitive MT neurons enlarges with increase of retinal eccentricity (Raiguel et al., 
1995, Albright, 1984),  Tadin et al. (2003) tested the hypothesis of whether the 
increase of eccentricity at high contrast would change the effect of size. They 
showed that with increase of eccentricity, duration thresholds decreased for all 
sizes and there was almost no effect at the largest eccentricity (54°) meaning 
that the critical size increases with increasing eccentricity. For all these reasons, 
they speculated that psychophysical spatial suppression has characteristics 
similar to centre-surround receptive fields of MT neurons and are, at least in 
part, a behavioural match to surround suppression in MT (Tadin et al., 2003). 
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1.3 Previous clinical studies 
Abnormalities in cortical inhibition and excitation has been shown in a range of 
conditions, such as senescence (Leventhal et al., 2003), autism (Rubenstein and 
Merzenich, 2003), schizophrenia (Wassef et al., 2003, Yoon et al., 2010), 
migraine (Aurora and Wilkinson, 2007), depression (Sanacora et al., 1999) and in 
epilepsy (Stief et al., 2007, Sloviter, 1987, Jefferys and Whittington, 1996, 
Bernard et al., 1999, Andre et al., 2001).   
If abnormality in excitation-inhibition could selectively affect different areas of 
visual cortex, the various metrics of psychophysical surround suppression could 
be differentially impacted (Yazdani et al., 2015). On the other hand, if cortical 
surround suppression reflects whole-organism properties such as genetics, age 
(Betts et al., 2009, Betts et al., 2012, Betts et al., 2005) or IQ (Melnick et al., 2013, 
Tadin, 2015), or if surround suppression in higher visual areas is “inherited” from 
processing in V1 (Tsui et al., 2010), then the various metrics would reflect a single 
fundamental neuronal property. Furthermore, if the level of surround 
suppression changes over time and determines whether a seizure occurs, then 
changes in visual psychophysics might be a useful predictor of seizures. 
Tadin et al. (2003) demonstrated that a perceptual consequence of surround 
suppression in motion analysis can be observed as impaired perception of large, 
high contrast moving stimuli. Therefore, any abnormality in this impairment can 
be predicted to be a result of impairment in surround suppression. 
Consequently, any improvement in perception of large, high contrast moving 
stimuli (better than normal perception), can perhaps predict an underlying 
deficit in the surround suppression.  
In essence, visual psychophysics has the potential to cast light on the underlying 
pathology in conditions with known compromised excitation-inhibition and 
could also provide clinically useful information about individual patients. 
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In the following section I will discuss a number of studies that have used visual 
psychophysics to find more information about a particular condition. 
 
1.3.1.1 Recent work in aging 
The first study that tested spatial suppression in a particular group was Betts et 
al. (2005) who studied changes in an aging population. They divided their 
participants into two groups of “younger” with mean age of 23 years old and 
“older” with mean age of 68, and reported that duration thresholds were higher 
for the older participants in the small stimuli (size= 2σ = 0.7°) at all contrasts but 
not different between the two groups for the large stimuli (size= 2σ = 2.7°). 
Moreover, they reported that younger participants showed spatial summation 
for all stimulus sizes at low contrast, and switched to spatial suppression as the 
stimulus size increased. They speculated that the better than normal duration 
thresholds for their older participants in large high contrast or the fact that they 
need less time to discriminate the direction of moving stimulus, is age related 
and caused by a reduction in efficacy of cortical inhibition with age (Leventhal et 
al., 2003, Eysel et al., 1998) and weakening of surround suppressive centre 
surround mechanisms (Betts et al., 2005).  
In a contrast detection task, Serrano-Pedraza et al. (2014) however, found no 
effect of age. They examined the ratio of contrast thresholds for a grating patch 
with a parallel surround to the threshold for an isolated patch (no-surround 
condition). Similarly, in studies that I present in this thesis, and that are now 
published, we also found a lack of effect of age in a contrast detection task and 
showed that the relationship between suppression index and age was only 
significant in a motion discrimination task (Yazdani et al., 2015).  
In addition, Karas and McKendrick group have reported an increase in surround 
suppression for older adults in some cases in a contrast discrimination task, a 
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result inconsistent with a broad age-related decrease in suppression strength 
(Karas and McKendrick, 2009, Karas and McKendrick, 2011, Karas and 
McKendrick, 2012, Karas and McKendrick, 2015). They showed that supra-
threshold patches appear lower contrast when presented with a parallel 
surround than when presented in isolation, and this surround suppression is 
higher for older adults (65–70 years old) than for younger ones (18-30 years old). 
They argued that this is a result of a reduction in the magnitude of brightness 
enhancement in their elderly group and related to neuronal synchronization 
(Karas and McKendrick, 2009). 
Another study sought to study the effect of senescence on orientation 
discrimination (Delahunt et al., 2008) as single unit recordings have shown 
reduction of orientation tuning of individual neurons with increasing age in 
macaque cortical areas V1 and V2 (Schmolesky et al., 2000, Yu et al., 2006). They 
found no difference between the younger (range: 20-30 years old) and older 
(range: 65-85 years old) groups. 
Similar to aging, recent results suggest that children may have less GABAergic 
inhibition (Boley et al., 2005, Pinto et al., 2010). In a motion discrimination task, 
Lewis et al. (2008) showed that 5-year old children in a motion discrimination 
task performed worse than adults for small but not big stimuli and had weaker 
inhibitory surrounds. 
In conclusion, what is clear is that this is a very complex field where many 
different stimuli and tasks have been used which are presumed to measure 
surround suppression. However, results presented in chapter 3 indicate that 
these tasks might be affected by different mechanisms and a simple term of 
surround suppression covers a great number of distinct neuronal mechanisms. 
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1.3.1.2 Recent work in schizophrenia 
A lot of studies have shown neural deficit in patients with schizophrenia. There 
is evidence of hypofunction in one of glutamate receptors (NMDA) in patients 
with schizophrenia (Olney and Farber, 1995, Moghaddam, 2003). Moreover, the 
concentration of GABA is about 10% lower in patients with schizophrenia (Yoon 
et al., 2010, Wassef et al., 2003). There is also a great body of knowledge about 
the impairment of cognitive processing and in particular visual perception in 
schizophrenia. Examples are reduced contrast sensitivity (Slaghuis, 1998, Keri et 
al., 2002), altered visual context processing (Uhlhaas et al., 2004), broader 
orientation tuning  (Rokem et al., 2011).  
A lot of studies have used visual psychophysics to study this group of patients. 
Tadin et al. (2006) examined the integrity of centre surround mechanisms in 
motion perception of patients with schizophrenia and showed patients have 
weaker surround suppression than controls and those with the most severe 
symptoms have the weakest suppression. Another study used a contrast 
discrimination task in which observers had to indicate whether there was a 
difference in contrast between one target and the other seven segments of an 
annulus (Yoon et al., 2009). They demonstrated that patients with schizophrenia 
had significantly lower surround suppression index compared to controls in 
parallel surround, but no difference among the groups in the orthogonal 
surround suppression. Hence, they concluded that patients with schizophrenia 
have abnormal surround suppression which is related to orientation.  
In a different study using contrast detection thresholds in a four alternative 
forced-choice task (4AFC) Serrano-Pedraza et al. (2014) supported the previous 
finding and showed that patients with schizophrenia had significantly lower 
thresholds than controls in the parallel surround condition. 
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Different results have been reported in a study of judgement of direction in a 
random moving dot paradigm with and without a surround in controls and 
patients with mild symptoms, which showed increased centre surround 
suppression in patients (Chen et al., 2008).  
Work done by Yang et al. (2013a), Yang et al. (2013b) using different visual tasks 
(luminance, size, contrast, orientation and motion) showed that weak surround 
suppression in patients with schizophrenia in one of these perceptual domains 
did not mean similar abnormalities existed in another visual task. This means 
that the abnormal visual context processing in schizophrenia is selective and is 
not a global dysfunction. Tibber et al. (2015) also came to a similar conclusion, 
showing that distinct visual dimensions are differentially affected in 
schizophrenia and in particular judgements of visual orientation are significantly 
impaired in patients with schizophrenia. 
1.3.1.3 Recent work in major depression 
Animal models of depression suggest a dysfunction of GABAergic inhibition and 
GABA agonists have anti-depressant effect in these models (Petty, 1995, Golomb 
et al., 2009, Petty et al., 1992, Kalueff and Nutt, 2007). The deficit in levels of 
inhibition among patients and healthy controls has also been shown by magnetic 
resonance spectroscopy (MRS) (Sanacora et al., 1999, Sanacora et al., 2003).  
Golomb et al. (2009) hypothesised that given patients with depression have 
decreased spatial suppression, they might exhibit better performance in a similar 
motion discrimination task to Tadin et al. (2003). In fact, these patients showed 
enhancement in motion perception compared to age matched controls. 
Additionally, those patients who had depression for a longer period of time 
performed the best in the high contrast motion discrimination task. 
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1.3.1.4 Recent work in autism 
Patients with autism may also suffer from deficits in visual motion processing. 
Bertone et al. (2003) showed the deficit is only observed in second-order 
(texture-defined) stimuli in patients with autism compared to healthy 
participants. 
In a motion direction discrimination task in children with autism, Foss-Feig et al. 
(2013) reported no difference in spatial suppression at high contrast among 
patients and healthy controls, but a significant increase of motion perception 
across all sizes in patients. The authors suggested that perhaps gain control 
abnormalities has masked the differences within the groups at high contrast 
(Foss-Feig et al., 2013, Katzner et al., 2011). 
1.3.1.5 Recent work in migraine 
There are some evidence suggesting that there is a link between migraine and 
cortical hyperexcitability (Aurora and Wilkinson, 2007). This would mean that 
psychophysical tasks should suggest weaker surround suppression in this 
condition. However, Battista et al. (2010), Battista et al. (2011) reported increase 
of motion and contrast suppression index in patients with migraine. 
1.3.1.6 Discussion of psychophysical clinical studies 
The previous sections explained some of the visual psychophysical work in 
different groups of patients. However, the results are complex and hard to 
interpret. It is important to emphasize that visual psychophysics have not been 
used as a method of diagnosis, but rather as a non-invasive way to understand 
more about the pathology of a patient’s group. There are some studies however, 
that are questioning the presumed link between surround suppression and 
cortical inhibition. Blockade of GABA receptors in primate MT, did not cause a 
decrease in surround suppression (Liu and Pack, 2014). Another possible reason 
for discrepancies might be that perhaps surround suppression can be affected 
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by other neural factors (Rubin et al., 2014). A study done by Ozeki et al. (2009) 
used intracellular recordings in cat V1 and reported that the inhibition that 
neurons receive by the effect of surround stimuli is decreased and instead, 
suppression is mediated by termination of excitation and V1 is operating as an 
inhibition-stabilized network.  Moreover, a lot of patients’ groups in the 
mentioned studies were on medication which may cause changes in inhibitory 
processes and consequently in the suppression index.  
 
1.4 Relevance to epilepsy 
Given the impaired spatial suppression in the above special population, it is 
possible to speculate that perhaps similar impairment could be detected by 
visual psychophysics in epilepsy. The so-called "GABA-hypothesis" in different 
types of epilepsy suggests that a reduction of GABA-ergic inhibition allows 
epilepsy and an enhancement of GABAergic inhibition results in an antiepileptic 
effect (Calcagnotto et al., 2005, Bernard et al., 1999, De Deyn et al., 1990). If the 
effects in vision broadly classed as “surround suppression” are mediated by 
GABAergic mechanisms, despite the criticisms just noted, then the GABA-
hypothesis in epilepsy implies that we might see abnormalities in visual surround 
suppression. We speculated that possible abnormalities in visual performance 
are more likely to be observed in genetic epilepsy or in occipital lobe epilepsy 
which is less common than other types of focal epilepsy, such as temporal lobe.  
In particular, cortical inhibition is believed to be a common deficit in a mouse 
model of human genetic epilepsy (Petrou and Reid, 2012). Even in the case of 
focal epilepsy, we might still see an effect on the visual performance if the focus 
is in another lobe. Because the inhibitory deficit might be widespread enough to 
be detected by the visual psychophysics. The overall cortical inhibition is more 
likely to be compromised in generalised epilepsy compared to focal epilepsy 
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where the affected area is only the focus of seizures, except in occipital lobe focal 
epilepsy. Furthermore, if the same class of interneuron that subserves surround 
suppression also stops seizures spreading, then failure in one role may predict 
failure in the other. In other words, we will take a far wider sample of seizure 
phenotypes, in order to examine visual deficits that arise from global deficits in 
inhibition. 
As the review of the literature has shown, “visual surround suppression” is not a 
single phenomenon, so it is entirely possible that one type of so-called “visual 
surround suppression” would be altered in epilepsy while other types would not 
be. To maximise the chance of finding an effect, we have chosen two different 
tasks, one based on motion and one based on contrast, which have been both 
used previously with a range of clinical groups.  
As reviewed above, previous studies have shown differences between control 
and patient populations in several different measures of visual surround 
suppression, although no one has yet examined these in epilepsy. However, as 
far as we are aware all these studies have only considered differences between 
these populations at a single point in time, even though many of the clinical 
conditions in question (for example schizophrenia, depression) are characterised 
by large fluctuations in severity. In this thesis, as well as considering differences 
between patient and control populations in epilepsy, I also examine within-
subject fluctuations over time (longitudinal study). Moreover, I was interested in 
whether psychophysical results correlated with seizure timings and therefore, 
could be used as a way of monitoring and in particular predicting the likelihood 
of seizure occurrence as a non-invasive method at home. 
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1.5 The aims of this thesis 
• To investigate whether visual psychophysics can be used as a potential 
tool to predict a seizure in patients with epilepsy. Three different 
paradigms of visual psychophysics which are believed to measure cortical 
inhibition were used, the motion discrimination, the contrast detection 
and the orientation discrimination tasks.  
• To investigate whether these visual psychophysical tasks are correlated 
with each other and what is their relationship. 
• To examine the differences in performance of patients with epilepsy and 
healthy controls. 
• To explore the possibility of using visual psychophysics as a method of 
predicting seizures. 
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Chapter 2  Materials and methods 
 
2.1 Ethics   
2.1.1 Newcastle 
Experimental procedures were approved by Newcastle and North Tyneside 1 
Research Ethics Committee (reference number 09/H0906/90). Participants gave 
written informed consent and were paid a nominal fee for their participation. 
2.1.2 India 
The study proposal was submitted and approved by the Institutional Ethics 
Committee (IEC) of the INK Hospital.  
2.2 Newcastle recruitment policies 
2.2.1 Healthy participants 
146 healthy volunteers with no visual or neurological problems (87 female; mean 
age: 36.6; range: 17.3-69.1) were recruited from Newcastle University data base 
of volunteer subjects. They were contacted by email or telephone by the 
researcher in order to set an appointment. All of the recruited healthy 
participants performed the motion discrimination task and from this population, 
43 participants took part in a contrast detection task (34 female; mean age: 42.2; 
range: 19.4-74.2), and 7 (4 male; mean age=30.3; range=23.1-47.8) in an 
orientation discrimination task. Several took part in longitudinal studies, 
gathering repeated performance data on these tests over multiple days to 
weeks.  
2.2.2 Patients with epilepsy 
54 patients with confirmed epilepsy (30 male; mean age: 42.3; range: 17-82.33) 
were recruited by the researcher from Royal Victoria Infirmary’s (RVI) epilepsy 
clinics, video-telemetry department, and a local epilepsy support group. Within 
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this population, 34 patients participated in a contrast detection task (18 female; 
mean age: 42.2; range: 21.7-82.3), and 2 patients (2 male; mean age: 55.8) in an 
orientation discrimination task. Twenty patients with epilepsy were recruited by 
the researcher for the longitudinal study, but four were unable to run the tests 
unaided, and so were excluded from further analysis. Therefore, 16 patients took 
part in the longitudinal studies. These patients were selected based on their high 
frequency of seizures, so that the chance of recording seizures at the time of 
running the tasks increases.  
Information regarding each patient is provided in Appendix 2. A few patients 
with confirmed epilepsy were suspected to have non-epileptic seizures in 
addition to epileptic seizures. The exclusion criteria were: patients were under 
18 years old, patients were suspected to only experience non-epileptic seizures, 
patients with significant visual impairment, and those with severe learning 
disability.  
Patients were given instructions about the tasks and the research question, and 
were encouraged to ask questions. They could decide at that time or later 
whether or not to participate. If they were interested, an appointment was set 
in the RVI and they were compensated for their travel expenses. Longitudinal 
patients were given instructions while they were in-patients at the video 
telemetry department in RVI. Patients (sometimes with the help of a family 
member or an accompanying friend) filled out a questionnaire regarding 
concurrent health issues and current medication, seizure frequency, type of 
seizures and the first time they had a seizure, however they were not asked 
directly about a history of depression and anxiety. Patients’ frequency of seizures 
was estimated in terms of the number of seizures per year, month, week or day 
(Appendix 2 and Appendix 6). This information was later used as a clinical marker 
of epilepsy severity. Most of the patients were unable to provide a precise 
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estimate of their number of seizures for different reasons, such as not keeping a 
record, not being aware of them, or not remembering. Specifically, there were 3 
patients who were unable to give an estimate of their number of seizures. In 
these instances frequency of seizures was extracted from their records. The 
numbers of seizures reported were derived from the best knowledge of the 
patients, their witnesses, or what was recorded in their medical records and are 
indeed subject to uncertainty. Frequency of seizures could change in any patient 
and patients may have periods of remission or active spontaneous seizures for 
months or years. Therefore, we used the information that was the one most 
close in time to the time of participation in the study. The analysis of seizure 
frequency was collated blind to the results of their performance in the 
psychophysics tests. 
Patients also completed an Addenbrooke’s Cognitive Examination (ACE) test 
(Mioshi et al., 2006) which showed no difference in performance on the test 
between the groups of epilepsy. Patients with focal epilepsy with a history of 
generalised seizures (F+, n = 19) have ACE = 90.5 +/- 6.2 (mean +/- std) with range 
of 72-96, patients with focal epilepsy without generalising seizures (F-, n = 24) 
have ACE = 88.5 +/- 6.3 with range of 73-99 and patients with generalized genetic 
epilepsy (GGE, n = 11) have ACE = 92.0 +/- 4.1 with range of 85-100.  
2.3 India recruitment policies 
2.3.1 The rationale of this recruitment 
Patient recruitment in Newcastle proved to be very slow, therefore patient and 
control recruitment was done as part of collaboration that was started between 
Institute of Neuroscience (IoN) in Newcastle and the Institute of Neurosciences 
Kolkata (INK) in India (INK; http://www.neurokolkata.org/). Patient recruitment 
was done by Dr. Jenny Read and collaborators in India (Dr. Ashish Datta, Dr. Rajib 
Samanta, Dr. Hrishikesh Kumar and Swagata Sen). Dr. Jenny Read trained MS. 
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Sen for around two weeks while she was conducting the test. After Dr. Read left 
India, recruitment and data collection continued for about six months. Based on 
the preliminary data collection from around 20 patients and 10 controls that we 
had acquired in India at the time, a power calculation using GPower statistical 
tool (Faul et al., 2007) suggested that with power of 0.08, we should aim to 
gather data from a further 36 patients and 15 controls.  
2.3.2 Healthy participants 
25 age and sex matched healthy controls to patients (17 male; average age: 
30.65; range: 18.16-60.5) were recruited from staff of INK or the accompanying 
family members. Results of the contrast detection task of one of the control 
participants (KC43) was missing at the time of analysis. 
2.3.3 Patients with epilepsy 
56 patients with confirmed epilepsy (37 male; average age: 33.7; range: 17.9-
64.6) were recruited based on their medical history and neurological 
examination from epilepsy clinics of the INK. Table 2 displays a full description of 
information regarding each patient. Results of the motion discrimination task of 
one of the controls in India (KP55) was missing at the time of analysis. The 
exclusion criteria were: patients were under 18 years old, patients who had 
epileptic seizures 24 hours prior to the test, patients who were suspected to only 
experience non-epileptic seizures, patients with significant visual impairment, 
and those with cognitive impairment sufficient to prevent them from providing 
informed consent.  
Patients were given instructions about the tasks and the research objectives, and 
were encouraged to ask questions. However, they were not asked about any 
history of depression or anxiety. The information regarding anti-epileptic drugs 
that were recorded for Indian patients was assessed by an independent 
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neurological clinician and was concluded that there is no significant difference 
between the prescribed drugs in Newcastle and India.  
 
2.3.4 Experimental protocol 
Patients were approached by the India based investigator (Ms. Swagata Sen) 
during their attendance at a routine out-patient appointment. They were given 
instructions prior to recruitment. A convenient time was arranged and possible 
questions were answered. The same protocol as in Newcastle was followed for 
motion direction and contrast discrimination tasks in India. An identical 
equipment to what was used in Newcastle was shipped to India (P1210 Compaq 
CRT (Cathode Ray Tube), Table 2.1). 
2.4 Visual psychophysics 
Before the invention of powerful techniques using computers, a common way to 
estimate a threshold in a contrast detection task was to display a stimulus on an 
oscilloscope and ask observers to manually change the contrast until the 
stimulus was “just noticeable” against the background (referred to as the 
method of adjustment) (Kingdom and Prins, 2010). However, nowadays 
“staircase methods” are mainly used which typically start with a high intensity, 
and the intensity of successive trials is then set based on the previous answer of 
the observer. The intensity is decreased until the observer makes a mistake, after 
which the intensity is increased in the subsequent trial. This will make an 
imaginary staircase that will “home in”, over relatively fewer trials, on the 
intensity that is close to the observer’s threshold (Pelli and Farell, 2010, Watson 
and Pelli, 1983, King-Smith et al., 1994, Treutwein, 1995). 
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Figure 2.1. An example of a psychometric function adopted from Kingdom and 
Prins (2010) showing data fitted with a logistic function which shows the 
threshold, defined as the stimulus value at which the performance gets 0.75. 
 
2.5 Apparatus 
Stimuli were created in MatLab (www.mathworks.com) with the Psychophysics 
toolbox called Psychtoolbox which interfaces between MatLab and the 
computer hardware (Brainard, 1997, Pelli, 1997).  Experiments were shown for 
all control subjects and 31 of patients with epilepsy on a 22inch P1210 Compaq 
CRT (Cathode Ray Tube) with 800×600 pixels resolution and frame rate of 160Hz. 
A DATAPixx Lite visual stimulator from VPixx Technologies 
(http://www.vpixx.com/products/visual-stimulators/datapixx-lite.html) was 
used to generate the visual stimuli with 12-bit pixel depth. A RESPONSEPixx 
tabletop (http://www.vpixx.com/products/response-boxes/tabletop.html) was 
used to record subject responses.  
For the purpose of testing subjects on a longitudinal basis, Samsung (model: 
XE700T1C) and Acer (model: TravelMate X313-M) tablets were used for 23 
patients (Table 2.1). 
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Table 2.1. Technical description of devices used to collect subjects’ responses 
 
Gamma correction was applied to perform grayscale calibration and linearization 
on monitors. This was necessary to precisely control the luminance on the 
screens. Each pixel on a monitor has a value between 0 (darkest) to 255 
(brightest). It is important that the same amount of increase in the pixel value 
results in the same increase in luminance emitted from the monitor, so that the 
response is linear. In most cases CRTs have a nonlinear response to input signal.  
The luminance is generally modelled as a power function of pixel value with an 
exponent called gamma (𝛾𝛾).  
𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿 =  𝐿𝐿𝑚𝑚𝑚𝑚𝑚𝑚 + (𝐿𝐿𝑚𝑚𝑚𝑚𝑚𝑚 − 𝐿𝐿𝑚𝑚𝑚𝑚𝑚𝑚) ∗ [𝑝𝑝𝐿𝐿𝑝𝑝𝐿𝐿𝑝𝑝 𝑣𝑣𝐿𝐿𝑝𝑝𝐿𝐿𝐿𝐿 − 𝑏𝑏𝑝𝑝𝐿𝐿𝐿𝐿𝑏𝑏𝑤𝑤ℎ𝐿𝐿𝑖𝑖𝐿𝐿 − 𝑏𝑏𝑝𝑝𝐿𝐿𝐿𝐿𝑏𝑏 ]𝛾𝛾 
Equation 2.1. Gamma is the power describing how fast the luminance rises as a 
function of pixel value. 𝐿𝐿𝑚𝑚𝑚𝑚𝑚𝑚 and 𝐿𝐿𝑚𝑚𝑚𝑚𝑚𝑚 represent luminance of black and white, 
respectively. Linearity is the case gamma=1. 
 
 
P1210 Compaq CRT 
(Cathode Ray Tube) Samsung XE700T1C 
Acer Travel Mate X313-
M 
Screen: 22 inch Screen: 11.6" touch screen Screen: 11.6" touch screen 
Resolution: 
800×600  Resolution: 1920 x 1080 Resolution: 1366 x 768 
frame rate: 160 Hz Frame rate: fps Frame rate: 17.5 fps 
Processor: Core i3, 
3.06 GHz Processor: Core i5, 1.7 GHz 
Processor: Core i5, 1.5 
GHz 
RAM: 4GB RAM: 4GB RAM: 4GB 
-  Storage Capacity: 128 GB SSD 
Storage Capacity: 120 GB 
SSD 
Windows Vista Windows 8 Pro 64-bit Windows 8 Pro 64-bit 
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Gamma (𝛾𝛾) can be calculated by making a table of pixel values versus luminance 
for the uncorrected monitor and then fitting a function in the form of 
Equation 2.1, where 𝐿𝐿𝑚𝑚𝑚𝑚𝑚𝑚  is the measured luminance when pixel value is set to 
black or 0 and  𝐿𝐿𝑚𝑚𝑚𝑚𝑚𝑚 is when pixel value is set to white or 255. 
To correct the nonlinearity, gamma correction applies a transformation to the 
graphic card (Cao et al., 2014, Eriksson et al., 1998) . Here, gamma was measured 
for the uncorrected monitor. Then the measured gamma was sent to the 
Psychtoolbox interface, so that in practice gamma was corrected to 1. 
Code displaying the drifting Gabor patch was programmed in MatLab using the 
Psychophysics Toolbox Version 3 (PTB-3) (Brainard, 1997, Kleiner et al., 2007, 
Pelli, 1997). For participants using the CRT, viewing was binocular at 100cm in a 
dimly-lit room (luminance reflected by a white sheet of paper in the room was 
about 0.8cd/m2).  Participants using tablets were instructed to perform tests in 
a dimly-lit room at distance set to 60cm. They were helped by the experimenter 
to find a suitable location.  
In order to test the effect of room ambient lighting on the measured thresholds, 
one control subject repeated motion discrimination task twice in three different 
ambient lighting conditions. Ambient lighting was measured by pointing a 
photometer towards the direction of the computer in a room with no source of 
light. A one-way ANOVA test was performed on the average of each condition 
(Table 2.2). Anova test showed no significant difference between groups in small, 
large duration thresholds and motion suppression index (For small duration 
thresholds: P=0.24, F=3.18; large duration thresholds: P=0.56, F=3.18; motion 
suppression index: P=0.478, F=1.09). However this difference might be due to 
within- and between-subject variabilities (Read et al., 2015). 
All room lighting measurements and gamma correction were performed using a 
Minolta photometer model Luminance Meter LS-100.  
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Table 2.2. Different measurements of ambient lighting and their corresponding 
duration thresholds and suppression index of one healthy subject 
Measured 
lighting 
Average of two 
small duration 
thresholds 
Average of two 
large duration 
thresholds 
Average of two 
motion 
suppression 
indices 
0.37 cd/m2 37.8345 
 
149.8025 
 
0.5994 
 
1.54 cd/m2 25.633 
 
132.269 
 
0.7127 
 
31.55 cd/m2 32.984 
 
107.514 
 
0.4918 
 
 
2.6 Motion direction discrimination task 
This protocol followed that described by Tadin et al. (2006), Tadin et al. (2003). 
Before each trial, there was 500ms during which a small fixation cross appeared 
and disappeared with a Gaussian temporal function with a standard deviation of 
80ms, to encourage participants to look at the centre. Then there was a 700ms 
interval during which the stimulus appeared and disappeared, with a Gaussian 
temporal function. The stimulus was a standard drifting Gabor patch, presented 
using CreateProceduralGabor function of Psychtoolbox-3 (Brainard, 1997, Pelli, 
1997). The stimulus always had its peak contrast halfway through the 700ms 
interval. 700ms was chosen as being long compared to the duration thresholds 
we expected, so that the temporal Gaussian would have time to rise smoothly 
from zero contrast and return to zero again within this window. A schematic of 
stimulus is shown in Figure 2.2. Gabor patches are commonly used in vision 
studies because they are localised in both frequency space and visual space. They 
are sinusoidal gratings within a temporal and spatial Gaussian window. Here 
different stimulus durations of Gabor patch was controlled by an adaptive 
staircase procedure. Participants were asked to distinguish the direction of 
motion of the drifting Gabor by pressing the left or right buttons on the 
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ResponsePixx box for the CRT, or touching the left or right side of the screen for 
the tablets (Figure 2.3). 
 
Figure 2.2. Schematic illustration of the motion discrimination task. A: Small 
stimulus with size 2σ=0.7⁰, B: large stimulus with size 2σ=5⁰. Stimulus was 
standard Gabor patch, a drifting vertical sine grating windowed by a Gaussian 
spatial envelope. Stimulus direction was rightward or leftward, and the task was 
to identify this moving direction. 
 
Figure 2.3. A schematic of the motion discrimination task. The stimulus appears 
and disappears, with a Gaussian temporal function. 
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The envelope was stationary on the screen, but the carrier sine wave moved 
horizontally at constant speed. The carrier spatial and temporal frequencies 
were 1 cycle per degree and 2 cycles per second (Hz) respectively, resulting in a 
speed of 2 degrees per second. Stimuli appeared within a temporal Gaussian 
envelope, so the stimulus contrast rose up from zero to a peak value which is the 
“Contrast” and then down again. Two different stimulus contrasts were used: 
“high contrast” (peak contrast = 92%) and “low contrast” (peak contrast = 2.8%). 
“Duration” of the stimulus was defined as twice the temporal Gaussian standard 
deviation, 2τ.  
Each trial was set to last 10τ, with the peak contrast occurring halfway through. 
This means that the total time taken by each trial depends on the value of τ. This 
was done so that the temporal Gaussian was never truncated; stimuli always 
began with zero contrast at the beginning of a trial rather than appearing 
abruptly. τ was constrained to lie in the range 10-1000ms if the staircase wanted 
to choose values outside this range. Size of the stimulus was defined as twice the 
spatial standard deviation of the Gaussian envelope (2σ), and used two different 
sizes, small stimuli with size of 2σ=0.7o and large stimuli with the size of 2σ=5o. 
Task difficulty was modulated by altering stimulus duration.  
2.6.1 Experimental protocol 
Patients were given instructions (Appendix 4) about the experiment and 
research question prior to recruitment, and were encouraged to ask questions. 
Control participants completed the entire task at one visit. Patients who did the 
tasks only once completed the tasks in a single appointment; however 
experiments were repeated multiple times over a longer period of time for 
longitudinal patients. The length of participation in the study was dependent on 
the number of seizures they experienced. They were encouraged to carry on till 
2 or more than 2 seizures were reported, however in some cases no seizure was 
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reported. All participants could ask for a break within each trial and also in 
between the tasks. The overall time to complete experiment was around 20 
minutes for controls and single visit patients, but for longitudinal patients this 
time was shortened to 10 minutes by reducing the number of repeat trials in the 
test.  
2.6.2 Psychophysical task 
“Surround suppression index” was introduced by Tadin et al. (2006) to measure 
the power of centre-surround suppression at high contrast. This term is defined 
as the logarithm of the ratio of the duration thresholds T for large and small 
stimuli: 
 
Motion suppression index =  log10�Tlarge −  Tsmall� =  log10 �TlargeTsmall� 
Equation 2.2. Motion suppression index was introduced, in order to quantify the 
amount of suppression. Duration thresholds of large and small stimuli are 
denoted by T. 
  
A positive motion suppression index shows that the large duration threshold is 
bigger than small duration threshold (shorter duration thresholds for small 
stimuli), whereas a negative index shows shorter duration thresholds for larger 
stimuli, which is indicative of spatial summation (Anderson & Burr, 1991). A 
motion suppression index of one show equal durations. Equation 2.2 can also be 
used in low contrast in which case it is called “motion summation index” and is 
usually negative.  
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2.7 Contrast detection task 
The stimuli is adapted from Serrano-Pedraza et al. (2012), which is a combination 
of what Yoon et al. (2010), Cannon and Fullenkamp (1991), and Petrov et al. 
(2005) have used. An example of the stimulus is shown in Figure 2.4. There is a 
large sinusoidal luminance grating at the background with spatial frequency of 
1.1 cycles per degree, contrast of 25%, diameter of 18°, and orientation of ±45° 
to the vertical. Four circular holes located on cardinal directions and centred on 
an eccentricity of 4.2° with diameter of 2.3° were cut out from the large 
background grating. On each trial one of these holes (target) was filled with the 
stimulus which was a sinusoidal grating with the same diameter as the hole and 
the same spatial frequency as the large background grating. The stimulus was 
presented within a temporal Gaussian window with standard deviation of 50ms. 
All gratings and holes were presented within a 10th-order Butterworth window 
in order to get smooth edges. At the start of each trial, a rotating fixation cross 
was shown at the centre of the screen for 500ms. A schematic of the process of 
presenting the stimulus is shown in Figure 2.5. The task was to detect the 
position of the target by choosing one of four buttons on the ResponsePixx box 
(for those who used the CRT), or touching the area surrounded by the target. 
This location and the orientation of the background were changed randomly on 
each trial. The target could have two orientations: parallel or orthogonal to 
surrounding background. The difficulty of the task was modulated by changing 
the contrast of target, which is the peak contrast within the temporal Gaussian 
window. 
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Figure 2.4. Schematic illustration of the contrast detection task. A: Stimulus with 
an orthogonal surround. B: Stimulus with a parallel surround. Task was to detect 
the location of the target appearing in one of the four holes in the periphery.  
 
Figure 2.5. A schematic of the contrast detection task. 
 
42 
 
2.7.1 Experimental protocols 
The contrast detection task was typically started after the motion discrimination 
task. For participants using tablets, the order of tests was randomly switched. 
The overall time to complete this task was around 10 minutes for controls and 
single visit patients, but for longitudinal patients this time was shortened to 5 
minutes.  
2.7.2 Psychophysical task 
A “Contrast suppression index” analogous to the motion suppression index was 
defined to measure the strength of centre-surround suppression for parallel and 
orthogonal conditions. This term was defined as the logarithm of the ratio of the 
contrast thresholds C for parallel and orthogonal conditions: Contrast suppression index =  log10�Cparallel −  COrthogonal�=  log10 � CparallelCOrthogonal� 
Equation 2.3. Contrast suppression index was introduced to quantify the amonut 
of suppression. Contrast thresholds of parallel and orthogonal stimuli are 
denoted by C. 
 
In this task, contrast thresholds for target surrounded by a grating of the same 
orientation (parallel) are usually higher than for those with an orthogonal 
surrounding grating (Ejima and Takahashi, 1985, Lev and Polat, 2011, Petrov et 
al., 2005, Polat and Sagi, 1993, Serrano-Pedraza et al., 2012, Snowden and 
Hammett, 1998b, Xing and Heeger, 2000, Yu and Levi, 2000).  
 
2.8 Orientation discrimination task 
This experiment was adopted from Edden et al. (2009b). An example of this 
experiment is seen in Figure 2.6. On each trial two circular gratings with two 
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different orientations were shown on the tablet screen. The mean orientation of 
the gratings was set to 45°.Participants were asked to determine if the second 
grating was tilted clockwise or counter clockwise relative to the first. Participants 
were instructed to give their responses by touching the right or left side of the 
screen.  
 
 
 
 
 
 
 
 
Figure 2.6. Schematic illustration of the orientation discrimination task. The 
grating has frequency of 0.02 cycle per degree and size of 1.47 degree. A is a 
grating with rotation of 10 and B with 35 degrees. 
 
2.8.1 Experimental protocol 
On each trial two circular gratings with diameter of 1.47° and spatial frequency 
of 0.02 cycle/degree were shown for 350ms on the tablet screen.  
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2.9 Data analysis 
In order to analyze the psychophysical data, programmes were run in the 
MATLAB environment. For statistical analysis Microsoft office 2013 (such as 
Excel), MATLAB built-in functions and IBM SPSS (Multiple regression analysis, 
Analysis of covariance, Analysis of variance, non-parametric tests) were used. 
The specific tool will be mentioned as I present the results. 
Some of the data throughout this thesis will be presented as a boxplot (shown in 
Figure 2.7).  
 
Figure 2.7. The distribution of data can be displayed as a boxplot based on the 
minimum, 75% quartile, median, 25% quartile and maximum. 
 
Boxplots provide a visualised way of demonstrating the distribution of data using 
z-scores. By definition z-score indicates how many standard deviations a data 
point is away from the mean.  
𝑧𝑧 = 𝑆𝑆𝑆𝑆 − 𝜇𝜇
𝜎𝜎
 
Equation 2.4. Calculating the z-score of suppression indices (SI) of each individual 
where 𝜇𝜇 is the mean and 𝜎𝜎 is the standard deviation. 
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These numbers can then be plotted in boxplots as bee swarm plots (plot spread 
points) using MatLab to present the spread of data points, outliers and the 
median in each group. 
 
2.9.1 Measurement of estimate of motion and contrast threshold 
Evaluating psychophysical thresholds can be achieved using adaptive or non-
adaptive methods (King-Smith et al., 1994). In adaptive methods, the intensity 
of each trial depends on the previous response (Falmagne, 1986). A correct 
response makes the next intensity get higher, while a wrong response results in 
a reduced intensity. When there is high uncertainty about the threshold, 
adaptive methods are recommended (King-Smith et al., 1994), as they are 
designed to present stimuli with most intensities close to threshold (Watson and 
Fitzhugh, 1990, Treutwein, 1995).  
Adaptive methods can be in different types, such as a simple staircase 
(Cornsweet, 1962) in which stimulus intensities are increased or reduced in fixed 
steps, or trials defined in set blocks of intensity (Taylor and Creelman, 1967, 
Findlay, 1978), or maximum likelihood (Hall, 1968, Pentland, 1980, Watson and 
Pelli, 1983) in which after each trial the most likely threshold is estimated and 
used as the intensity for the next trial.  
Maximum likelihood offers high efficiency among other types of adaptive 
threshold methods, and the final threshold is the most likely estimate of 
threshold after the last trial (King-Smith et al., 1994). The best known maximum 
likelihood method is the Quest method (Watson and Pelli, 1983). In Quest, the 
experimenter`s knowledge about the probability of different threshold values is 
taken into account. This is known as the initial probability density function (pdf), 
and the mode of this pdf is chosen as the first stimulus intensity. Based on the 
answer to the first stimulus, next stimulus intensity is chosen. Watson and Pelli 
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(1983) showed that the pdf after trial i, 𝑞𝑞𝑚𝑚(𝑇𝑇), is the product of previous pdf with 
the corresponding likelihood function using Bayes’ theorem. Given T as the log 
threshold: 
 
𝑞𝑞𝑚𝑚(𝑇𝑇) = 𝑝𝑝(𝑟𝑟𝑚𝑚 ,𝑝𝑝𝑚𝑚 ,𝑇𝑇)𝑞𝑞𝑚𝑚−1(𝑇𝑇) 
Equation 2.5. 𝑞𝑞𝑚𝑚(𝑇𝑇) is the pdf after trial i,  𝑝𝑝(𝑟𝑟𝑚𝑚 ,𝑝𝑝𝑚𝑚 ,𝑇𝑇) is the likelihood function 
and the probability that the subject gives response 𝑟𝑟 (1 for a correct response 
and 0 for an incorrect response) to a stimulus with intensity 𝑝𝑝𝑚𝑚, and 𝑞𝑞𝑚𝑚−1(𝑇𝑇) is 
the pdf of the previous response. 
 
While in the original paper of Watson and Pelli (1983) method of choosing the 
stimulus intensity of each trial was preferred to be the mode of the pdf, here 
mean of the pdf was used (ZEST method). ZEST is believed to be more efficient 
and precise for finding the threshold (King-Smith et al., 1994, Alcala-Quintana 
and Garcia-Perez, 2004). 
Here duration and contrast thresholds were measured using 2 or 3 randomly 
interleaved adaptive Bayesian staircases (Treutwein, 1995) with each containing 
50 or 30 trials. In the case of longitudinal study, 30 trials with 2 staircases were 
used to reduce the time of experiment. The code for this section was written in 
MatLab by a previous post doctorate research associate of Dr. Read (Dr. Ignacio 
Serrano-Pedraza). I used this code and made occasional changes at different 
stages of the study. 
Psychometric function (𝜓𝜓) refers to the probability of success against the 
stimulus level, here the stimulus duration (Treutwein, 1995, Luce and 
Krumhansl, 1988, Baird and Noma, 1978).  It is also important to account for the 
events that are higher than the threshold, but the participant fails to notice them 
(lapse rate or 𝑝𝑝𝑙𝑙) and events that are below the threshold, but the participant 
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answers correctly (guess rate or 𝑝𝑝𝑔𝑔). Considering all these parameters a 
psychometric function can be estimated using (Whichmann and Hill, 2001): 
𝜓𝜓 =  𝑝𝑝𝑔𝑔 + �1 − 𝑝𝑝𝑔𝑔 − 𝑝𝑝𝑙𝑙� ∗ 𝐹𝐹(𝑝𝑝) 
Equation 2.6. Psychometric function (𝜓𝜓). 𝑝𝑝𝑔𝑔 is the guess rate, 𝑝𝑝𝑙𝑙 is the lapse rate 
and 𝐹𝐹(𝑝𝑝) is a choice of sigmoid function for the stimulus intensity x. 
 
This psychometric function was fitted to all trials collected for each participant 
to estimate duration thresholds (Figure 2.8). To model 𝐹𝐹(𝑝𝑝), a logistic function 
was used to define the probability that each participant correctly discriminates 
the direction of the motion for stimulus duration of τ (Equation 2.7) in motion 
discrimination task and the correct contrast of stimulus τ for the contrast 
detection task.  
𝐹𝐹(𝜏𝜏) = 1[1 + exp�b(a − lnτ)�] 
Equation 2.7. Logistic psychometric function. 𝜏𝜏 is the stimulus duration. This 
function has two parameters. Parameter “a” defines how steeply the function 
rises as it passes through its midpoint, and parameter “b” determines the 
intercept of the function. Here “b” was set to 10, and duration threshold was 
estimated by calculating parameter “a”. 
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Figure 2.8. Schematic example of obtaining participants` responses either 
correct or wrong (in blue circles) to motion discrimination task in different 
stimulus durations at three different conditions: correct, chance (50%), and 
wrong. In order to find the overall trend of data, moving average of data points 
was plotted in solid blue line. Green solid line is the fitted psychometric function. 
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Figure 2.9. Schematic illustration of obtaining participants` responses (in blue 
circles) to contrast detection task in different stimulus contrasts at three 
different conditions: correct, chance (25%), and wrong. The blue solid line is the 
moving average of all correct and wrong responses for each stimulus contrasts. 
Green solid line is the fitted psychometric function. 
 
With substitution of 𝐹𝐹(𝜏𝜏) in Equation 2.8:  
𝜓𝜓(𝜏𝜏) = 𝑝𝑝𝑔𝑔 + 1 − 𝑝𝑝𝑔𝑔 − 𝑝𝑝𝑙𝑙1 + exp�b(a − lnτ)�  
Equation 2.8. A logistic psyhometric function where 𝑝𝑝𝑔𝑔 is the guess rate, 𝑝𝑝𝑙𝑙 is the 
lapse rate, The initial estimate of a and b were set to mean log of stimulus 
intensity and 10, respectively. For motion discrimination task 𝑝𝑝𝑔𝑔 was set to 50% 
or 0.5 since we used a 2-alternative paradigm. For contrast detection task 𝑝𝑝𝑔𝑔 was 
25% or 0.25 since we used a 4-alternative paradigm.  The lapse rate 𝑝𝑝𝑙𝑙 was set 
to 0.01 for both tasks.  
 
Duration threshold 𝜃𝜃 was defined as the minimum time that each participant 
needed to correctly identify the direction of the moving stimuli on 82% of trials. 
The 82% value is the value that was used in Tadin et al. (2003) and Watson and 
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Pelli (1983) (From equation 13 page 116). Likewise, contrast threshold 𝜃𝜃 was 
defined as the minimum contrast that each participant needed to correctly 
detect the contrast of the target stimuli on 62.5% of time. The 62.5% value was 
chosen as it is half way from chance (25%) to perfect (100%). 
If 𝜓𝜓(𝜏𝜏) = 82% or 62.5 % = t, then: 
𝑖𝑖 = 𝑝𝑝𝑔𝑔 + 1 − 𝑝𝑝𝑔𝑔 − 𝑝𝑝𝑙𝑙1 + exp�b(a − lnθ)� 
Equation 2.9. 
Therefore:  
𝑏𝑏(𝐿𝐿 − 𝑝𝑝𝐿𝐿𝜃𝜃) = ln [1 − 𝑝𝑝𝑔𝑔 − 𝑝𝑝𝑙𝑙
𝑖𝑖 − 𝑝𝑝𝑔𝑔
] 
Equation 2.10. 
To estimate the value of threshold (𝜃𝜃), MatLab function fminsearch was used to 
determine the amount of “a” which maximizes the likelihood of a correct 
response (Read et al., 2015). 
 
2.9.2 Measurement of confidence intervals- bootstrap resampling 
Bootstrap resampling was used to extract 95% confidence intervals for the fitted 
thresholds. 10,000 resampled data with replacement from the total number of 
trials was generated. The threshold θ was then fitted to this new data set and 
95% confidence interval on θ was extracted from 2.5% and 97.5% percentiles in 
the resampled fits. 
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2.9.3 Measurement of estimate of orientation threshold 
Orientation discrimination thresholds were measured using Quest toolbox from 
MatLab (Quest) which implements Quest Bayesian (Watson and Pelli, 1983). For 
the orientation discrimination task, the same staircase stimulus selection was 
used, however a different approach for estimating the threshold was used 
(Quest). I wrote the entire code in MatLab as a pilot study. 
 In order to use the toolbox, first a structure with necessary information to create 
a Weibull psychometric function (Equation 2.11) was created using QuestCreate 
function.  
𝑝𝑝𝑇𝑇ℎ𝑟𝑟𝐿𝐿𝑟𝑟ℎ𝑜𝑜𝑝𝑝𝑜𝑜 = 𝑝𝑝𝑙𝑙 ∗ 𝑝𝑝𝑔𝑔 + (1 − 𝑝𝑝𝑙𝑙) ∗ (1 − �1 − 𝑝𝑝𝑔𝑔� ∗ 𝐿𝐿−10𝛽𝛽∗(𝑥𝑥−𝑥𝑥𝑥𝑥ℎ𝑟𝑟𝑟𝑟𝑟𝑟ℎ𝑜𝑜𝑜𝑜𝑜𝑜)) 
Equation 2.11. Weibull distribution 
The Weibull parameters were set to the following: 𝛿𝛿 = 0.01 (lapse rate), 𝑝𝑝𝑔𝑔= 0.5 
(chance rate), 𝛽𝛽 = 3.5. Then, using this prior knowledge a number of trials were 
shown, and the observer`s response and the actual intensity were reported to 
another function (QuestUpdate). Information was saved in a structure and 
eventually at the end of the trials, Quest provided a final threshold estimate 
(using QuestMean and QuestSd) which was the mean and standard deviation of 
the pdf (Farell and Pelli, 1999, Watson and Pelli, 1983).  
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Chapter 3  Relationship between different psychophysical measures of 
surround suppression 
 
3.1 Introduction 
Psychophysical properties of surround suppression have been widely studied for 
several decades (Barlow and Mollon, 1982). These studies have used several 
forms of psychophysics to measure different thresholds such as contrast, 
duration, and orientation. Fascinating findings such as longer duration of time 
needed to perceive the direction of a large moving stimulus in compare to a 
smaller size (Tadin et al., 2003), or the decreased perceived contrast of a stimulus 
surrounded by another stimulus (Andriessen and Bouma, 1976, Cannon and 
Fullenkamp, 1991, Petrov et al., 2005, Snowden and Hammett, 1998a), are 
believed to be instances of psychophysical surround suppression. These findings 
are thought to be the perceptual correlate of inhibitory neuronal mechanisms in 
visual cortex (Tadin et al., 2003).  
The apparent psychophysical measures of surround suppression are linked to 
different parts of visual cortex. For example, discrimination of direction of a 
drifting grating is attributed to surround suppression processing in V5 (MT) 
(Tadin et al., 2003), or contrast detection of a visual stimulus surrounded by a 
different stimulus is attributed to surround suppression in V1 (Zenger-Landolt 
and Heeger, 2003). While a lot of studies have used these psychophysical 
phenomena as a way of understanding the underlying pathology of different 
clinical conditions, such as schizophrenia (Yoon et al., 2010, Yoon et al., 2009, 
Chen et al., 2008, Robol et al., 2013, Serrano-Pedraza et al., 2014, Tibber et al., 
2013, Yang et al., 2013a), autism (Flevaris and Murray, 2014, Foss-Feig et al., 
2013, Koldewyn et al., 2010), and migraine (Battista et al., 2010, Battista et al., 
2011), a number of them have found conflicting results. For example, Tadin et 
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al. (2006) found weakened centre-surround interactions in patients with 
schizophrenia, although Chen et al. (2008) reported increased surround 
suppression in patients with schizophrenia relative to matched controls. As 
Tibber et al. (2013) discussed, the problem lies in the fact that most of these 
studies usually use different psychophysical tests and diverse patients groups. In 
fact, one study by Yang et al. (2013a) used a similar methodology and patient 
group to test psychophysical thresholds on luminance, contrast, orientation, size 
and motion, and surprisingly only found decreased contrast surround 
suppression in the patient group compared to controls, suggesting no significant 
correlation between different measures of surround suppression in 
schizophrenia. The same group tested patients with bipolar disorder across 
similar visual tasks (Yang et al., 2013b), and found no significant difference in any 
of the psychophysical contextual tasks among patients and controls.  
Psychophysical tasks have also been investigated to understand visual 
processing in senescence (Betts et al., 2009, Betts et al., 2005, Betts et al., 2012). 
While there is a broad age-related decrease in surround inhibition strength, 
studies done by Karas and McKendrick have shown that perceptual centre-
surround inhibition of contrast is greater for older adults (61-84 years) than for 
younger people (18-33 years) (Karas and McKendrick, 2011, Karas and 
McKendrick, 2009, Karas and McKendrick, 2012, Karas and McKendrick, 2015).  
The main question here is whether these different psychophysical measures 
reflect a single property of visual cortex, or each is an assessment of inhibition 
related to different areas of the visual cortex. Differences between patients and 
healthy control groups have been linked to altered GABA-ergic inhibition (Yoon 
et al., 2010, Tadin et al., 2006, Betts et al., 2005). One such patient groups with 
altered GABAergic inhibition includes people with epilepsy (Bromfield et al., 
2006, Calcagnotto et al., 2005). The seizure onset might be within a distinct 
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location of the cortex. However, the activity can spread to engage other areas, 
and this is thought to reflect the quality of inhibitory restraint shown in these 
secondary territories (Trevelyan et al., 2006, Schevon et al., 2012, Trevelyan and 
Schevon, 2012). Patients with epilepsy can be diagnosed with focal seizures 
(within a discrete location of the cortex) or generalised seizures. An interesting 
possibility is that visual psychophysics may provide a way of assessing the 
inhibitory restraint mechanism, even in patients with epilepsy arising outside the 
visual cortex. On the other hand, if changes in GABA concentration occur 
independently between different regions of cortex, then different metrics of 
psychophysical surround suppression could potentially yield different results, 
which may be a possible cause of discrepancies in literature. There is no 
published study at this time about measures of surround suppression in epilepsy 
and visual psychophysics in the literature. I will show results of patients and 
healthy control groups in chapter 4. 
In this chapter, I will discuss the relationship between motion and contrast 
suppression indices in a group of 36 healthy volunteer subjects (10 male; mean 
age: 42.3; range: 19.4-69.1), first to provide a benchmark for comparison with 
data from patients with epilepsy, which will be described in subsequent 
chapters. Participants had normal, or corrected to normal, visual acuity. They 
were recruited from Newcastle University data base of volunteer participants. 
This is a sub-section of the whole control population, as only thirty six control 
participants completed both direction discrimination and contrast detection task 
at the same visit and on the same equipment. 
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3.2  Results 
3.2.1 Longer duration thresholds for large grating in high contrast, but 
shorter in low contrast 
Duration thresholds were measured from 36 healthy control participants. 
Figure 3.1 shows a plot of duration thresholds on the motion discrimination task 
as a function of age. The top panels in Figure 3.1 show thresholds for high 
contrast stimuli; the bottom panels of Figure 3.1 (C-D) for low contrast stimuli. 
In high contrast, duration thresholds were longer for large stimuli than for small, 
meaning that it took longer time for participants to discriminate the moving 
direction of the stimulus when it is larger. This was reversed for low contrast 
stimuli, where participants showed longer duration thresholds for small 
stimulus, which means that shorter duration of time was needed to accurately 
perceive the large stimulus. Duration thresholds significantly increased with age 
in small high contrast stimuli (p=0.02, Figure 3.1 B) and in small low contrast 
stimuli (p=0.0009, Figure 3.1 D). 
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Figure 3.1. Plot showing duration thresholds as a function of age on log axes for 
36 healthy participants for the motion discrimination task. A is large high 
contrast (92%), B small high contrast (92%), C large low contrast (2.8%), and D 
small low contrast (2.8%). Error bars show 95% confidence intervals. The black 
solid lines show significant regression with age, and dashed lines non-significant 
regression with age. R2 and p values are shown in each panel. 
 
3.2.2 Magnitude of motion suppression declines with age, while the 
magnitude of motion summation increases 
Motion suppression and motion summation indices (Equation 2.2) were plotted 
as a function of age (Figure 3.2). Both motion indices showed a significant 
decrease with age (p=0.01 for both motion suppression and summation index). 
However, the effect of age on the magnitude of each index was opposite. Motion 
suppression indices were mainly positive in youth declining towards zero in age, 
while motion summation indices were near zero in youth declining towards more 
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negative numbers in age. This means that the magnitude of motion suppression 
decreases with age, while the magnitude of motion summation increases. 
Motion suppression indices were mainly positive, and motion summation indices 
negative, meaning that while the magnitude of motion suppression index 
decreases with age, the magnitude of motion summation index increases with 
age, that is summation index was stronger in older participants. Moreover, as 
duration thresholds for large and small low contrast were very close (Figure 3.1), 
spatial summation was nearly absent in younger participants (Figure 3.2 B).  
Figure 3.2. Motion-discrimination task: index is log ratio of large/small duration 
thresholds, shown for 36 subjects as a function of age. (A) Suppression index for 
high contrast stimuli; (B) summation index for low contrast stimuli. As before, 
error-bars show 95% confidence intervals, and the black line is the regression 
line.  The solid horizontal line shows index=0, i.e. thresholds are the same for 
large vs small stimuli. The inner and outer dashed lines mark values of the index 
where thresholds differ by a factor of 2 and 4 respectively. The fitted regression 
lines are: (A) Index=-0.006*(Age in years)+ 0.65 and (B) Index =-0.0085*(Age in 
years) +0.04. R2 and p values are marked in each panel. 
 
Betts et al. (2005) showed similar results of decline in their population for a 
motion discrimination task, with a slope of 0.004 per year and average of around 
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0.02 at 23 years old and 0 at 68 years old. Motion suppression index was 
fractionally higher than what Betts et al found at around 0.5 at 25 years with a 
slope of 0.006 per year (Figure 3.2 A).  Summation index also declines with age 
at a similar rate (0.008 per year; Figure 3.2 B). This decline is slightly sharper than 
that implied by the difference between the “younger” and “older” groups of 
Betts et al. (2005).  
Motion suppression and motion summation indices both decrease with age, 
suggestive that they may be positively correlated. No such correlation was 
found, though, when the paired indices from individuals were plotted 
(Figure 3.3).  The plot shows a positive slope, but the regression line between 
the two is non-significant (p= 0.16). Figure 3.3 also showed that most observers 
lay in the bottom right quadrant, which means that they show motion 
summation at low contrasts, and motion suppression at high contrasts. 
Nevertheless, even though the relationship between the two indices was not 
significant, participants with the highest motion suppression index showed 
lowest motion summation index (they tend to be younger). Also, those with the 
least suppression showed the highest magnitude of summation indices (and they 
are older). 
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Figure 3.3. Scatter-plot of motion summation index against suppression index 
for 36 subjects. R2 and p values for the Pearson correlation coefficient are 
marked in the box. The green line shows the regression line, fitted assuming that 
both variables are subject to the same amount of error (Draper and Smith, 1998). 
The slope of this regression also did not differ significantly from zero. The solid 
black lines show index = 0. 
 
3.2.3 Significant correlation between motion discrimination task and age, but 
not for the contrast detection task 
While Figure 3.2A shows a significant correlation between motion suppression 
index and age, there was no significant relationship between contrast 
suppression index and age. Figure 3.4 shows that contrast suppression index 
(Equation 2.3) had no correlation with age for 36 participants (R2=0.003, p=0.75). 
The surround suppression index was 0.56 ± 0.2 (mean ± population SD). The fact 
that contrast suppression index is independent of age comes from a roughly 
equal increase in both parallel and orthogonal surround thresholds with age 
(Figure 3.5), which means the ratio of thresholds stays constant. Figure 3.5 shows 
that contrast thresholds increase with age in both (A) parallel and (B) orthogonal 
60 
 
conditions, however this increase was only significant for orthogonal surround 
(p=0.006). 
Figure 3.4. Contrast suppression index of the contrast detection task for 36 
subjects as a function of age. Error-bars show 95% confidence intervals, and the 
black dashed line is the regression between contrast suppression index and age. 
There is no significant relationship between age and surround index (p=0.75). 
Figure 3.5. Contrast thresholds for the contrast detection task, plotted against 
age, when the background grating was (A) parallel or (B) orthogonal to the 
target. Error-bars show 95% confidence interval. Solid line is where the 
regression with age was significant, dashed line where it was non-significant. R2 
and P values are marked in each panel. The fitted regression lines are (A) log10 
(threshold) =0.003*(Age in years) + 0.57; (B) log10 (threshold) =0.004*(Age in 
years) -0.02. 
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3.2.4 Motion suppression and contrast suppression indices are not correlated 
between individuals 
I then asked if there was a relationship between motion suppression and 
contrast suppression indices. For each individual who participated in both tasks 
they were plotted all against each other. If both indices measured the same 
underlying quantity, points should be scattered around the line of equality. 
Figure 3.6 depicts this relationship for 36 participants with the black solid line 
representing the line of equality. The population means and standard deviations 
were relatively similar for both suppression indices, 0.40 (SD=0.22) for the 
motion discrimination task, and 0.56 (SD=0.19) for the contrast detection task, 
but critically, the two suppression indices were not correlated with one another. 
Green dashed line shows non-significant regression line (p=0.24). 
Figure 3.6. Scatter plot of surround suppression index of motion discrimination 
task compared to contrast detection task for 36 participants. The dashed line is 
the regression line (p=0.24) and the solid black line indicates the line of equality. 
There is no significant correlation between motion discrimination SI and contrast 
detection SI (correlation coefficient RHO= -0.1978, p=0.24). 
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3.2.5 No significant relationship between motion suppression and contrast 
suppression indices with orientation discrimination threshold between 
individuals 
The important role of GABAergic inhibition is well documented in orientation 
selectivity (Allison and Bonds, 1994, Hubel and Wiesel, 1962, Blakemore and 
Tobin, 1972). Moreover, there is a strong link between orientation 
discrimination performance and GABA concentration (Edden et al., 2009a, 
Ferster et al., 1996, Ferster and Miller, 2000).  
A study done by Edden et al. (2009a) showed that individual performance on a 
task of orientation is correlated with resting concentration of GABA in the 
primary visual cortex (V1). Concentration of GABA measured by magnetic 
resonance spectroscopy was significantly negatively correlated with orientation 
thresholds for obliquely oriented patterns. They showed for the first time that 
individual performance on a visual psychophysics task could be linked to GABA 
concentration in humans. We argued that if motion and contrast suppression 
indices are ways of assessing cortical inhibition, then it might be possible to 
compare them with an orientation task. Therefore, we used a similar test to that 
of Edden et al. (2009a) as a pilot study to further investigate the relationship 
between different psychophysical surround suppression tasks. Orientation 
discrimination threshold was used for seven healthy participants. Correlation 
analysis between motion suppression index and orientation discrimination 
threshold proved to be non-significant (Figure 3.7 A, a negative trend with 
p=0.63). Similar behaviour was observed for contrast suppression index and 
orientation threshold with a non-significant regression line (Figure 3.7 B, 
p=0.55). However, with only 7 subjects and lack of power it is not possible to rule 
out a correlation.  
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Figure 3.7. Scatter plot of motion suppression index (A) and contrast suppression 
index (B) against orientation discrimination threshold for 7 healthy participants. 
The dashed black line is the non-significant regression line, fitted assuming that 
both variables are subject to the same amount of error (A: p=0.63, B: p=0.55) 
(Draper and Smith, 1998). 
 
3.2.6 Significant difference in suppression indices between female and male 
participants in the contrast detection task only 
There are a number of studies suggesting the possibility of gender differences in 
the structure of V5/MT (Amunts et al., 2007). A study by Cohn et al. (1985) 
indicated that a strong stimulus to V5/MT produced larger amplitudes in young 
female participants compared to young males with differences weakening with 
increasing age (age range: 5-14 years old). Regional specific differences between 
men and women, and lower BOLD amplitudes in women were reported in a fMRI 
study (Kaufmann et al., 2001). A pattern reversal study showed that the P1 
component of the visual-evoked potential was considerably shorter in female 
than male infants (Malcolm et al., 2002). Central field stimulation produced a 
larger right than left-hemispheric response in females, whereas males had only 
nonsignificant larger left hemisphere event-related potentials, suggesting a 
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greater right-hemispheric responsiveness to moving stimuli in females 
(Andreassi and Juszczak, 1982). 
To assess the effect of gender on suppression indices, average of motion 
suppression index (Figure 3.8; green) and contrast suppression index (Figure 3.8; 
red) were plotted for female and male participants. The bar chart shows 26 
female and 9 male mean suppression indices for motion discrimination task in 
green, and contrast detection task in red. Average age of female participants was 
43 years old and 40 years old for male. The significant difference is only among 
men and women in contrast detection task (p=0.02). In order to find differences 
in means of multiple groups, one-way ANOVA test was applied. ANOVA only 
shows if there is any significant difference between groups. Then, post hoc 
comparison procedures should be conducted to find where the significant 
difference is. However this will not tell any information regarding the p values. 
In this case pair wise comparisons between means must be applied. On the other 
hand, this might increase the risk of Type 1 error, which is the probability of 
rejecting the null hypothesis by mistake. To address this issue, Bonferroni 
correction was used. The significant p value after Bonferroni correction is 0.02 
(0.05/2). As a result, p=0.02 is survived after the Bonferroni correction and is in 
fact a significant difference.  
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Figure 3.8. Bar chart of motion suppression indices is shown in green for male 
and female participants (26 female, 9 male), and in red for contrast suppression 
indices. There was no significant difference between female and male in motion 
suppression task (p=0.41). There was a significant difference among female and 
male in contrast detection task (p=0.02). Error bars are standard error of mean. 
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3.3 Discussion 
Surround suppression is found in many visual cortical areas, for example in 
primary visual cortex V1 (Allman et al., 1985a, Sengpiel et al., 1998, Sengpiel et 
al., 1997), secondary visual cortex V2 (Shushruth et al., 2009), and V5/middle 
temporal (Allman et al., 1985a, Huang et al., 2007, Huang et al., 2008, Tsui and 
Pack, 2011). This has led to the assumption that surround suppression is a 
fundamental property of visual system, and consequently a vast number of 
studies have focused on measuring psychophysical properties of surround 
suppression. Recently, a growing number of studies have used changes in 
psychophysical surround suppression between healthy subjects and different 
patients groups to provide clinically useful information. For example, Tadin et al. 
(2006) used motion suppression index, and found patients with schizophrenia 
had lower suppression index compared to controls. They found patients had 
significantly higher thresholds for small stimulus compared to controls, but had 
similar thresholds for large stimulus, causing their suppression index to be lower. 
Given that GABA is the main neurotransmitter underlying cortical inhibitory 
mechanisms, and there is a good body of evidence on deficits of GABAergic 
system in schizophrenia in the literature, they speculated the possibility of the 
role of GABA deficits in the observed abnormality in surround suppression in 
schizophrenia (Wassef et al., 2003, Tadin et al., 2006). In fact, using Magnetic 
Resonance Spectroscopy (MRS), Yoon et al. (2010) showed lower concentration 
of GABA (10% lower) in visual cortex of patients with schizophrenia (Yoon et al., 
2010). A number of studies in human subjects and animals showed that this may 
be a result of reduced transcription of the 67 kDa isoform of glutamic acid 
decarboxylase (GAD67) within parvalbumin-staining cortical neurons (PV) 
(Akbarian et al., 1995, Yoon et al., 2010, Hashimoto et al., 2008, Hashimoto et 
al., 2003, Chattopadhyaya et al., 2007, Asada et al., 1997). Yoon et al. (2009) and 
Serrano-Pedraza et al. (2014) showed altered contrast suppression in patients 
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with schizophrenia. A study on motion discrimination task in patients with major 
depressive disorder also reported lower suppression indices (Golomb et al., 
2009), and suggested that this was reflecting a deficit in GABAergic inhibition in 
these patients. In another study by Edden et al. (2009a) the importance of 
GABAergic inhibition in orientation selectivity was demonstrated, and showed 
that interindividual performance on an orientation discrimination task is related 
to GABA concentration. Using magnetic resonance spectroscopy (MRS) they 
demonstrated that differences in performance were correlated with the resting 
GABA concentration within an individual`s primary visual cortex (V1). In other 
words, orientation discrimination threshold may be a way of assessing cortical 
inhibition. Thus, in all these papers the suppression indices have been 
considered as a way of measuring cortical inhibition. However, how these 
psychophysical measures correlate to each other and what exactly they measure 
is not yet clear.  
In this chapter, I have demonstrated that individual variations in the two 
examined suppression indices were not correlated. In fact, if anything, they are 
negatively correlated (Figure 3.6, p=0.24). The population means and standard 
deviations were quite similar for both indices, at 0.4 (SD=0.22) for motion 
discrimination task, and 0.56 (SD=0.19) for the contrast detection task, but the 
suppression indices were not correlated (𝜌𝜌=-0.20). Error bars in Figure 3.2A for 
motion suppression index and Figure 3.4 for contrast suppression index were 
fairly unreliable. Each index is the log ratio of two thresholds, which are both, 
individually, subject to experimental noise. Specifically, the contrast detection 
task in the condition of parallel (Figure 3.5) was according to the participants the 
hardest among all the tests, meaning that participants had a large number of 
mistakes and uncertainty in this task. This could potentially explain the large 
error-bars in the contrast thresholds when the background grating was parallel 
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to the target and consequently in the contrast suppression index (Figure 3.4). 
How much the measurement error reduces the observed correlation depends 
on the size of the measurement error relative to the variability present in the 
population. In Read et al. (2015), in a similar population to here, we 
demonstrated that the true correlation considering the presence of the 
measurement noise (error) could only be as high as 𝜌𝜌=-0.27. Thus, it would be 
hard to consider them to be positively correlated. The fact that these two indices 
have different nature is further verified by showing their different relationship 
to age; Motion suppression index decreased with age, as does motion 
summation index (Figure 3.2), however the contrast suppression index showed 
no change with age (Figure 3.4). Conversely, Karas and McKendrick (2011) 
showed that contrast suppression increases with age with supra-threshold 
contrasts (Karas and McKendrick, 2011, Karas and McKendrick, 2009, Karas and 
McKendrick, 2012, Karas and McKendrick, 2015). These results suggest that the 
two suppression indices mirror different features of cortical functioning. 
Surround suppression index is in fact a division of two durations and is important 
to consider it as a relative measurement that depends on two measurements, a 
control condition (without surround) and a suppressive condition (with 
surround). It is not possible to know if for a particular subject suppression is 
strong or weak with only considering one absolute measurement in one 
condition. The justification to use duration thresholds is based on the 
assumption that if the neural response to a stimulus is weak and/or noisy, then 
a longer stimulus exposure is necessary for a correct perception (Tadin et al., 
2006). That is a process of accumulation of sensory evidence over time is 
required to judge the moving direction of an object (Tadin et al., 2006, Gold and 
Shadlen, 2000, Roitman and Shadlen, 2002). Hence, a longer duration threshold 
(longer required exposure duration) could be evidence of noisy or attenuated 
neuronal responses.  
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The contrast suppression index shows selectivity for stimulus orientation, 
suggesting an early visual cortical locus (Yoon et al., 2010). Intracellular 
recordings of V1 neurons showed that a surround stimulus triggered an increase 
in inhibitory conductance, with a reduction in excitatory and inhibitory 
conductance, in which all showed orientation selective manner (Ozeki et al., 
2009). In a study by Zenger-Landolt and Heeger (2003) fMRI responses as a 
function of contrast and psychophysical contrast thresholds were quantitatively 
compared, and they found that psychophysics explain 96.5% of the variance in 
the measured V1 responses, suggesting V1 to be a likely site for mediating 
surround masking. Spatial (Angelucci et al., 2002, Cavanaugh et al., 2002, 
Serrano-Pedraza et al., 2012) and temporal (Bair et al., 2003) properties of 
contrast surround suppression agrees with the properties of primary visual 
cortex V1 neurons. This antagonism is believed to be implemented by feedback 
projections from extrastriate cortex, mediated by inhibitory projections from 
nearby interneurons (Alitto and Dan, 2010, Angelucci and Bressloff, 2006, 
Yazdani et al., 2015). . In contrast, impaired visual performance in motion 
discrimination task has been speculated to be the perceptual correlate of 
antagonistic centre surround mechanisms (Westheimer, 1967, Tadin et al., 
2003). Moreover, centre surround motion neurons are found in cortical areas 
V5/MT, primary visual cortex V1 (Jones et al., 2001), and medial superior 
temporal MST (Eifuku and Wurtz, 1998). From these areas, the critical size where 
the strong surround suppression starts is only similar to that of a V5/MT centre 
surround neuron (Tadin et al., 2003). Tadin et al. (2011) further showed that 
disruption of V5/MT by offline 1 Hz transcranial magnetic stimulation (TMS) 
improved motion discrimination of large moving stimuli by reducing the strength 
of surround suppression. Therefore, the motion suppression index is believed to 
reflect the receptive field properties of centre surround neurons in V5/MT (Tadin 
et al., 2003, Betts et al., 2012, Churan et al., 2008).  
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I also presented data investigating the relationship of motion and contrast 
suppression indices to orientation discrimination threshold (3.2.5). A human 
study done by Edden et al. (2009a)  presented a link between animal 
neurophysiology and human behavioural studies, in which they showed that 
variability of threshold on an orientation detection task was significantly 
negatively correlated with resting GABA concentration in an individual`s cortex 
for obliquely orientated stimuli (p<0.015). Data in Figure 3.7 shows that 
orientation discrimination thresholds of seven healthy participants were not 
correlated with motion and contrast suppression indices (motion discrimination 
task: p=0.63, contrast detection task: p=0.55).  However, with small numbers of 
participants, and the consequent lack of power, it is not possible to rule out a 
correlation.  Another possible explanation might be that orientation 
discrimination thresholds are probably set in a different cortical area from the 
motion and contrast thresholds. Neuronal orientation preference might be 
partly due to feedback signals from higher level areas (V4 or V3) ) (Liang et al., 
2007). Therefore, if motion and contrast discrimination thresholds are 
measuring GABA inhibition within area V5/MT and V1, then it might perhaps 
explain the lack of significant relationship between them and orientation 
threshold. 
A possible explanation for lack of correlation between motion and contrast 
indices might be that they indeed measure cortical inhibition in V5/MT and V1 
respectively, but that inhibition in these different areas are independently 
modulated. However, it is not clear why contrast suppression index was not 
correlated with age. If contrast suppression index provides psychophysical 
estimates of the strength of GABAergic inhibition, then it should have shown a 
relationship with age. Several studies have suggested that the effective strength 
of GABAergic inhibition reduces with age, but this has been shown to affect both 
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V1 (Fu et al., 2013, Hua et al., 2008, Yu et al., 2006, Leventhal et al., 2003, Pinto 
et al., 2010) and MT (Liang et al., 2010). 
Another possible reason might be that one or both of these indices does not 
provide psychophysical measure of cortical inhibition. Churan et al. (2008) 
showed that many visual cortical neurons do not show surround suppression, 
and only at brief stimuli (<40ms) MT centre surround neurons got activated. 
However, other studies have shown centre surround inhibition in long duration 
stimuli (Tadin et al., 2009, Aaen-Stockdale et al., 2009). Another study with a 
different theory claimed that psychophysical surround suppression may not be 
a perceptual correlate of surround-suppressed neurons in V5/MT, but it is due 
to the differences in contrast sensitivity at different sizes (Aaen-Stockdale et al., 
2009). Using a different task, they showed that the effect of size vanishes when 
the contrast of different size stimuli was normalised relative to their contrast 
thresholds. To reject this justification, Glasser and Tadin (2010) used duration 
threshold measurements, and showed that strong spatial suppression was 
present even when the contrast of the stimuli were normalized relative to their 
contrast threshold. Thus, motion discrimination task does in fact reflect both 
surround suppression and spatial summation. 
Another theory that might explain the independency of contrast and motion 
suppression indices is that there are a lot of studies arguing that there are 
physiologically distinct forms of surround suppression even within V1. For 
instance, activation of orientation tuned surround suppression in the lateral 
geniculate nucleus (LGN) might lead to reduced excitation in V1 (Ozeki et al., 
2004), lateral connections within V1 were believed to form surround suppression 
(Gilbert and Wiesel, 1983), or more recently feedback connections from higher 
cortical areas (Webb et al., 2005, Angelucci and Bressloff, 2006, Ichida et al., 
2007, Tailby et al., 2007, Bair et al., 2003).  Therefore, the term “surround 
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suppression” that is used in different psychophysical studies might cover 
different neuronal mechanisms.  
In addition, when comparing the suppression indices in males and female I 
observed a significant difference between male and female participants (with no 
significant difference in age) in the contrast detection task (Figure 3.8). The 
observed gender difference is unexpected, but hard to say if it is real. Our sample 
contained only 9 males as compared to 26 females; the difference is not highly 
significant (p=0.02) and this was not a planned comparison. This might be worth 
investigating in a future study.  
 
Next chapter will show results of visual psychophysics in patients with epilepsy 
and the differences between controls and patients with different frequency of 
seizures. 
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Chapter 4  Relationship of seizure susceptibility to performance in 
psychophysics tests 
 
4.1 Introduction 
Surround suppression can be observed in many different areas, such as central 
nervous, motor (Beck and Hallett, 2011) and sensory systems (retina, 
somatosensory, vision). In visual neuroscience, surround suppression refers to 
reduction of a neuron’s response to a stimuli situated outside of its classic 
receptive field (Benevento et al., 1972, Maffei and Fiorentini, 1976), and is 
believed to be mediated by GABAergic inhibitory connections (Alitto and Dan, 
2010, Angelucci and Bressloff, 2006, Gieselmann and Thiele, 2008, Nurminen 
and Angelucci, 2014). Recently, there have been a number of studies 
investigating surround suppression in different patient groups using visual 
psychophysics. For example, surround inhibition is believed to be compromised 
in patients with schizophrenia (Lewis et al., 2005, del Pino et al., 2013), which 
leads to various cognitive impairments (Yoon et al., 2010). Using a motion 
discrimination task Tadin et al. (2006) showed that patients with schizophrenia 
had significantly weaker surround suppression compared to healthy controls, 
and those with severe symptoms had the  lowest surround suppression index.  
Interestingly, there is a high prevalence of psychotic episodes in patients with 
epilepsy (Sachdev, 1998, Slater et al., 1963). A study done by Gutierrez-Galve et 
al. (2012) showed that reduction in cortical thickness in the inferior frontal gyrus 
is implicated in psychosis and specifically temporal lobe epilepsy. Some studies 
suggested that patients with long duration of epilepsy were more susceptible to 
develop psychosis (Kanemoto et al., 2012). Patients with epilepsy were shown 
to have nearly 2.5 times the risk of developing schizophrenia in comparison with 
general population (Qin et al., 2005). There is also, a bidirectional link between 
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patients with schizophrenia and epilepsy (Chang et al., 2011), meaning that 
patients with schizophrenia are around 6 times more likely to have seizures. 
Therefore, we speculated that visual psychophysics could potentially offer a non-
invasive way of assessing the integrity of suppressive centre-surround 
mechanisms and disease state in epilepsy.  
In this chapter, I will show the results of a group of 54 patients with epilepsy on 
the motion discrimination and the contrast detection tasks to compare them 
with 146 control participants, and to investigate if there is any significant 
difference between patients and healthy participants and whether this is related 
to patients’ seizure frequency. We therefore compared surround suppression 
indices in patients with frequent seizures versus infrequent seizures, the 
prediction being that if seizures were generated due to the reduction in steady 
state inhibition, then psychophysical evidence of this would be expected to be 
observed as a lower surround suppression index. 
 
4.1.1 A grading system to define frequent and infrequent seizures (Grading A 
and B) 
There have been many efforts (Cramer and French, 2001) to find the best 
assessment of seizure severity in the past. The optimal method would be one 
that is easy to administer by patients and physicians, is precise and sensitive to 
changes after a modification in medication and does not intrude too much on 
the patient’s time and effort. The most important criterion is that the method is 
relevant to the individual and reflects on their quality of life: some people are 
happy with 3 seizures a month, however for others, 3 seizures/month is a 
disaster. After all epilepsy is a set of conditions that not only affects patients’ 
health, but also their families’ day to day lives.  
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One of our goals was to grade seizure frequency, but there is no universally 
accepted scale for this. Several rating scales are available that assess severity of 
epilepsy based on several measures including quality of life, and an assessment 
of seizure frequency. Examples of these scales are VA scale (Cramer et al., 1983), 
Chalfont seizure severity scale (Duncan and Sander, 1991), the national hospital 
seizure severity scale (O'Donoghue et al., 1996), Liverpool scale (Baker et al., 
1998) and recently the Global Assessment of Severity of Epilepsy (GASE) Scale in 
children (Chan, 2014). Given that there was no single consistent means of 
assessing seizure frequency between these scales, we came up with our own, 
based on the seizure frequency. 
Patients were divided into two groups: patients with frequent seizures and 
patients with infrequent seizures. Due to the lack of precise information 
regarding seizure frequency, a new system was administered in this study. 
Table 4.1 depicts this method, which was used to systematically sort these 
reported numbers into five different categories. This table ranges from category 
1 (least severe) to 5 (most severe), where category 1 represents patients with 
only one reported seizure or multiple seizures occurring one or more years apart 
during the last three years and category 5 which represents patients with one or 
more seizures per day.  
Dividing patients into these five categories proved to be challenging because 
many patients fell in the border line of two or more categories, or the reported 
frequency of seizures was not always accurate. We therefore felt it was 
inappropriate to perform sub-group analysis on what were ill-defined groups, 
and instead amalgamated these into two groupings of “frequent” versus 
“infrequent” seizures. The definition of frequent in this setting is of course 
arbitrary, and we therefore examined two different cut-offs for this definition, 
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“grading A” and “grading B”. Grading B was defined to examine the robustness 
of observed results in Grading A.  
Based on Table 4.1 in grading A, a patient with one or more than one seizure per 
week, and in grading B a patient with one or more than one seizure per month 
were considered as a patient with frequent seizures. Based on this, grading A 
consisted of 20 patients with frequent and 34 patients with infrequent seizures, 
and, grading B comprised of 35 patients with frequent seizures and 19 patients 
with infrequent seizures. Other groups have defined frequent and infrequent 
seizures based on scores giving to patients based on counting seizures, using 
cardinal scales (few, many, fewer or more seizures) or patients’ self-reports of 
their seizure frequency. A review of all these methods can be found in Cramer 
and French (2001).  But defining frequency based on “grading A” and “grading 
B” made it possible to assess how robust our results were, given the inherent 
unreliability of the reported number of seizures.  
There is a strong link between sensory discrimination and intelligence quotients 
(IQ) (Melnick et al., 2013, Tadin, 2015). Melnick et al. (2013) showed that 
participants with higher IQ were better at discriminating moving of the small 
stimuli, however needed more time to perceive larger stimuli. Therefore, 
cognitive function was measured to account for the possibility of IQ being a 
potential confound for the measured surround suppression. Cognitive function 
among patients with epilepsy is generally described by deterioration of memory 
function (Motamedi and Meador, 2003). Therefore, patients were interviewed 
and assessed for cognitive impairment. Addenbrooke’s Cognitive Examination-
Revised (ACE-R) is a useful method for identifying mild cognitive impairment and 
dementia and measuring six cognitive domains including: orientation, attention, 
memory, verbal fluency, language, and visuospatial ability (Mioshi et al., 2006). 
All patients were above the cut-off threshold (cut off score 75). Although test of 
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ACE-R is superior to most of available tools for cognitive examination, it has some 
downsides. For example, there are other patterns reflecting on cognitive 
dysfunction in patients with epilepsy, such as reduced speed processing (Dow et 
al., 2004, Arzimanoglou et al., 2005), attention and executive dysfunction 
(Stretton and Thompson, 2012). One of the problems with ACE-R is that only five 
points of it is allocated to attention and it is largely influenced by level of 
education of patients (Komadina et al., 2011). 
 
Table 4.1. Description of the scale used to determine seizure frequency.  Grading 
A consisted of infrequent (frequency 1, 2, 3) and frequent ( frequency 4, 5). 
Grading B consisted of infrequent (1, 2) and frequent (3, 4, 5).  
 
 
4.1.2 Data analysis 
Parametric tests such as regression analysis and ANOVA assume that data fit the 
normal distribution. Therefore, data must be checked for normality before any 
statistical analysis. One method of assessing normality is to perform the 
probability plot or Quantile-Quantile (Q-Q) plot in SPSS. This test is a powerful 
Seizure 
frequenc
y  
Description Grading A 
Grading 
B 
1 More than a year was between each seizure 
In
fre
qu
en
t 
In
fre
qu
en
t 
2 More than or equal to 1 per year, but less than 1 per month 
3 More than or equal to 1 per month, but less than 1 per week 
Fr
eq
ue
nt
 
4 More than or equal to 1 per week, but less than 1 per day 
Fr
eq
ue
nt
 
5 More than or equal to 1 per day 
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analysis compared to histograms and is a non-parametric approach to check data 
distribution. If data is normally distributed, the points shown on Q-Q plot lie on 
a straight diagonal line.  
As age was shown to be a confounding factor, an analysis of regression was 
followed to check if age confound was the reason that the distributions were not 
normal or Gaussian. First a line of best fit was plotted for all three groups. 
Residuals are the difference between the observed value of each data set and 
predicted value by the line of best fit. In order to compress data into a single 
number without the effect of age, residuals were plotted from the line of best fit 
and checked if they are around zero.  
In order to compare the groups with each other, Kruskal-Wallis which is a non-
parametric test, was used. Kruskal-Wallis is the equivalent to ANOVA to compare 
three or more groups together.  
As an alternative test, Kolmogorov-Smirnov (KS), another non parametric test, 
was used to compare cumulative probabilities of different groups to find their 
differences.  In order to perform the KS-test, cumulative distributions of different 
groups were plotted and the statistic D, which is the maximum difference 
between cumulative distributions, was calculated. 
The null hypothesis is that samples are drawn from the same distribution, and 
can be rejected at level α if: 
 𝐷𝐷𝑚𝑚1,𝑚𝑚2 > 𝐿𝐿(𝛼𝛼) ∗ �𝑚𝑚1+𝑚𝑚2𝑚𝑚1∗𝑚𝑚2  
                                                             Equation 4.1. The Kolmogorov-Smirnov test. 
 
And the value of c(α) can be derived from Table 4.2. 
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Table 4.2. The value of c(α) is given in the above table for each level of α. 
 
 
 
4.2 Results 
4.2.1 Analysis of the motion discrimination task 
Duration thresholds were measured and plotted against age for 146 healthy 
controls (Figure 4.1) and 54 patients with epilepsy (Figure 4.2). The top panels in 
both figures show duration thresholds of high contrast (A-B), and the bottom 
duration thresholds of low contrast (C-D).  
In Figure 4.1, as for data presented in chapter 3, duration thresholds of control 
participants were found to be longer in large high contrast stimuli than for small 
high contrast stimuli. Also, comparable results were observed for regression 
lines, where duration thresholds increased with age in small high contrast 
(p<0.001) and small low contrast (p<0.001).  
 
 
α 0.10 0.05 0.025 0.01 0.005 0.001 
c(α) 1.22 1.36 1.48 1.63 1.73 1.95 
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Figure 4.1. Duration thresholds of 146 healthy participants as a function of age 
on log axes for the motion discrimination task. Four stimulus conditions are 
shown: (A) Large high contrast (92%), (B) Small high contrast (92%), (C) Large low 
contrast (2.8%), and (D) Small low contrast (2.8%).  Error bars show 95% 
confidence intervals. Lines show regression with age; solid lines are those where 
the regression with age was significant, dashed lines where it was non-
significant. R2 and p values are marked in each panel. 
 
Figure 4.2 shows duration thresholds of 54 patients with epilepsy as a function 
of age. Similar to controls, high contrast duration thresholds were longer in large 
stimuli compared to small high contrast.  And, in low contrast duration 
thresholds were relatively shorter in large than small stimuli. For the purpose of 
comparison, Figure 4.1 and Figure 4.2 are superimposed in Figure 4.3. 
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Similar trends in regression lines were observed between patients and controls 
duration thresholds in all conditions except in large high contrast. A steep 
significant regression line in large high contrast was observed for patients, 
whereas controls showed a non-significant steady regression with age.  
Another difference is in small high contrast where on the contrary to controls 
regression line did not reach significance (Figure 4.3 B, p=0.26). 
Figure 4.2. Duration thresholds of 54 patients plotted as a function of age on 
semi-log axes for the motion discrimination task. Four stimulus conditions are 
shown: (A) Large high contrast (92%), (B) Small high contrast (92%), (C) Large low 
contrast (2.8%), and (D) Small low contrast (2.8%).  Error bars show 95% 
confidence intervals. Lines show regression with age; solid lines are those where 
the regression with age was significant, dashed lines where it was non-
significant. R2 and p values are marked in each panel.  
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Figure 4.3. Overlaid duration thresholds of 146 healthy controls (in green) and 
54 patients with epilepsy (in red) for the motion discrimination task. 
 
An interesting difference between patients and healthy controls was that a 
number of patients showed an exceedingly long duration thresholds for the large 
high contrast. Figure 4.3 A shows a few patients had very high duration 
thresholds (around 1000ms). These high durations are not exactly 1000ms, but 
rather that the staircase method could not estimate a threshold because the 
subject made repeated false judgements (mistakes) of the direction of grating 
movement. Also, there were a couple of patients with similar long duration 
thresholds in large low contrast (Figure 4.3 C). These long durations were not 
reported in other similar studies (Betts et al., 2009, Tadin et al., 2006, Tadin et 
al., 2003). There was no significant difference in these patients’ seizure 
frequencies to others.  
83 
 
Figure 4.4 and Figure 4.5 further explore these differences.  
Figure 4.4 shows frequency of duration thresholds for both patients and healthy 
participants for large high (top panel) and small high (bottom panel) stimuli. It is 
noticeable that there are 6 patients with duration thresholds of over 900ms in 
large high contrast (Figure 4.4-Top panel around 11% of total number of 
patients). However, the maximum duration thresholds of controls were between 
600 - 700ms (around 2% of total number of controls). Figure 4.5 is normalised 
cumulative frequency plots of duration thresholds in controls and patients which 
show a deviation of the two samples’ distributions at the high tail end in the large 
high contrast Figure 4.5, top figure). Kolmogorov-Smirnov test (K-S) showed that 
the two distributions are significantly different in the large high contrast at 
p=0.005. 
 
 
 
 
 
 
 
 
 
Figure 4.4. Frequency histogram of duration thresholds of 146 healthy controls 
and 54 patients with epilepsy were plotted in large high (top panel) and small 
high (bottom panel) contrasts. 
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Figure 4.5. Normalised cumulative frequency plots of duration thresholds for 
large (top) and small (bottom) high contrast for 54 patients (in purple) and 146 
controls (in green). The cumulative relative frequency of patients and controls 
are significantly different in large high contrast at p=0.005. 
 
Motion suppression index (Equation 2.2) of 146 controls and 54 patients with 
epilepsy were plotted against age in Figure 4.6. There was a significant decrease 
in motion suppression in both groups with increase of age (in both patients and 
controls: p<0.001). Magnitude of motion suppression decreased with age in both 
controls and patients. 
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Figure 4.6. Motion suppression index plotted as a function of age. Motion 
suppression index, the log ratio of large/small duration thresholds, is shown for 
54 patients in red and 146 healthy participants in green. Error-bars show 95% 
confidence intervals, and solid lines are significant regression lines (Patients: 
Index= -0.0094*(Age in years) + 0.852; Controls: Index= -0.0040 *(Age in years) 
+ 0.4833. 
 
4.2.2 Analysis of the contrast detection task 
Impaired contrast detection could be a confounding factor in the motion 
discrimination task. Moreover, there have been some studies using contrast 
detection tasks to measure inhibition in schizophrenia (Serrano-Pedraza et al., 
2014, Ekstrom et al., 2015, Slaghuis, Keri et al., 2002). The contrast detection 
task is a grating situated in the visual periphery which becomes less visible if is 
surrounded by a grating with the same spatial frequency and orientation (Petrov 
et al., 2005, Lev and Polat, 2011, Snowden and Hammett, 1998a, Xing and 
Heeger, 2000). We hypothesised that this experiment as well as the motion 
discrimination task might show possible cortical alterations including reduced 
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concentration of GABA which affects surround suppression in patients with 
epilepsy (Serrano-Pedraza et al., 2014). To compare performance of patients and 
healthy participants in the contrast detection task, contrast thresholds of 43 
controls and 34 patients with epilepsy were plotted against age in Figure 4.7. 
There was a significant relationship between contrast thresholds and age in both 
parallel and orthogonal in patients (Figure 4.7C, p=0.002 and in D, p= 0.01). 
However, in controls significant correlation with age was only observed in 
orthogonal condition (Figure 4.7B, p=0.002). Both patients and control 
participants showed more variability and longer thresholds in parallel condition 
(Figure 4.7 A and C), which might be because it was a harder task relative to 
orthogonal (Serrano-Pedraza et al., 2014, Petrov et al., 2005, Lev and Polat, 2011, 
Ejima and Takahashi, 1985, Snowden and Hammett, 1998a). Figure 4.8 shows 
superimposed contrast thresholds of controls and patients. 
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Figure 4.7. Contrast thresholds for contrast detection task plotted against age 
for 43 controls and 34 patients with epilepsy, when the background grating was 
parallel (A, C) or orthogonal (B, D) to the target. Error-bars show 95% confidence 
interval. The solid line is where the regression with age was significant, the 
dashed line where it was non-significant. R2 and P values are marked in each 
panel.  
Figure 4.8. Overlaid contrast thresholds of 43 controls (in green) and 34 patients 
with epilepsy (in red) for the contrast detection task.  
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Contrast suppression (Equation 2.3) of 43 controls and 34 patients with epilepsy 
were plotted against age in Figure 4.9. The difference in number of participants 
between the motion discrimination task and the contrast detection task was due 
to the fact that smaller number of patients participated in both tasks. Neither 
patients nor control groups showed a significant relationship with age (p=0.81: 
in both patients and control groups). 
 
Figure 4.9. Contrast suppression index on the contrast-detection task for 34 
patients with epilepsy (red) and 43 healthy controls (green) as a function of age. 
Error bars show 95% confidence intervals. Dashed lines represent non-significant 
regression lines between contrast suppression index and age in both controls 
and patients.  
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The next stage of the analysis was to see whether visual psychophysics predicted 
seizure frequency at the group level where patients were devided based on their 
seizures to five different groups, and ultimately whether it could predict the 
likelihood of seizures in individual patients. 
  
4.2.3 Analysis of psychophysics data with respect to seizure frequency   
As explained before, patients were divided into two different groups of frequent 
and infrequent seizures according to their seizure frequency starting from 1 to 5 
(Table 4.1-Grading A). In order to examine whether results of this grouping were 
robust, we then plotted the same data but with the shifted threshold between 
the frequent and infrequent seizures and named it Grading B. Number of 
patients and healthy participants in each grading is shown in  
Figure 4.10. For example, there are 35 patients with frequent seizures and 19 
patients with infrequent seizures with 146 healthy controls in grading B.  
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Figure 4.10. Schematic diagram of the distribution of patient groups and healthy 
participants in Grading A and B for the motion discrimination and contrast 
detection tasks. 
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The distribution of data within each group of patients (frequent and infrequent) 
and healthy controls are demonstrated in Figure 4.11 (Grading A) and Figure 4.12 
(Grading B). Lilliefors and Jarque-Bera tests of normality rejected the null 
hypothesis of data being normal for healthy control participants (p=0.05). 
Therefore, non-parametric analyses were performed on the groups to compare 
them against each other. Results are presented in the following sections.  
 
Figure 4.11. Box plot figures of motion suppression and contrast suppression 
indices for Grading A. The central red mark is the median, the edges of the box 
are the 25th and 75th percentiles, the whiskers extend to show the maximum and 
the minimum of the data points, and the red plus signs show the outliers.  
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Figure 4.12. Box plot figures of motion suppression and contrast suppression 
indices for Grading B. The central red mark is the median, the edges of the box 
are the 25th and 75th percentiles, the whiskers extend to show the maximum and 
the minimum of the data points, and red plus crosses show the outliers.  
 
4.2.3.1 Results of grading A: 
The motion discrimination task: 
By pooling all the data together, a significant regression equation was found in 
the motion discrimination task (F=23.23, p<0.001), with R2= 0.1 (Motion 
suppression index = -0.0054*Age + 0.573.  
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Residuals were calculated to check if the linear regression model is appropriate 
for the motion discrimination task. Then, they were plotted as a function of 
predicted value of regression analysis to check their variance from line zero 
(Figure 4.13). The variance of error was not always constant and errors appeared 
to expand with increase of the predicted value. 
 
Figure 4.13. Scatter plot of residuals calculated from linear regression analysis 
for the motion discrimination task. Predicted value by the regression model is on 
x-axis and the distance from horizontal line y=0 shows how well the model was 
for each data point (Field, 2013). 
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To analyse the normality of data, a probability plot (quantile plot or Q-Q) was 
plotted for all the residuals. Figure 4.14 shows a Q-Q plot for the motion 
discrimination task. Residuals appeared to be deviated from normality around 
the beginning and the end of the diagonal line. If data were normal, points would 
lie on the diagonal line. 
Figure 4.14. Normal Q-Q plot of regression standardized residuals in the motion 
discrimination task. Black circles represent all residuals. Normally distributed 
data will lie approximately on the black straight line. 
 
From Figure 4.13 and Figure 4.14, I concluded that non-parametric analysis was 
more appropriate to apply on the data. Three different non-parametric tests 
(Analysis of Kruskal-Wallis, Kolmogorov-Smirnov and Mann-Whitney test) were 
conducted all of which gave similar results. 
Analysis of Kruskal-Wallis showed significant difference between the three 
groups with p=0.002 and Chi-Square=12.46. Mann-Whitney test indicated 
significant difference was between patients with frequent seizures and healthy 
controls (p<0.001, U=735), and between patients with frequent seizures and 
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patients with infrequent seizures (p=0.04, U=226). There was no significant 
difference between patients with infrequent seizures and healthy participants 
(p=0.2). 
Kolmogorov-Smirnov test (K-S) also confirmed significant difference (Figure 4.15) 
between patients with frequent seizures (in blue) and healthy controls in grey 
with p=0.05, although it did not reach significant among the two patients groups. 
 
Figure 4.15. Normalised cumulative frequency plots for patients with frequent 
seizures (in blue), patients with infrequent seizures (orange), and healthy control 
participants (in grey) for the motion discrimination task in grading A. X-axis 
shows frequency motion suppression index bins and y-axis is the cumulative 
frequency. 
 
The contrast detection task: 
Analysis of regression in the contrast detection task was non-significant (p=0.87). 
The Kruskal-Wallis test indicated significant difference between the groups with 
p=0.006, and Chi-Square=10.24. Mann-Whitney test showed significant 
difference among patients with frequent and infrequent seizures (p=0.011, 
U=71), and patients with frequent seizures and healthy controls (p=0.002, 
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U=179). There was no significant difference between patients with infrequent 
seizures and healthy controls (p=0.787). Similar results were also observed in 
Kolmogorov-Smirnov test (K-S) (Figure 4.16, p=0.05). 
 
Figure 4.16. Normalised cumulative frequency plots for patients with frequent 
seizures (in blue), patients with infrequent seizures (orange), and healthy control 
participants (in grey) for the contrast detection task in grading A. X-axis shows 
frequency motion suppression index bins and y-axis is the cumulative frequency. 
 
4.2.3.2 Results of grading B: 
The motion discrimination task: 
Similar non-parametric tests were performed for groups in Grading B where 
patients with more than or equal to 1 per month are the group with frequent 
seizures (Table 4.1).  The Kruskal-Wallis test showed a significant difference 
between groups with p=0.001 and Chi-Square=13.15. Further analysis using 
Mann-Whitney test showed the significant difference was between patients with 
frequent seizures and healthy control participants (p<0.001, U=1553) and 
between patients with frequent seizures and patients with infrequent seizures 
(p=0.024, U=208). No significant difference was found between patients with 
infrequent seizures and healthy participants (p=0.8).  
97 
 
Further support of the observed difference in the frequent seizure group can be 
seen in Figure 4.17 which is a normalised cumulative frequency plot for the three 
groups using the Kolmogorov-Smirnov test (K-S). This plot also confirmed the 
significant difference between patients with frequent seizures (in blue) and the 
other two groups (controls in grey, and patients with infrequent seizures in 
orange) and no significant difference between the controls and patients with 
infrequent seizures.  
 
Figure 4.17. Normalised cumulative frequency plots for patients with frequent 
seizures (in blue), patients with infrequent seizures (orange), and healthy control 
participants (in grey) for the motion discrimination task in grading B. X-axis 
shows frequency motion suppression index bins and y-axis is the cumulative 
frequency. 
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Moreover, K-S test indicated a significant difference between the overall 
patients groups and healthy participants at p<0.005 shown in Figure 4.18. 
 
Figure 4.18. A normalised cumulative frequency plots with added distribution for 
all patients (in yellow) for motion discrimination task. X-axis shows frequency 
motion suppression index bins and y-axis is the cumulative frequency. 
 
 
The contrast detection task: 
The Kruskal-Wallis and the Kolmogorov-Smirnov tests (K-S) showed no 
significant difference within the groups in the contrast detection task (p=0.1). 
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4.2.4 Surround suppression is not affected by seizure frequency  
To further investigate the differences between patients in regards to their 
seizure frequencies, individual suppression indices were plotted for each 
frequency scale in both the motion discrimination and contrast detection tasks 
in red for the patients and green for the controls (Figure 4.19). Averages of each 
seizure frequency were then calculated and plotted on each scale (black 
diamonds).  
Age was found to have a significant relationship with the suppression indices in 
the motion discrimination task.  Figure 4.19-top shows motion suppression 
indices plotted as a function of seizure frequency. Initial inspection of this plot 
suggested that, in addition to the effect of age, frequency of seizures might also 
influence the motion suppression indices. We therefore examined the relative 
importance of this potential predictor along with the factor of age, by performing 
multivariate regression analyses (Table 4.4). The adjusted R-squared is a 
modified version of R-squared that has been adjusted for the number of 
predictors in the model. When considering both age and epilepsy diagnosis 
together, we found marked increases in the adjusted R2 values when first 
subdividing the complete data set (age alone, R2 = 0105, Table 2) into controls 
and epilepsy subjects (adjusted R2 = 0.183). Importantly though, the model was 
not improved substantially by adding the factor of frequency (adjusted 
R2=0.192). Therefore, we concluded that frequency is not a significant predictor 
of the model.  
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Multiple regression analysis showed that age and frequency were not significant 
predictors of the contrast suppression index (age: beta=0.001, t=0.5, p=0.6; 
grading: beta=0.078, t=1.55, p=0.13). Therefore, there is no relationship 
between seizure frequency and the contrast suppression index (Figure 4.19, 
bottom panel). 
 
Figure 4.19. Suppression indices for patients (in red) and controls (in green) as a 
function of seizure frequency. Top panel represents motion suppression and 
bottom panel contrast suppression indices for individual participants. Black 
diamonds represent average of suppression index within each seizure frequency 
scale.  
4.2.5 Comparison of patients with a history of generalised seizure and 
without  
SUDEP (Sudden Unexpected Death in Epilepsy) affects approximately 1 in 1000 
patients with epilepsy per year, and the single biggest risk factor is the presence 
of uncontrolled generalised tonic-clonic seizures, increasing the risk to 1 in 150 
patients per year (Pack, 2012, Duncan and Brodie, 2011, Nashef et al., 2007). 
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Patients were divided into three different groups: focal seizures without 
generalising seizures (F-, n=24, age range: 22.2-72.5), focal seizures evolving into 
bilateral convulsive seizures (F+, n=19, age range: 17.5-82.3) and generalised 
seizures in the context of a Genetic Generalised Epilepsy (GGE) (n=11, age range: 
17-55.4). Details of the individual patients are provided in . The control group is 
not a normal distribution and therefore data is presented in the form of boxplots 
(Figure 4.20).  
 
Figure 4.20.  Bee swarm boxplots of patients groups and controls. Significance 
p<0.001 is shown as ** in the figure. 
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Table 4.3. Individual patient data with respect to their type of seizures 
 
The motion suppression index is dependent on age as was shown in chapter 4, 
Figure 4.6.  
Figure 4.21 shows the relationship between each group of participants as a 
function of age with corresponding regression lines.  The distribution of SSI values 
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differed significantly between the four groups (F+ (Focal+GTCS), F- (Focal no GTCS), 
GGE and controls; ANOVA, F(3,196) = 11.66, p < 0.0001; Figure 4.20), with post hoc 
t-tests indicating that the F- group was the outlier.  The previously noted 
regression with age was apparent for each subgroup individually ( 
Figure 4.21), although this was only significant for the two larger sample groups, 
F+ (n = 19, R2 = 0.259, p < 0.05) and F- (n = 24, R2 = 0.527, p < 0.001) but not for 
GGE.  To examine the relative importance of this potential predictor along with 
the factor of age, multivariate regression analyses (Table 4.4) were performed. 
We found marked increase in the adjusted R2 value in a model of suppression 
index-age after subclassifying into the F+, F- and GGE subtypes (adjusted R2 = 
0.318, Table 4.4). 
Importantly though, the age and subtype model was not further improved by 
adding the seizure frequency (adjusted R2 = 0.315, Table 4.4).  This lack of effect 
of seizure frequency was better appreciated when this predictor was plotted for 
the three seizure subtypes individually (Figure 4.22).  These plots also show that 
in our samples, the F- patients tended towards a higher seizure frequency. This 
mismatch in the seizure frequency between the groups can explain the increase 
in R2 going from a model using just “Age” to one using “Age + Frequency” 
(Table 4.4): in this case, in which seizure subtype was ignored, the subtype acts as 
a hidden predictor and distorts our interpretation of the effect of frequency. The 
important comparison is that a model using all three predictors actually explains 
no more of the variance than one using just age and seizure subtype.  
The regression table for the three-predictor model indicates highly significant p 
values for the control intercept and slope (p << 0.001), and for the change in 
intercept and slope for the F- group (p << 0.001), but for no other comparison, and 
notably frequency was non-significant (p = 0.632).  We conclude, therefore, that 
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only age and seizure subtypes were significant predictors of motion suppression 
index. 
 
 
Figure 4.21. Motion suppression index of patients and controls as a function of 
age. Patients with focal seizures are shown in red, with focal seizures evolving 
into bilateral convulsive seizures in magnet, with GGE in blue and controls in 
black. Solid lines show where the regression with age was significant. 
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Table 4.4. Model comparisons. The optimal model is indicated by *, and the 
parameters for that model (**, P << 0.001).  Note that for the Control group 
statistics, what is being tested is significant difference from zero, and for the 
other groups, it is the significant difference from the controls.   
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Figure 4.22. Boxplots of the suppression indices with respect to frequency of 
seizures for the pooled epilepsy cohorts, and for each of the three subgroups of 
epilepsy patients, plotted separately (B-D, all non-significant).   
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4.2.6 No significant effect of anti-epileptic drugs on motion suppression 
indices  
There are a number of factors affecting cognition in patients with epilepsy, for 
instance age of onset, aetiology of seizure, seizure frequency, severity and 
duration of seizures, as well as epilepsy treatment or anti-epileptic drugs 
(Motamedi and Meador, 2003, Loring et al., 2007, Carpay et al., 2005). Certain 
anti-epileptic drugs (AEDs) are one possible confounding parameter to interact 
with the GABAergic system, and indeed this is presumed to contribute to their 
clinical effect (Walker and Surges, 2009).  One of the reasons of high prevalence 
of psychosocial problems within patients with epilepsy in spite of the fact that 
most have normal intelligence, is the possibility of negative influence of AEDs 
(Drane and Meador, 1996, Kalviainen et al., 1996, Kwan and Brodie, 2001). For 
instance, in a monotherapy study on 110 patients with epilepsy treated with 
Carbamazepine (CBZ), Sodium Valproate (VPA) and Phenytoin and 24 controls, 
Carbamazepine treated patients showed poorer psychomotor scores than 
controls and Sodium Valproate treated patients (p<0.05), and Phenytoin treated 
patients scored less well on the composite memory scale compared to other 
groups (Gillham et al., 1990). A study on children with epilepsy treated with 
Phenobarbital done by Sulzbacher et al. (1999) showed the adverse effects of 
Phenobarbital on language skills and worsening of behavioural disorders. Other 
examples are in patients treated with Benzodiazepines, Clonazepam and 
Clobazam, which can cause cognitive impairment and sedation (Dichter and 
Brodie, 1996, Kwan and Brodie, 2001). A study on patients treated with 
Topiramate found significant decline in measures of attention and word fluency 
at acute doses (Martin et al., 1999). Another study on patients treated with 
Zonisamide showed mild degrees of abnormal thinking and impaired verbal 
learning (Berent et al., 1987, Kwan and Brodie, 2001). We have rather poor 
understanding of how antiepileptic drugs (AEDs) work (Macdonald and Kelly, 
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1995), but it is reasonable to assume that some will affect inhibitory processes, 
including Sodium valproate, Clobazam, Zonisamide, Retigabine, Topiramate, 
Primidone, and Phenobarbital.  Valproate Acid (VPA) may enhance GABA 
mechanisms through the synthesis of GABA by stimulating GAD enzyme 
(glutamic acid decarboxylase). A study using voltage clamp recordings 
demonstrated that VPA selectively modulates the voltage dependence of 
sodium current steady-state inactivation and reduces cellular excitability 
(Taverna et al., 1998, Vreugdenhil and Wadman, 1999). Clobazam is a GABAA 
receptor agonist and may influence voltage-sensitive conductance of calcium 
ions and the sodium channels (Sankar, 2012). Phenobarbital has a direct action 
on GABAA receptors which prolongs the duration of chloride channel opening 
(Polc, 1982). Topiramate might enhance GABA through increase of Chloride 
influx (White et al., 1997). Zonisamide increases GABA-mediated inhibition 
(Wilfong and Willmore, 2006) and Retigabine increases inhibitory 
neurotransmission via a direct influence on the GABAA receptor (van Rijn and 
Willems-van Bree, 2003, Otto et al., 2002).  
Therefore, the pattern of medication of all the patients (total of 54) were 
analysed. Collectively, patients were on 17 different medications (Table 4.5). 
Seven patients were recruited at the time of diagnosis and were not therefore 
on medication when they did the psychophysical tests, 18 patients were on 
monotherapy, and the rest were on multiple drugs (Figure 4.24, A). 
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Table 4.5. Subdivision of the drugs into those that are known to affect the 
GABAergic system, and those that are thought to have their effect independent 
of GABA. 
 
The GGE patient group tended to be on a lower numbers of drugs, with the F+ 
and F- groups taking similar numbers (1.84 and 2.33 respectively). The most 
commonly prescribed drugs were levetiracetam (19 patients), lamotrigine (14 
patients) and sodium valproate (13 patients), but notably the pattern of drug 
prescriptions for the patients with generalised seizures (GGE and F+) and those 
without (F-) were broadly similar (Figure 4.24, B).   
Since the psychophysics test is presumed to reflect cortical GABAergic function, 
we subdivided the epilepsy cohort into two groups according to whether or not 
they were on drugs that are known to interact with GABA (Table 4.5; note that 
both groups contain people on polypharmacy). Notably, there was no difference 
in the SSI for these two groups (Figure 4.23, Non- GABA drug group, n = 27, SSI = 
0.40 +/- 0.37; GABA group, n = 27, SSI = 0.49 +/- 0.36).  
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Furthermore, including the presence or absence of drugs with GABAergic effects 
as a predictor in the regression analyses did not explain any additional variance 
(adjusted R2 =0.316). This was also true when the regression analyses were 
restricted to the epilepsy subjects (age / epilepsy subtype, adjusted R2 = 0.475; 
age / epilepsy subtype / GABA effect, adjusted R2 = 0.464).  
Finally, we examined whether patients with low versus high SSI scores 
(subdivided at the median SSI) were predominantly within the GABAergic / non-
GABAergic drug interactions groups (Figure 4.24). There was no significant 
difference between the low and high SSI patients (Fisher’s exact tests), either for 
all the patients pooled irrespective of seizure type, nor for the generalised and 
focal groups alone. We concluded, therefore, that drug interactions do not 
underlie the effects of seizure type and age on the surround suppression index. 
Figure 4.23. Boxplot of motion suppression index of patients with epilepsy in two 
groups of patients who used AEDs known affecting GABA and not affecting 
GABA. P value and number of patients in each box plot are shown. 
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Figure 4.24. Patterns of medication for the three subgroups in the patient cohort. 
(A) Cumulative frequency plots of the proportions of the patients in the three 
groups taking different numbers of anti-epileptic drugs (AEDs). (B) Histogram 
showing the numbers of patients in each group taking the different AEDs. The 
abbreviations of the drugs are given in Table 4.5. (C) Proportions of patients with 
either low SSIs or high SSIs who are on medication that either interacts with, or 
is considered independent of, the GABAergic system. In each case, the cohort 
was subdivided at the median score SSI (Ci, all patients, n = 27 for both low and 
high SSI groups; Cii, patients with generalized epilepsy (F+ and GGE), n = 15 for 
both groups; Ciii, patients with exclusively focal epilepsy (F-), n = 12 for both 
groups). 
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4.3 Discussion 
The relationship between excitation and inhibition has an important role in 
maintaining proper dynamics of neuronal networks in the cortex (Douglas et al., 
2003, Buzsáki, 2011). Concurrent rises in excitation and reduction in inhibitory 
forces has been shown to produce pathological conditions such as epilepsy 
(Dichter and Ayala, 1987). Recent studies have demonstrated the important role 
of GABAergic inhibition on cortical processing at single cell and network level 
where inhibition has an influence on setting the state of the network and cortical 
oscillation (Alitto and Dan, 2010). 
To explore the idea of using visual psychophysics as a way of measuring the 
quality of surround suppression, first differences between patients with epilepsy 
and healthy participants were investigated. In epilepsy the number of seizures is 
an important factor in determining the severity of epilepsy. Therefore, patients 
were divided to five category based on their seizure frequency (Table 4.1). In 
fact, Figure 4.19 showed that patients with no seizures or less than one in a year 
(group1) did not show any difference in their suppression index to healthy 
controls. We then defined two grading: Grading A included patients with more 
than one seizure per week as frequent, while grading B included those with more 
than one seizure per month as frequent. These cut-offs are arbitrary and were 
chosen to give us a consistent grouping for patients’ frequency of seizures. In 
addition, a lot of patients could not give precise information on their number of 
seizures. Therefore, Grading A and B with two different cut-offs (for example: 
more than 1 seizure per week versus more than 1 per month) gave us the 
opportunity to show whether the results in any of the tasks were robust. 
However, with limit of time we did not investigate other cut-offs which are worth 
investigating, such as those who are in remission and those with less than one 
seizure per month.  
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Figure 4.19 indicated that the average of motion surround suppression tends to 
escalate with the increase of seizure frequency in the motion discrimination task. 
However, further investigation showed that patients with exclusive focal 
seizures tended towards a higher seizure frequency (Figure 4.22). This mismatch 
in the seizure frequency between the groups can explain the subtle increase in 
R2 going from a model using just “Age” to one using “Age + Frequency (Table 4.4). 
In the case, in which seizure subtype was ignored, the subtype acts as a hidden 
predictor and distorts our interpretation of the effect of frequency. The 
important comparison is that a model using all three predictors actually explains 
no more of the variance than one using just age and seizure subtype. The lack of 
effect of seizure frequency was clearer when this predictor was plotted for the 
three seizure subtypes individually (Figure 4.22). We conclude, therefore, that 
only age and seizure subtypes were significant predictors of the motion 
suppression index.  
It is important to remember that although visual psychophysical methods 
measure surround suppression in the occipital lobe, we think that the produced 
suppression index measured for each person either by the motion discrimination 
or the contrast detection tasks is an indication of the global quality of the 
inhibitory mechanisms. In other words, patients with a focal epilepsy, as well as 
having a focal excitation, may have a global inhibitory impairment (Trevelyan and 
Schevon, 2012). For instance, the calcium-binding protein Parvalbumin (PV) 
plays an important role in the regulation of local inhibitory effects applied by 
GABAergic interneurons on pyramidal neurons and Parvalbumin deficiency 
results in increased susceptibility to epileptic seizures (Schwaller et al., 2004). 
Therefore, it might be reasonable to hypothesise that the observed elevated 
baseline of inhibition in patients with epilepsy, especially in those with more 
frequent seizures, exists to oppose the possibility of increase of activity in an 
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over excited network, compared to healthy controls or patients with less 
frequent seizures. How and why exactly this antagonism mechanism fails and 
leads to a seizure propagation is still not clear. Some studies have shown 
evidence of interneurons not firing (Cammarota et al., 2013a), perhaps due to a 
depolarising block (Ziburkus et al., 2006). In addition, there is evidence of a short 
term depression through presynaptic inhibition, GABAergic vesicular depletion, 
post synaptic desensitization (Trevelyan and Schevon, 2012), and increase of 
postsynaptic chloride (Thompson and Gahwiler, 1989a, Thompson and Gahwiler, 
1989b, Ellender et al., 2014, Fujiwara-Tsukamoto et al., 2010). Further analysis 
of covariates (ANCOVA) indicated a significant difference in motion suppression 
index between healthy controls and patients with higher number of seizures 
(namely group 3 and 4, p<0.005). Moreover, patients with less number of 
seizures were significantly different compared to those with higher number of 
seizures. These findings are in line with the non-parametric tests that were done 
in grading A and B.  
Another interesting finding was the existence of very long duration thresholds in 
the motion discrimination task (over 800ms) only in patients with epilepsy 
(Figure 4.3 A and Figure 4.4). All of these patients had frequent seizures and 
more than half of them had twice higher duration thresholds in small patterns 
relative to average patients. It is not clear why these patients exhibited these 
very long duration thresholds. Some of them showed some degree of confusion 
in identifying the moving direction in large high contrast, however they had no 
problem for the small high contrast task. Thresholds with this intensity have 
never been published in other studies to our knowledge. 
Similar to the control subjects’ data presented in chapter 3, age was a significant 
factor in the motion discrimination task in patients. And, the fact that contrast 
suppression did not display any correlation with age is additional evidence 
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pointing to the fundamental differences within these two paradigms (Yazdani et 
al., 2015). 
Anti-epileptic drugs (AEDs) could be a possible confounding factor to affect 
neuronal networks by suppressing excitation or enhancing inhibition. Therefore, 
it was plausible for this to be a reason of observed differences in patients’ 
groups. There are a vast number of studies on the negative effects of AEDs on 
the visual performance often on patients with prolonged AED use (Roff Hilton et 
al., 2004, Verrotti et al., 2007, Steinhoff et al., 1997b). Examples of these 
disturbances are mild diplopia, blurred vision and nystagmus. Some studies have 
presented data supporting that GABAergic and glutamatergic neurotransmission 
may be mediators of retinal signal transmission (Steinhoff et al., 1997a, 
Slaughter and Bai, 1988). One study has linked AEDs such as Vigabatrin and 
Carbamazepine with reduced contrast sensitivity (Nousiainen et al., 2000). None 
of the patients in my study reported any visual deficit. Colour perception was 
assessed in some patients using Ishihara test and was found to be normal. It is 
important to note that the stimuli in high contrast (92%) is way above the 
threshold for someone with normal contrast sensitivity, but not for someone 
with impaired contrast sensitivity. Here patients were not contrast impaired in 
general because the mean of the contrast threshold in orthogonal condition for 
controls and patients were very close (controls: 1.47 and patients 1.67). Analysis 
of Student’s t test showed that the two are not significantly different with t=-1.1, 
df=75 and p=0.3. On the other hand, the mean of the contrast threshold in 
parallel condition is higher in patients than in controls (t=-2.2, p=0.021), 
consistent with higher surround suppression, but within-subject comparison by 
computing the surround suppression index, showed this not to be significant. 
Therefore, its relevance is unclear. Since the psychophysics test is presumed to 
reflect cortical GABAergic function, we subdivided the patients into two groups 
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according to whether or not they were on drugs that are known to interact with 
GABA (Table 4.5). There was no difference in the SSI for these two groups. 
Furthermore, including the presence or absence of drugs with GABAergic effects 
as a predictor in the regression analyses, did not explain any additional variance 
(adjusted R2 = 0.316). This was also true when the regression analyses were 
restricted to the epilepsy subjects. In addition, the pattern of drug prescriptions 
for the patients with generalised seizures (GGE and F+) and those without (F-) 
were broadly similar (Figure 4.24, B). We concluded, therefore, that AEDs 
interactions do not underlie the effects of seizure type and age on the surround 
suppression.  
We next sub-grouped the epilepsy group with respect to seizure type (Berg et 
al., 2010). Patients with focal epilepsy and a history of a generalised tonic-clonic 
seizure were compared with focal and GGE (Figure 4.20 and  
Figure 4.21). Interestingly, regression and analysis of ANOVA showed a clear 
difference between patients with exclusive focal seizures and all the other 
groups (p<0.001). Our original hypothesis had been that people with epilepsy 
would have a reduced SSI, indicative of lowered inhibitory restraint. Instead, 
results indicated that patients with generalised seizures are not different from 
control subjects, but those with focal epilepsy that does not generalise (F-), have 
a raised SSI. This surprising finding contrasts with the reduced SSI in other 
groups: people with schizophrenia (Tadin et al., 2006), depression (Golomb et 
al., 2009), low IQ (Melnick et al., 2013) and aged subjects (Betts et al., 2005, 
Yazdani et al., 2015). The significantly raised SSI in the F- patient group, relative 
to the other epilepsy groups, could not be explained by differences in age or IQ 
(there was no difference in ACE scores between the epilepsy groups). And while 
we cannot fully discount a confounding effect of concurrent depression, this 
117 
 
condition is not known to be differentially associated with the presence, or 
absence, of generalised seizures in patients with focal epilepsy.  
One of the speculations was that the behavioural consequence of surround 
suppression might be more likely to be observed in generalised compared to 
focal epilepsy. However, this result provides evidence that the visual 
psychophysical tests might also be useful in focal epilepsy. It can potentially be 
useful to predict who might have generalised seizures when at first the patient 
is presented with focal epilepsy, a fact that is critical for determining the risk of 
death in SUDEP (Sudden Unexplained Death in Epilepsy). In addition, this might 
explain why the start of a focal seizure could lead to recruiting the whole 
neuronal network in patients with generalised seizures. Perhaps this is 
suggestive of the effectiveness of inhibitory restraint in this group of patients 
(manifest as a higher suppression index). It is possible to speculate that the 
ability to increase the level of inhibition in respond to a seizure focus, protects 
these patients from seizure spread. But, other groups cannot increase their 
inhibitory restraint above controls’ suppression level, and that is why they have 
generalised seizures. This might potentially suggest that an increased 
suppression index could be a sign of a lower risk of SUDEP compared to other 
patients with epilepsy. 
Here we showed that patients with focal seizures without GTCS have distinctive 
surround inhibition compared to other patients groups (Figure 4.25). 
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There are different possible confounders between group of focal seizures and 
patients with generalised seizures, for example mesial temporal sclerosis often 
causes focal seizures, frontal lobe epilepsies often only cause focal seizures, and 
in patients with post traumatic, post stroke or tumour the incidence of GTCS is 
increased. Figure 4.25 demonstrates that those patients who have only focal 
seizures, have larger duration thresholds in the large high contrast. They have 
larger error-bars and more elevated duration thresholds of small high contrast 
compared to the other two groups. This raises the possibility of an inherent 
problem in this patients group due to factors other than motion discrimination.  
It is clear that the results of this group might be less reliable compared to other 
groups. The question that needs to be further studied is that are these patients 
have attentional difficulties?  
 
Figure 4.25. Duration threshold of small high contrast (top row) and large high 
contrast for patients based on their seizure subtypes. Patients with focal no GTCS 
show high thresholds of the large high contrast stimuli.  
 
There are parallels between our study and a previous study of patients with 
migraine, who also showed evidence of increased suppression in a closely 
related perceptual task measuring contrast perception (Battista et al., 2011). The 
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intriguing possibility is that in these patients with focal (non-generalising) 
epilepsy, the pathological activity is kept focussed by an enhanced inhibitory 
restraint. Furthermore, it may therefore be possible to assess the quality of this 
restraint in regions of the cortex far removed from the focal pathology, as we do 
here with an assay of visual cortical function that appears to have relevance to 
foci elsewhere in the cortex. This presents an interesting question concerning 
whether the enhanced surround inhibition is independent of the epilepsy, or has 
arisen in reaction to the pathology, which will be addressed in future studies, 
requiring longitudinal, repeated testing of patients from the time of diagnosis. 
Whilst we have shown these differences between patients and controls, one 
major aim of this project was to see whether psychophysical tests could be a 
useful tool to predict seizures. For this to be the case we needed to see whether 
these once off changes persisted and indeed altered in the run up to a seizure. 
Hence the next set of experiments in the next chapter presents longitudinal data, 
from patients who were tested repeatedly over periods of days to weeks.  
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Chapter 5  Longitudinal study 
 
5.1 Introduction 
The occurrence of seizures is not uniformly distributed in time. They can occur 
as single seizures, or clusters, and it is this inherent unpredictability that causes 
a lot of risks such as higher chances of injury or psychological problems for 
patients. All of these associated risks with seizures decrease the overall quality 
of life in patients with epilepsy (Momeni et al., 2015, Ryan et al., 2015, Vickrey 
et al., 1994, Fisher et al., 2000). Therefore, there has been a great deal of interest 
in finding ways of predicting seizures (Cook et al., 2013) to give patients a better 
chance of avoiding injury, and the possibility of tailoring their medication to the 
current seizure risk.  
Seizure prediction mainly consists of differentiating between preictal (time 
before a seizure) and interictal (time between seizures) signals in the brain. A lot 
of studies have shown that there are changes in the brain prior to seizures 
(Schwartz et al., 2011) and have concluded cortical hyperexcitability as a pre sign 
of the onset of clusters of seizures (Cook et al., 2013, Wright et al., 2006, Badawy 
et al., 2009). A functional MRI (fMRI) study done by Zhao et al. (2007) 
demonstrated focal increases in perfusion and decreases in hemoglobin 
oxygenation prior to seizure generation in one patient with epilepsy. In another 
fMRI study in three patients with intractable focal epilepsy highly significant, 
focal BOLD (Blood Oxygen Level Dependent) signal changes were observed prior 
to onset of seizures. These changes support the existence of a pre ictal state, 
however the changes were contralateral to the presumed seizure focus based 
on the symptoms in two of the patients (Federico et al., 2005). Other studies 
have shown evidence of changes between preictal and during interictal events 
(Perucca et al., 2014, Mormann et al., 2005). A number of studies suggested that 
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power spectral density of the EEG of patients with epilepsy is different before 
and during seizures (Bandarabadi et al., 2015, Park et al., 2011).  Power spectral 
density has been used to design programmable devices to detect seizure activity 
and therefore send an electrical stimulation to stop the seizure activity. 
However, there have been a lot of problems with these studies, such as high 
number of false alarms and low sensitivity of seizure detection. Another 
significant problem with this method is heterogeneity of epileptic pathologies 
and that preictal and interictal events vary largely between patient to patient 
and even with a single patient these patterns could be different from a seizure 
to another (Zhang and Parhi, 2015). The most salient problem is that patients 
either need to have implanted devices or be connected to an EEG system, making 
it complicated for long-term home use.  
In the previous chapter, I showed that people with different frequency of 
epilepsy syndromes appear to have differences in their measured suppression 
indices. We hypothesized therefore that these tests may also be used to follow 
these fluctuations in inhibition-excitation balance. If visual psychophysics are a 
means of indirectly measuring cortical inhibition, then using them might work as 
a way of monitoring and possibly an alternative tool to predict patients’ seizures. 
This is what I test in this chapter; the performance of a number of patients with 
epilepsy were assessed in a longitudinal method to investigate whether there 
are changes in the inhibition in the run up to a seizure. Their performance were 
tested repeatedly over periods of days to weeks to observe their suppression 
indices variability over that period of time corresponding to their seizures in 
order to detect these extreme rare events (seizures). 
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5.2 Recruitment of subjects 
Four healthy control participants were recruited for longitudinal test (3 male; 
mean age: 35.8; age range: 26.3-46.4). One control participant only took part in 
the motion discrimination task and 3 completed both the motion discrimination 
and contrast detection tasks.  
Twenty patients with epilepsy were recruited for this longitudinal study, but four 
were unable to run the tests unaided, and so were excluded from further analysis 
(Table 5.1). Twelve patients were recruited from the video telemetry 
department of Royal Victoria Infirmary (RVI), 2 from a local epilepsy support 
group, and 6 from epilepsy clinics of RVI. Data of seven patients for the motion 
discrimination and 6 for the contrast detection tasks are presented as boxplots 
with respect to their timing of seizures. The rest of patients’ suppression indices 
are shown in boxplots according to the time of their tests.  
Table 5.1. Description of type of epilepsy in the longitudinal patients 
Type of epilepsy-Aetiology Number of longitudinal patients 
Focal -unknown  9 
Focal -structural-metabolic 6 
Generalized -genetic 1 
 
5.3 Experimental protocol 
Tests were done on Samsung and Acer computer tablets (Table 2.1). Similar 
protocols that were explained in chapter 2 were followed for both the motion 
discrimination and the contrast detection tasks. Those who were recruited from 
the video telemetry department completed the tests in their hospital rooms; 
others took computer tablets to their homes. Before starting data collection all 
the patients were seen by the experimenter and had a chance to practice and 
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get familiarised with the equipment. Patients were told to repeat the tests at 
least 2 times per day, and as soon as possible after a seizure. Patients continued 
their medication while they were doing the tests. 
 
The z-score of surround suppression indices for the motion discrimination and 
the contrast detection tasks were calculated using Equation 2.4, and based on 
the known time for a seizure, before and after points of that seizure were 
extracted.  
 
These numbers were then plotted in boxplots as bee swarm plots (plot spread 
points) using MatLab to present the spread of data points, outliers and the 
median in each group. 
 
5.4 Results 
5.4.1 Controls showed surround suppression fluctuations during different 
times of a day or week 
Results of surround suppression index of four controls during 4-5 continuous 
days are shown in Figure 5.1 and Figure 5.2. The upper panel in each figure 
respresents data collected from the motion discrimination task (Motion SI), and 
the bottom panel data from the contrast detection task (Contrast SI). 
Participants did the tests following each other, so each data point from upper 
and bottom panel were corresponding to one single point of time and one single 
run. Red data points are corresponding to the tests done before 12 in the 
morning and blue data points to those after 12 pm. Dotted vertical lines show 
the start and end of each day. If data points are not shown in any of the panels, 
it means that participant did not complete the test on that time of the day. 
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Figure 5.1. Longitudinal results of two control participants for motion 
discrimination task (Motion SI) and contrast detection task (Contrast SI). Y axes 
represents suppression index and x axes the time of the day at which the test 
was performed. Dotted lines show the end of each day of data collection. Data 
collection was done in continuous days. Blue and red points show data collected 
in the afternoon and before noon, respectively. Error bars represent 95% 
confidence intervals. 
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Figure 5.2. Longitudinal results of two more longitudinal control participants: top 
figure representing results of one control for the motion discrimination task 
(Motion SI) and contrast detection task (Contrast SI) and Bottom figure 
representing the motion discrimination task. This control did not perform the 
contrast detection task. Y axes represents suppression index and x axes the time 
of the day at which the test was performed. Dotted lines show the end of each 
day of data collection. Data collection was done in continuous days. Blue and red 
points show data collected in the afternoon and before noon, respectively. Error 
bars represent 95% confidence intervals. 
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5.4.2 There is no indication of a link between circadian rhythm and 
fluctuations in the suppression indices  
There is evidence suggesting that circadian changes might have interactions with 
epilepsy. The circadian rhythm is the system that makes organisms to be able to 
adapt to their environment with a cycle period of 24 hour. The primary circadian 
clock in mammalian is located in the cells of suprachiasmatic nuclei (SCN) 
situated in the anterior hypothalamus (Quigg, 2000). The circadian system is 
modulated by the external solar light and there are some evidence showing a 
link between seizures and their occurrence at nights in some types of epilepsy 
(Scheffer et al., 1995, Hofstra and de Weerd, 2009, Pung and Schmitz, 2006). 
Epilepsy and sleep have been studied greatly. For example, non-REM stage of 
sleep can increase the chance of partial seizures (Bazil and Walczak, 1997). We 
could not run the visual psychophysical tests during the subjects’ sleep, however 
they were advised to run the tests between 2 to 3 times per day. Therefore, 
boxplots of controls (Figure 5.3) and patients (Figure 5.4) were plotted in order 
to find any difference between fluctuations of suppression indices and time of 
the day.  
 
127 
 
 
Figure 5.3. Bee swarm boxplots of controls showing their motion suppression 
index before noon (in red AM) and after noon (in blue PM).   
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Figure 5.4. Bee swarm boxplots of 16 patients showing their motion suppression 
index z-score before noon (in red AM) and after noon (in blue PM). Every two 
boxplots belongs to one patient and the lack of a boxplot for any patient 
indicates that patient did not perform the motion discrimination task in that time 
period of that day.  
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Figure 5.5 captures a plot of boxplots comparing all the patients and controls 
based on the time of performing the test (before noon (AM) and after noon 
(PM)). 
Figure 5.5. Bee swarm boxplots of all sixteen patients (in orange) and four 
controls (in green) with their motion suppression index z-scores before noon 
(AM) and after noon (PM).  
 
5.4.3 Patients and controls showed non-significant difference in variations in 
suppression indices 
When considering the differences in the two groups with repeated 
measurements, it is important to study both the between subject and within-
subject variations. To do so, first suppression indices of controls and patients 
were normalised to their mean and then were plotted in Figure 5.6 for the 
motion discrimination task and in Figure 5.7 for the contrast detection task. 
Similarly, Figure 5.8 and Figure 5.9 demonstrate normalised suppression indices 
for all the individual participants. Nine patients did not have any seizures during 
the course of the test. The number of seizures out of the overall duration of the 
test is shown on the top of Figure 5.8 and Figure 5.9. For example 3(25) means 
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that this patient had 3 seizures in 25 days of running the test. And where there 
is no number it simply means that this patient did not have any seizures.   
Figure 5.6. Bee swarm plots of pooled data of normalised suppression index for 
all the patients (in orange) and controls (in green) for the motion discrimination 
task.  
Figure 5.7. Bee swarm plots of pooled data of normalised suppression index for 
all the patients (in orange) and controls (in green) for the contrast detection task.  
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Figure 5.8. Bee swarm plots of pooled data of sixteen patients and four controls 
in the motion discrimination task. The number of seizures and the duration in 
days for which the patients repeated the tests are shown in the figure. Thoese 
patients who are not enumerate did not have any seizures. 
Figure 5.9. Bee swarm plots of pooled data of sixteen patients and three control 
subjects in the contrast detection task. One control did not perform the contrast 
detection task. The number of seizures and the duration in days for which the 
patients repeated the tests are shown in the figure. Those patients who are not 
enumerated did not have any seizures. 
 
132 
 
Figure 5.8 and Figure 5.9 show participants variability in their surround 
suppressions as boxplots. However, it is necessary to calculate the variability in 
the suppression indices in both between subjects and within-subjects. The 
estimate of the variability in the patients and control groups are shown in 
Table 5.2. 
Table 5.2. Estimated standard deviations of between and within subjects 
 
 
 
 
 
 
 
 
 
A non-parametric Levene's test showed equality of between-subject variances in 
both controls and patients (Motion suppression index: p=0.46; Contrast 
suppression index: p=0.06; with data being the mean suppression index obtained 
across repeated measurements for each person). To compare the within-subject 
error, we computed the SD of the repeated measurements for each person, so 
ending up with a set of within-subject SDs for patients and for controls. A non-
parametric Mann-Whitney U test indicated that these did not differ significantly 
(Motion suppression index: Mann-Whitney U=11, p=0.05 (two-tailed); Contrast 
suppression index: Mann-Whitney U=20, p=0.7). 
 PATIENTS (n=16) CONTROLS 
 Motion 
suppression 
index 
Contrast 
suppression 
index 
Motion 
suppression 
index (n=4) 
Contrast 
suppression 
index (n=3) 
Between 
subjects 
error 
0.367 0.159 0.195 0.080 
Mean 
within-
subject 
error 
0.258 0.283 0.135 0.276 
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We were also interested to find whether there is any relationship between 
fluctuations in suppression indices and patients’ time of seizures, because for 
the visual psychophysics to be a useful predictor of seizures it must provide us 
with a detectable change leading up to a seizure. Therefore, patients’ data were 
separated into four individual groups with respect to their seizures over the time 
course of participation. These groups were data from “before a seizure”, “after 
a seizure”, “other” data points which were times when no seizure was reported, 
and “overall data points” which was the pooled collection of all data points. Since 
there were occasions that patients did not know the exact time of their seizures, 
or did not properly record them, three different timescales were considered: 24 
hour, 12 hour, and 6 hour before and after a seizure.  
Only seven patients had seizures during the time of participation in the 
longitudinal task. The following plots demonstrate data of seven individual 
patients for motion discrimination and contrast detection tasks as bee swarm 
and longitudinal plots.  
Figure 5.10 demonstrates bee swarm figure of one of these patients with 
presumed temporal focal dyscognitive seizures on the motion discrimination 
task. There was a change of medication in the time course of participation in this 
patient, in which Perampanel was added to reduce the number of seizures 
(started with 6mg which was later increased to 8mg). After this point, some 
adverse behavioural changes were observed in the patient. There seems to be 
an elevated suppression index in both before and after seizure groups, however 
it is not clear whether this was due to medication or different underlying 
neuronal mechanisms. Student’s t test (unpaired t-test) showed significant 
differences between before a seizure and other data points (t=3.08, p=0.03) and 
between after a seizure and all data points (t=5.5, p<0.001) in all conditions. This 
patient declined performing the tests after a few days of starting Perampanel, 
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and further correspondence was unsuccessful. Therefore, it was impossible to 
gather further data to increase the sample size and to capture more seizures in 
order to increase the data points in “before” and “after” a seizure groups. The 
fact is that most of the data points are in the “other” group and the result of the 
analysis could be distorted with some data points as outliers in the “other” 
group. As it is clear in further figures for the rest of patients, we did not find any 
significant difference between any of the groups. 
Figure 5.10 to Figure 5.23 show bee swarm results of the rest of patients who 
did the longitudinal tests. Detailed description of each patient is included in 
corresponding figure legend. Note that y-axis in the bee swarm plot are the z-
score representation. There was no significant difference between times of 
seizures and other data points in the other patients. Therefore, there was no sign 
of a consistent relationship between the times of seizures and suppression 
indices. 
 
Figure 5.10. Longitudinal results of a patient (EP01) representing results of the 
motion discrimination task (Motion SI) and contrast detection task (Contrast SI). 
Y axes represents suppression index and x axes the time of the day at which the 
test was performed. Dotted lines show the end of each day of data collection. 
Data collection was done in continuous days. Blue and red points show data 
collected in the afternoon and before noon, respectively. Black circles show the 
exact time of seizures. Error bars represent 95% confidence intervals. 
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Figure 5.11. Bee swarm plots representing longitudinal results of a patient (EP01) 
in the motion discrimination task. Y-axis represents SSI Zscores .The duration of 
participation was 1 month, during which 3 seizures were reported. This patient 
was diagnosed with (presumed) temporal focal dyscognitive seizures with 
frequency of more than one per week. Medication was Levetiracetam and 
Pregabalin. Perampanel was added later after which, the patient showed severe 
behavioural changes.   
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Figure 5.12. Longitudinal results of a patient (EP02) representing results of the 
motion discrimination (Motion SI) and contrast detection tasks (Contrast SI). Y 
axes represents suppression index and x axes the time of the day at which the 
test was performed. There were 4 weeks between the two set of data collection. 
Dotted lines show the end of each day of data collection. Data collection was 
done in continuous days. Blue and red points show data collected in the 
afternoon and before noon, respectively. Black circles show the exact time of 
seizures. Error bars represent 95% confidence intervals. 
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Figure 5.13. Bee swarm plots representing longitudinal results of a patient (EP02) 
in the motion discrimination (left panel) and contrast detection tasks (right 
panel). Y-axis represents SSI Zscores .The duration of participation was around 2 
weeks, during which 3 seizures were reported. This patient was diagnosed with 
temporal focal dyscognitive seizures with frequency of more than one per week 
as clusters. The medication was Lamotrigine and Pregabalin. 
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Figure 5.14. Longitudinal results of a patient (EP03) representing results of the 
motion discrimination (Motion SI) and contrast detection tasks (Contrast SI). Y 
axes represents suppression index and x axes the time of the day at which the 
test was performed. Motion discrimination task data collection was shorter than 
the contrast detection task because the results of staircases were inconclusive. 
Dotted lines show the end of each day of data collection. Data collection was 
done in continuous days. Blue and red points show data collected in the 
afternoon and before noon, respectively. Black circles show the exact time of 
seizures. Error bars represent 95% confidence intervals. 
 
 
 
 
 
 
 
139 
 
 
 
Figure 5.15. Bee swarm representing longitudinal results of a patient (EP03) in 
the motion discrimination (left panel) and contrast detection tasks (right panel). 
Y-axis represents SSI Zscores. Five seizures were reported during the time of 
participation. This patient was diagnosed with (presumed) fronto-temporal focal 
dyscognitive and absence seizures with frequency of more than one per week. 
The medication was Sodium Valproate and Lamotrigine. 
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Figure 5.16. Longitudinal results of a patient (EP04) representing results of the 
motion discrimination task (Motion SI) and contrast detection task (Contrast SI). 
Y axes represents suppression index and x axes the time of the day at which the 
test was performed. Dotted lines show the end of each day of data collection. 
Data collection was done in continuous days. Blue and red points show data 
collected in the afternoon and before noon, respectively. Black circles show the 
exact time of seizures. Error bars represent 95% confidence intervals. 
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Figure 5.17. Bee swarm representing longitudinal results of a patient (EP04) in 
the motion discrimination (left panel) and contrast detection tasks (right panel). 
Y-axis represents SSI Zscores. The duration of participation was 27 days, during 
which 5 seizures were reported. This patient was diagnosed with frontal focal 
dyscognitive seizures with frequency of more than one per week. The medication 
was Sodium Valproate, Pregabalin, Eslicarbazepine, and Phenobarbitone. 
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Figure 5.18. Longitudinal results of a patient (EP05) representing results of the 
motion discrimination (Motion SI) and contrast detection tasks (Contrast SI). Y 
axes represents suppression index and x axes the time of the day at which the 
test was performed. Dotted lines show the end of each day of data collection. 
Data collection was done in continuous days. Blue and red points show data 
collected in the afternoon and before noon, respectively. Black circles show the 
exact time of seizures. Error bars represent 95% confidence intervals. 
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Figure 5.19. Bee swarm plots representing longitudinal results of a patient (EP05) 
in the motion discrimination (left panel) and contrast detection tasks (right 
panel). Y-axis represents SSI Zscores. The duration of participation was 17 days, 
during which 6 seizures were reported. This patient was diagnosed with 
nocturnal seizures initiated from temporal lobe with possible abnormality in left 
hippocampus. The frequency of seizures was more than one per week. The 
medication was Pregabalin, Levetiracetam, Tegretol, Phenytoin, and Clobazam. 
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Figure 5.20. Longitudinal results of a patient (EP07) representing results of the 
motion discrimination (Motion SI) and contrast detection tasks (Contrast SI). Y 
axes represents suppression index and x axes the time of the day at which the 
test was performed. Dotted lines show the end of each day of data collection. 
Data collection was done in continuous days. Blue and red points show data 
collected in the afternoon and before noon, respectively. Black circles show the 
exact time of seizures. Error bars represent 95% confidence intervals. 
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Figure 5.21. Bee swarm plots representing longitudinal results of a patient (EP07) 
on motion discrimination (left panel) and contrast detection tasks (right panel). 
Y-axis represents SSI Zscores. The duration of participation was 33 days, during 
which 6 seizures were reported. This patient was diagnosed with temporal lobe 
epilepsy with left mesial temporal sclerosis. The frequency of seizures was more 
than one per week. The medication was Clobazam, Epilim (sodium valproate), 
and Carbamazepine. 
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Figure 5.22. Longitudinal results of a patient (EP09) representing results of the 
motion discrimination (Motion SI) and contrast detection tasks (Contrast SI). Y 
axes represents suppression index and x axes the time of the day at which the 
test was performed. Dotted lines show the end of each day of data collection. 
Data collection was done in continuous days. Blue and red points show data 
collected in the afternoon and before noon, respectively. Black circles show the 
exact time of seizures. Error bars represent 95% confidence intervals. 
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Figure 5.23. Bee swarm plots representing longitudinal results of a patient (EP09) 
on motion discrimination (left panel) and contrast detection tasks (right panel). 
Y-axis represents SSI Zscores. The duration of participation was 12 days, during 
which 3 seizures were reported. This patient was diagnosed with generalised 
tonic clonic epilepsy with complex partial seizures. The frequency of seizures was 
around 1 every two months. The medication was Lamotrigine and Topiramate. 
 
Figure 5.24 shows bee swarm figures of data pooled from all the patients based 
on 24 hour, 12 hour and 6 hour before and after a seizure along with other data 
points. Statistical tests did not show any significant difference among the groups. 
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Figure 5.24. Bee swarm plots of all the patients pooled according to 24 hour, 12 
hour and 6 hour before and after a seizure. Other points demonstrate those 
times that were not associated with a seizure. Note that y-axis is the z-score 
representation 
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Figure 5.25 shows boxplot figures of 24hr, 12hr and 6hr before a seizure for all 
the patients in the motion discrimination (top figure) and the contrast detection 
tasks (bottom figure). Statistical tests indicated no significant differences 
between the groups. 
 
Figure 5.25.  Bee swarm figures of the motion discrimination task (top) and the 
contrast detection task (bottom) for all the patients 24 hr, 12 hr and 6 hr before 
a seizure. Note that y-axis is the z-score representation. 
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5.5 Discussion 
Longitudinal tests of the motion discrimination and contrast detection tasks 
were performed on 20 patients with epilepsy and 4 healthy controls. Only seven 
patients had seizures during the longitudinal test, and therefore data analysis of 
these seven patients were provided in details in this chapter. In chapter 4 we 
found a significant difference between patients and controls in the motion 
suppression indices measured at a single time point, and so in this chapter we 
investigated the possibility of a link between inhibitory fluctuations and 
occurrence of seizures in patients with epilepsy using visual psychophysical tests. 
We hypothesized that these fluctuations reflect an altered state of excitability 
and inhibitory forces in patients and could therefore be a used as an indication 
or warning for predicting a seizure. We speculated that patients with epilepsy 
will show variation in their suppression indices, and variations below a 
hypothetical threshold might suggest a relationship with timing of their seizures. 
Accordingly, controls would display no, or less, variation in the measured 
surround suppressions compared to patients (Figure 5.26 to Figure 5.28).  
 
 
 
 
 
 
Figure 5.26. Examples of fluctuations in surround suppression in a control (in 
blue) and a patient (in red). Shift in the baseline or fluctuation can produce a 
seizure. 
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Figure 5.27. Examples of fluctuations in surround suppression in a control (in 
blue) and a patient (in red). Increase in the fluctuations in red might produce a 
seizure (here in red). 
 
 
 
 
 
 
Figure 5.28. Examples of fluctuations in surround suppression in a control (in 
blue) and a patient (in red). Another example of occurrence of a seizure could be 
with shifted baseline along with increased fluctuations (here in red). 
 
In order to obtain results, twenty patients agreed to perform the tests in over 
periods of 1 week to 2 months, repeating the tests at least twice a day. They 
were asked to continue doing the tests until they had more than two seizures. 
This was done to ensure having minimum 2 points of seizures to perform the 
assessment between seizures and non-seizures data points.  Final assessment 
revealed that only 7 people with epilepsy had seizures during the course of 
participation and the remaining declined to perform the test, or could not use 
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the tablet computers (even after training). The experimenter had regular visits 
to patients’ houses to ensure patients were following the correct protocol. 
Results from these 7 patients are shown in Figure 5.10 to Figure 5.23. The 
outcome of these plots did not point to any significant relationship between the 
fluctuations and timing of seizures that was also consistent in all of the patients. 
Only one of the patients (EP01), shown in Figure 5.11, had significant difference 
in suppression indices among the groups of before, after, and other data points. 
Due to worsening of seizures, this patient was prescribed with Perampanel at 
the same time of performing the tests. Perampanel is an alpha-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist which reduces 
excitatory synaptic transmission. Although the frequency of seizures decreased 
dramatically, it resulted in distress and violent behaviour. Perampanel is a 
relatively new drug with potential impact on the prognosis of patients with 
intractable focal onset seizures (Ledingham and Patsalos, 2013, Plosker, 2012), 
however there is at least one more report on similar observations of side effects 
in a patient with intellectual disability to what is reported here (Dolton and 
Choudry, 2014, Schulze-Bonhage and Hintz, 2015). This patient had normal 
intellectual ability, with no sign of depression. 
To investigate the variations in suppression indices of patients and controls, box 
plot figures of individual participants were plotted in Figure 5.8 and Figure 5.9 
and the between- and within-subject errors were calculated in Table 5.2. The 
results showed that patients had higher between- and within-subject errors. 
However, non-parametric tests indicated that the difference was not significant. 
One possible reason might be because of the small number of controls (n=4) 
compared to 16 patients in the longitudinal test. In addition, patients had 
repeated the test much longer than controls. This is worth investigating in a 
future study with more control subjects. 
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The purpose of this chapter was to investigate whether visual psychophysical 
tests could be a suitable tool for assessing seizure susceptibility at home. There 
were different problems that were impossible to overcome during this study, 
however are potential examples that must be considered for future studies. For 
example, small number of sample sizes in both groups. Specifically, for patients 
group the fact that 20 people with epilepsy were originally recruited and only 7 
of them managed to finish shows how difficult it is to perform clinical research 
in epilepsy. All these patients were from the group of patients with frequent 
seizures, however in practice we could only capture a small number of seizures 
in each patient. Perhaps continuing the study could help increase this number, 
however it was not possible within the time frame of this study. In addition, 
despite all the efforts of the experimenter to make the task as user friendly as 
possible, yet some people with epilepsy found it difficult to work with.  
In conclusion, results from this chapter showed that both control participants 
and patients with epilepsy has fluctuations in their suppression indices. 
Longitudinal data showed no strong link between timing of seizures and 
suppression indices in patients. Further non-parametric analyses showed no 
significant difference between variations in between subject and within-subject 
errors among patients and controls. Future studies are necessary to draw any 
strong conclusion. 
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Chapter 6  Results from India cohort 
 
6.1 Introduction 
One of the obstacles for recruiting patients in Newcastle was that recruitment 
was very slow. Therefore, as an addition to the original study, 56 patients and 25 
healthy controls were recruited as part of collaboration between Institute of 
Neuroscience (IoN) in Newcastle and the Institute of Neurosciences Kolkata (INK) 
in India (INK; http://www.neurokolkata.org/). Patients’ recruitment was done by 
Dr. Jenny Read and collaborators in India.  
In this chapter I present results of 56 patients with confirmed epilepsy (37 male; 
average age: 33.7; range: 17.9-64.6) along with 25 healthy controls with age and 
sex matched to patients (17 male; average age: 30.65; range: 18.16-60.5). 
Patients with epilepsy were confirmed based on their medical history and 
neurological examination from epilepsy clinics of INK. Control participants were 
recruited from staff of INK or the accompanying family members. Further 
information about the patients are listed in Appendix 3 . The general analysis 
followed that performed on the Newcastle cohort, but these are presented 
separately because of subtle differences between the India and Newcastle data 
sets.   
 
 
 
155 
 
6.2 Significant relationship between motion suppression indices with age, but 
no relationship between contrast suppression indices and age in the India 
cohort 
Figure 6.1 shows duration thresholds of 55 patients with epilepsy and 25 healthy 
controls in India. Indian patients and controls showed higher durations 
thresholds compared to those in Newcastle (Figure 6.1 compared to Figure 4.3). 
Next the relationship between motion suppression index and contrast 
suppression index were investigated. Similar to results of Newcastle, there was 
a significant relationship between motion suppression indices and age in both 
patients and healthy participants. Figure 6.2 shows the regression lines with 
p=0.013 for healthy controls, and p<0.001 for patients. 
 
Figure 6.1. Duration thresholds of 25 controls and 55 patients with epilepsy in 
India as a function of age. Error bars show 95% confidence intervals. Lines show 
regression with age; solid line is where the regression of duration threshold with 
age is significant, dashed lines where it was non-significant. R2 and p values are 
marked in each panel. 
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Figure 6.2. Motion suppression index as a function of age for 55 patients with 
epilepsy (in triangles) and 25 healthy participants (in circles). There was a 
significant relationship between suppression indices and age in both groups. For 
patients: Index=-0.0075*Age(in years)+0.3317, R2=0.217, P<0.001, For controls: 
Index = -0.0077*Age(in years)+0.3804, R2=0.238, p=0.013. 
 
Figure 6.3 shows contrast thresholds for controls and patients in India. Indian 
patients and controls show higher contrast thresholds compared to participants 
in Newcastle. Similar to Newcastle, patients and controls in India showed more 
variability and higher thresholds in the parallel condition. 
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Figure 6.3. Contrast thresholds of 25 controls and 55 patients with epilepsy in 
India as a function of age. Error bars show 95% confidence intervals. Lines show 
regression with age; solid line is where the regression of contrast threshold with 
age is significant, dashed lines where it was non-significant. R2 and p values are 
marked in each panel. 
 
 
 Figure 6.4 shows contrast suppression indices as a function of age and 
consistent with results in Newcastle, there was no significant relationship 
between age and contrast suppression indices in both patients and controls). 
This further confirms the differences between the two tasks that were further 
shown in Newcastle.  
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Figure 6.4. Contrast suppression index as a function of age for 56 patients with 
epilepsy (in blue) and 25 healthy participants (in purple). There was non-
significant relationship between suppression indices and age in both groups. For 
patients: patients Index=-0.002*Age (in years)+0.6144, R2=0.016, P=0.35, for 
controls: Index=-0.002*Age(in years)+0.813,  R2=0.005, p=0.75 
 
 
 
6.3 Significant difference in suppression indices between patients and 
controls in Newcastle and India 
Average of indices of patients and controls in Newcastle and India were plotted 
for the motion discrimination and contrast detection tasks in  
Figure 6.5. Suppression indices of patients and controls in India were greatly 
lower for the motion discrimination task relative to participants in Newcastle. 
This was also observed in Figure 6.1 which shows patients and controls in India 
have shorter duration thresholds compared to participants in Newcastle. 
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In addition, contrast suppression indices were higher in comparison with motion 
suppression indices at both Newcastle and India. And, while mean of contrast 
suppression in healthy control subjects is lower than patients in Newcastle, 
controls in India showed higher mean of contrast suppression index. The 
difference in mean of contrast suppression index of controls in Newcastle and 
India was significant with t=2.03 and p=0.003. Figure 6.3 shows that Indian 
controls and patients have higher contrast thresholds compared to participants 
in Newcastle. 
 
Figure 6.5. Comparison of motion and contrast suppression indices in patients 
and healthy control participants of Newcastle and India. Error bars are standard 
error of means. 
 
Comparing summation indices, Indian controls had significantly higher 
summation index compared to controls in Newcastle (t-test; t=2.07, p=0.008) 
with average of 0.6 compared to 0.3. There was no significant difference in the 
summation indices between patients in India and Newcastle.  
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6.4 Analysis of psychophysics data with respect to seizure frequency in the 
India cohort 
Individual suppression indices were plotted for each frequency scale (Figure 6.6) 
in both the motion discrimination and contrast detection tasks along with the 
controls. Average of each seizure frequency was then calculated and plotted on 
each scale (black diamonds). Age was found to have a significant relationship 
with the suppression indices in the motion discrimination task. Using a multiple 
regression analysis, age but not grading was found to be a significant predictor 
of motion suppression index (age: beta:-0.008, t=-4.8, p<0.001; grading: beta: 
0.006, t=0.4, p=0.69). That is, on average motion suppression index decreases by 
0.08 with each decade of age, similar to the decrease of 0.06/ decade found in 
Newcastle (Yazdani et al., 2015). The overall model explains 22% of the variance 
in the motion suppression index (F(2, 74) = 11.8, p<0.001, adjusted R2=0.22). 
Therefore, I conclude that there is a non-significant correlation between the 
motion suppression index and seizure frequency, after controlling for the effect 
of age in India cohort (Figure 6.6, top panel).Multiple regression analysis showed 
that age and grading were not significant predictors of the contrast suppression 
index (age: beta=0.002, t=0.6, p=0.5; grading: beta=-0.011, t=-0.4, p=0.6). 
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Therefore, there is no relationship between seizure frequency and the contrast 
suppression index (Figure 6.6, bottom panel). 
 
Figure 6.6. Suppression indices for patients in India as a function of seizure 
frequency. Top panel represents motion suppression and bottom panel contrast 
suppression indices for individual patients (red circles). Suppression indices of 
healthy controls are shown in green circles. Black diamonds represent average 
of suppression index within each group.  
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Similar to the analysis that was performed in Newcastle, patients from India 
were divided into two different groups of frequent and infrequent seizures 
according to their seizure frequency starting from 1 to 5 (based on Table 4.1- 
Grading A). In order to examine whether results of this grouping were robust, 
the same data but with the shifted threshold between the frequent and 
infrequent seizures were plotted and named as Grading B. Figure 6.7 and 
Figure 6.8 show the distribution of data as boxplot figures for Grading A and 
Grading B in the motion discrimination and the contrast detection tasks.  
 
Figure 6.7. Boxplots of the motion and contrast suppression indices for Grading 
A of patients and controls in India.  
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Figure 6.8. Boxplots of the motion and contrast suppression indices for Grading 
B of patients and controls in India.  
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6.5 No significant difference within the groups of controls, patients with 
frequent and patients with infrequent seizures in India cohort 
Analysis of comparison between the indices in the groups of controls and 
patients with frequent and infrequent seizures are the following sections:  
6.5.1 Results of grading A 
There were 9 patients with frequent seizures, 43 with infrequent seizures, and 
25 healthy controls in grading A. A significant regression equation for pooled 
data was found in the motion discrimination task (F=23.37, p<0.001), with R2= 
0.23 (Motion suppression index = -0.008*Age + 0.356), however regression 
analysis was non-significant in the contrast detection task (p=0.538).  Scatter plot 
of residuals for the motion discrimination task is shown in Figure 6.9. This plot 
showed that the regression model was relatively good in capturing all the data 
points and data points were randomly scattered around the line of y=0. This 
figure pointed to two possible outliers in the population.  
Figure 6.9. Scatter plot of residuals calculated from linear regression analysis for 
the motion discrimination task for 77 Indian participants. Predicted value by the 
regression model is on x-axis and the distance from horizontal line y=0 shows 
how well the model was for each data point. 
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Figure 6.10. Q-Q plot of the motion suppression indices indicating a normally 
distributed data. Black circles represent all 77 Indian participants.  
 
In order to check data normality, a Q-Q plot was created (Figure 6.10). This figure 
demonstrated that the population was normally distributed with most of the 
points aligned on the diagonal line. This figure also showed one likely outlier data 
point. Levene’s test showed data was homogeneous (p=0.876). Therefore, as 
these data sets show a good approximation to a normal distribution ANOVA and 
ANCOVA tests were performed.  
ANCOVA analysis further confirmed age to be a significant covariate (F=20.1, 
p<0.001). Further analysis showed no significant difference between the groups 
(F=2.1, p=0.12).   
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Q-Q analysis of the contrast detection task showed that data has a normal 
distribution (Figure 6.11), and therefore ANOVA analysis was performed to 
identify any possible differences within the groups. Data analysis showed no 
significant difference between the groups (F=0.6, p=0.6). 
 
Figure 6.11. Normal Q-Q plot of the contrast suppression indices. Black circles 
represent all 78 Indian participants. Normally distributed data will lie 
approximately on the black straight line. 
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6.5.2 Results of grading B: 
There were 17 patients with frequent seizures, 35 with infrequent seizures, and 
25 healthy participants. Analysis of covariance (ANCOVA) confirmed age to be a 
significant factor in the motion discrimination task with F=20.4, p<0.001. Further 
analysis showed that there was no significant difference between the groups 
after controlling for age (F=1.34, p=0.3).  
ANOVA analysis showed no significant difference within the groups in the 
contrast detection task, F=0.47, p=0.63. 
 
Therefore, there was no significant difference within the controls and patients 
with frequent and infrequent seizures in India cohort. 
 
6.6 Suppression index as a function of number of Anti Epilepsy Drugs (AED) 
in India cohort 
As AEDs could be a possible confound, mean of suppression indices were plotted 
as a function of number of AEDs in India (Figure 6.12). 
ANOVA analysis only indicated a significant difference between the mean of the 
motion suppression indices of patients who are on three AEDs compared to four 
with p=0.05. 
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Figure 6.12. Mean of motion (A) and contrast suppression (B) indices as a 
function of number of AEDs. Error bars are standard error of means (SEM). 
 
To explore the discrepancies observed between Newcastle and India, a group of 
10 Indians (average age=30.1) who live in Newcastle were tested. They had spent 
from 10 years to several decades in India, and between 3 weeks to 14 years in 
Newcastle. The average of the motion suppression index in this group was 
around 0.27 which is very close to the average of control participants in 
Newcastle (0.3) and much higher than the average in India (0.14) (t=-1.9, df=33, 
p=0.06 (two tail)). It is worth mentioning that the p value of 0.06 is close to 
significance. A power analysis showed that recruiting 8 more participants would 
help achieve a definite answer (95% confidence interval, sample size=18). 
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6.7 Discussion 
Analysis of patients in India did not show any significant difference between 
patients and healthy controls. Moreover, patients in India did not exhibit 
duration thresholds over 600ms. These findings were in contrast to some of the 
results found in Newcastle. Participants in India showed shorter duration 
thresholds and higher contrast thresholds compared to participants in Newcastle 
(Figure 6.1 and Figure 6.3).  
ANOVA analysis indicated that the number of AEDs had a significant effect on 
the motion surround suppression indices (between 3 and 4 AEDs, p=0.05). 
However, this could be caused by the surprising negative mean of the motion 
suppression index in patients who were on three AEDs in India, or the high 
standard error of mean in patients with four AEDs.  
Participants in India demonstrated a similar relationship with age in the motion 
discrimination and the contrast detection tasks to participants in Newcastle.  
The mean of the motion suppression index in India was significantly lower than 
the measured motion suppression in participants in Newcastle in both patients 
and controls (p<0.001). In the contrast detection task, controls in India had 
significantly higher suppression indices compared to controls in Newcastle 
(p<0.001).  
When considering the age differences between groups, a multiple regression 
analysis showed a non-significant relationship between the motion and contrast 
suppression indices and seizure frequency. The other observed difference 
between Newcastle and India was that patients in India did not show any 
duration threshold over 600ms. In addition, a group of 10 Indians who live in 
Newcastle were tested and showed very similar results to participants in 
Newcastle.  
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These intriguing differences in results between Newcastle and India are highly 
unlikely to be caused by differences in the device that was used, since it was a 
similar computer and program which was shipped to India. Moreover, control 
subjects who did the tests on both devices did not have significantly different 
results.  
Other probable explanations might be in the differences with age or AEDs 
between groups in Newcastle and India. However, participants in India were 
actually younger compared to Newcastle participants. The average age of 
patients with epilepsy in India was 33.73 (range: 17.83, 64.6), compared to 
patients in Newcastle with 42.34 (range: 17, 82.3). Similarly, the average age of 
healthy controls in India was lower than the one in Newcastle. Details of 
information of Indian patients were also checked by an independent neurologist 
who confirmed that there were no significant differences in AEDs that were 
prescribed between Newcastle and India. And in any case this cannot explain the 
observed differences in the control subjects. It should also be noted that these 
patients in India were seen at a clinic which has the standard of a western 
hospital (INK; http://www.neurokolkata.org/) specifically in terms of expertise 
and diagnostic tests.  
 One potential reason for the observed differences could be that infective causes 
are a bigger proportion of Indian cases (Amudhan et al., 2015) due to inadequate 
resources, lower income and education and the low importance given for public 
health aspects of epilepsy. Another possibility might be in dietary differences; a 
recent short study done by Baker et al. (2015) demonstrated that yeast extract 
as a GABA precursor could affect neural responsivity. They measured visual 
evoked potentials in fourteen participants with sine wave gratings flickering at 
various contrasts. Then the same stimuli were tested on them after consuming 
marmite for four weeks. They showed that this intervention reduced neural 
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responses at higher contrasts by up to 20%, but did not change the baseline 
activity to a blank screen. Nevertheless, this is a very preliminary study only 
reported at the European Conference on Visual Perception (ECVP 2015). Other 
studies showed black cumin (a major ingredients in Indian food) might have 
effects on reducing excitability, induction of seizures and improving adverse 
effects of AEDs (Ezz et al., 2011, Bhandari, 2014, Hosseinzadeh and Parvardeh, 
2004, Akhondian et al., 2007). Another study reported Rhizoma Curcumae, a 
common Chinese dietary spice, as an anti-convulsive agent (Ding et al., 2014).  
All these studies point to possible effects of diet on cortical inhibition, however 
more investigation is necessary to draw any strong conclusion.  
 
 
 
 
 
 
 
 
 
 
 
 
172 
 
Chapter 7  General discussion 
 
7.1 Overview  
There are several studies investigating the role of inhibition in maintaining 
proper dynamics of neuronal networks in the cortex with a great range of 
computational models (Ledoux and Brunel, 2011), experimental techniques 
(Muldoon et al., 2015) and novel genetic approaches (Dhindsa and Goldstein, 
2015, Guerrini and Noebels, 2014). A lot of efforts have also been made to find 
a way to predict seizures (Freestone et al., 2015) and improve the lives of 
patients. Although substantial progress has been made by a close relationship 
between clinical, computational and basic epilepsy research in recent years, 
research into human epilepsy is still facing a lot of limitations. There remain 
many questions about the process of seizure generation, termination, and even 
how the anti-epileptic drugs work, but in particular, one significant obstacle in 
seizure prediction is that most of the approaches are invasive and still not 
accurate enough to predict a seizure.  
Endogenous inhibitory mechanisms are believed to restrict the spread of 
epileptic discharges in cortical networks. Similar inhibitory mechanisms also 
influence physiological processing. Therefore, we used psychophysical assays of 
these physiological processing to gather information about the quality of 
inhibitory restraint in individuals with epilepsy. Visual psychophysics is a 
fascinating tool to study the relationship between physical properties of a 
stimulus and its perception non-invasively (Pelli and Farell, 2010). Comparing 
similar patterns of results in the neurophysiology findings to psychophysical 
results, helps experimenters to speculate about the specific neural substrate.  
There are different visual psychophysics paradigms which are believed to 
measure cortical inhibition (Tadin, 2015, Tadin et al., 2003) and the aim of this 
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thesis was to probe some of these methods to investigate whether they could 
be used as a potential tool to predict a seizure in patients with epilepsy. In fact 
visual psychophysics tests have been explored in other clinical disorders such as 
schizophrenia (Tadin et al., 2006, Serrano-Pedraza et al., 2014), autism 
(Koldewyn et al., 2010) and depression (Golomb et al., 2009). However, here for 
the first time visual psychophysical measures of surround suppression have been 
investigated in epilepsy as a way of monitoring and improving treatment. Our 
hypothesis was that if seizures are generated due to the reduction in inhibition, 
then psychophysical evidence of this could be expected to be observed as a 
reduced surround suppression index in patients with epilepsy.  If so, it may be 
manifest not only as a difference between controls and patients, but also as a 
change leading up to a seizure so that it might be used also for prediction rather 
than diagnosis. The idea was that we want to have a simple non-invasive method 
with minimal instructions to set up and run for individuals with epilepsy to 
measure their suppression index for the day and determine how it compares to 
their general average to aid clinical management. This approach must meet 
several requirements, such as be able to predict seizures arising from any part of 
the brain, be accurate and does not produce too many false positives, gives 
enough time for the patients to respond (for example take extra AED), ease of 
use and the ability to do it at home. 
Three different psychophysical paradigms were explored; the motion 
discrimination task in which duration thresholds were measured in high (82%) 
and low contrasts (2.5%), the contrast detection task in which contrast 
thresholds were estimated when the stimulus was surrounded by a stimulus of 
parallel and orthogonal orientations to the background stimulus, and the 
orientation discrimination task in which orientation thresholds were calculated.  
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These methods produce a suppression index which is suggested to reflect 
cortical inhibition. However it has not been clearly established that these 
suppression indices really relate to any aspect of cortical inhibition, and even if 
they all do, it remains possible that they reflect different aspects of cortical 
inhibition.  For instance they might measure cortical inhibition of different areas 
of the cortex. Hence, a way of testing whether these suppression indices do 
reflect similar aspects of cortical inhibition is to examine whether they are 
correlated across a population of different individuals.  
In Chapter 3, I presented these results from a subgroup of healthy controls who 
did both the motion discrimination and the contrast detection tasks following 
each other in the same condition (similar room lighting, distance, time of the 
day). The goal of this chapter was to try to answer the first aim of this thesis 
which was to investigate whether or not these different paradigms of surround 
suppression reflect the same property of the visual cortex. Results indicated for 
the first time that the motion and the contrast suppression indices that are 
widely linked to cortical inhibition in a range of studies were actually not 
significantly correlated and are measuring different aspects of cortical function. 
What this finding shows is that the surround suppression indices that are widely 
used in the literature are in fact not the same and must be used cautiously. We 
found the motion discrimination task to be a more effective task in terms of 
showing differences between controls and patients and in particular in respect 
to patients’ types of seizures. Moreover, I reproduced the previously reported 
correlation between age and the motion discrimination surround suppression 
index (Betts et al., 2005). The contrast suppression index however was not 
correlated with age. This was another evidence to show the lack of correlation 
between the two indices.  
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I also found that the summation index declined with age at a rate of 0.008 per 
year. Control subjects similar to results of Tadin et al. (2003) had longer duration 
thresholds for the large gratings in high contrast, but shorter duration thresholds 
in low contrast. Chapter 3 demonstrated that motion and contrast suppression 
indices are not measuring the same property of the cortex. However, for the 
study of epilepsy because we did not know which measure reflects the network 
relevant in epilepsy we included both of the tests to investigate whether either, 
neither or both show a correlation with frequency of seizures. To do so, patients’ 
suppression indices in the motion discrimination and the contrast detection 
tasks were divided based on two grading (Grading A and B) into patients with 
frequent and infrequent seizures. Since GABAergic blockade is one of the basic 
causes of seizures and epilepsy (Curtis et al., 1970, Schevon et al., 2012), we 
hypothesised that suppression index measured by visual psychophysics may 
perhaps indicate a relationship between the reduced suppression index and 
higher frequency of seizures. Using non-parametric analyses we showed in 
chapter 4 that patients with higher frequency of seizures tend of have higher 
amount of suppression index in the motion discrimination task. However, 
multivariate regression analyses showed that frequency was not a significant 
factor (Table 4.4). This lack of effect of seizure frequency was better observed 
when frequency was plotted for the three seizure subtypes individually 
(Exclusively focal, focal seizures evolving into bilateral convulsive and GGE, 
Figure 4.22).  These plots showed that, patients with exclusive focal seizures 
tended towards a higher seizure frequency. This mismatch in the seizure 
frequency between the groups was the reason to distort my interpretation of 
the effect of frequency in the preliminary analysis of the data. Therefore, we 
concluded that there is a relationship between suppression index and the 
likelihood of seizure generalization and a lack of relationship with seizure 
frequency. This was importantly different to what we previously anticipated in 
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which people with epilepsy would have a reduced suppression index (SI), 
indicative of lowered inhibitory restraint. Instead, we found that as a group, 
patients with generalised seizures are no different from control participants, but 
those with focal epilepsy with no generalization have a raised SI (Figure 4.20 and  
Figure 4.21). The significantly raised suppression index in patients with focal 
epilepsy, relative to the other epilepsy groups, could not be explained by 
differences in age or IQ. And while we cannot fully discount a confounding effect 
of concurrent depression, this condition is not known to be differentially 
associated with the presence, or absence, of generalised seizures in patients 
with focal epilepsy. Drug interactions were difficult to assess because the diverse 
drug regimes in our patient cohorts made it difficult to control for this variable.  
Since the SI is considered to reflect cortical GABAergic interactions, we 
performed several different analyses to compare drugs that are known to 
modulate GABAergic activity and showed that the different epilepsy cohorts had 
broadly similar pharma-profiles. There was also no apparent difference between 
patients with high and those with low suppression indices.  It remains a 
possibility that some AEDs may interfere with performance on the test, but this 
is highly unlikely to explain the differences between the epilepsy groups.  
Multiple regression analysis for the contrast detection task, showed that age and 
grading were not significant predictors of the contrast suppression index (age: 
beta=0.001, t=0.5, p=0.6; grading: beta=0.078, t=1.55, p=0.13) and reported 
none significant relationship between seizure frequency and the contrast 
suppression index (Figure 4.19). This result also provide further evidence to show 
that the motion and the contrast suppression indices are not measuring the 
same property of the cortical inhibition.  
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The association of SSI with age persisted in all groups and the largest increases 
of SI were found in young patients without a history of seizure generalisation. 
This group showed a significantly steeper association which may represent a 
progressive change in the risk of seizure generalization; undoubtedly some 
people in this group will at some stage in their life experience a generalized 
seizure, meaning that they would have moved epilepsy groups in our analysis.  
At an early age, then, these people might be considered “latent” with respect to 
seizure generalization.  
Furthermore, in chapter 4, given the association between seizure generalization 
and SUDEP, and the fact that currently there is no reliable biomarker of SUDEP 
before the occurrence of a generalised seizure, we divided patients based on a 
history of GTCS and compared them against each other and the control group. 
Results showed a significant difference between patients with focal seizures and 
all the other groups. Specifically, patients with exclusive focal seizures had higher 
average of motion suppression index and patients with focal seizures evolving 
into bilateral convulsive seizures had the lowest suppression index (Figure 4.23). 
We suggest that the suppression index may prove to be a promising candidate 
for a SUDEP biomarker: the raised SI seen in patients who have never previously 
had a generalised seizure indicating a lower risk of SUDEP, whereas the normal 
SSI seen in patients with a history of generalised seizures indicating a higher risk. 
Since SSI also tends to decrease with age, this index will be most useful for 
patients who develop, or are diagnosed, epilepsy early in life. This could be 
interpreted that patients with focal seizures, might have an ability to increase 
inhibition as a response to a seizure focus and therefore are less likely to develop 
a generalised seizure and suggest that patients with higher suppression index 
(stronger inhibition) are potentially in less risk of SUDEP.  
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One of the main hypothesis of this thesis was whether visual psychophysics could 
be used in a clinic to help with managing patients care. These tests are simple 
and non-invasive, however it takes time and patience for the patients to learn 
them. However, it might one day be possible to use this as a tool in clinics to 
measure the risk of SUDEP in patients who might be in the risk of SUDEP. It might 
be easier and less time consuming to ask a patient whether he or she has a 
history of GTCS, however experience shows that in a lot of cases there might be 
no witness at the time of a generalised seizure (the patient might even be not 
aware of it) and also it is beneficiary to have a tool to warn the neurologist about 
the risk factor before the generalised seizure has actually happened. Again, for a 
more robust conclusion longitudinal studies of progression and variability in SI in 
individuals with epilepsy is necessary.   
These results validated the potential usefulness of these tests in epilepsy 
management, and so motivated the second aim of this thesis which was to 
investigate whether visual psychophysical tests could be used for predicting 
seizures. To investigate whether suppression indices change in relationship to a 
seizure, we performed longitudinal tests in sixteen of the patients.  
There were a lot of practical difficulties in collecting data for longitudinal tests. 
Firstly, finding patients who would agree to run the tests in a long run was 
difficult. This was less anticipated considering the short length of the tests (10 
minutes for each run) and the fact that patients had the freedom to adapt the 
time of running the tests into their lifestyle. Secondly, two patients reported to 
feel dizziness and agitated after a couple of days of start. One of these patients 
(male, 29 years old, diagnosed with focal dyscognitive seizures for the last ten 
years, medication: Lamotrigine and Topiramate) was recruited through a local 
epilepsy support group and I did not have access to his full medical history to 
accurately assess his condition. He reported to have had one seizure every 6 
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weeks prior to doing the test, but then reported a sudden increase in seizure 
frequency, and so after doing five rounds of tests, decided to stop. The second 
patient (Male, 50 years old, diagnosis: temporal lobe epilepsy with focal 
dyscognitive seizures with possibility of absence seizures for the last 2 years; 
Medication: Levetiracetam) did not report any problems until his medication was 
increased. His family felt that the experiment was causing him stress, and he 
decided to withdraw from the experiment. Change of medication and 
psychological problems had a strong role on declining from participation in these 
two patients. Thirdly, some patients with reportedly frequent seizures did not 
have any seizures in the longitudinal process. These patients had seizures at least 
twice a month and yet had no seizure in the course of participation. This might 
have caused by poor previous report of these patients’ seizures, or the fact that 
these patients might have been more mindful of their epilepsy and consequently 
took their AEDs more regularly. And lastly, a lot of the recruited patients were 
not keeping a precise record of their seizures even after recommending them to 
do so. Different methods were discussed with patients, such as keeping a record 
in a diary, note taking using their phones and different phone applications. At 
least one of them had mainly night time seizures (nocturnal seizures). These 
problems along with the fact that the experimenter had minimal control over 
the condition of the room where the test was done and that recruitment had to 
be done via the usual clinical team made it challenging to increase the accuracy 
of the conclusions.   
The hypothesis of the longitudinal test in chapter 5 was to investigate the 
possibility of observing a different pattern in the measured suppression indices 
leading to a seizure and to investigate if this change can be used as a way of 
determining the time of seizure occurrence. In other words to investigate 
whether these tests could be a possible approach to predict patients’ seizures in 
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practice. A lot of the current approaches need patients to be connected to an 
electroencephalogram (EEG) or go through surgically placed implants which are 
in long run impossible or with a lot of implications. We reported that both 
controls and patients had fluctuations in their surround suppression indices in 
the motion discrimination and the contrast detection tasks. This was not only 
among different days, but also during different times of a day, however there 
was no clear pattern that reliably predicted when a seizure was likely to occur. 
The observed variability of suppression indices in controls could indicate that 
reduction in inhibition is not on its own enough to cause seizures and that the 
level of inhibition always remains significantly higher than the threshold for 
producing a seizure. In order to assure stable periods of activity in the cortex a 
balance interplay between recurrent excitation and inhibition is necessary (Shu 
et al., 2003, Schevon et al., 2012). Studies suggest that local cortical networks 
apply proportional inhibition in response to increasing excitation (Shu et al., 
2003). Therefore, the observed fluctuations in controls could be in fact the 
interplay between excitation and inhibition. As it was explained by Isaacson and 
Scanziani (2011) the idea of a balance between excitation and inhibition does 
not mean that these two forces are equal. They are not equally distributed along 
the soma and dendrites of neurons and therefore their ratio depends highly on 
the place that it is being measured. Acute experimental manipulation has 
showed that excitation and inhibition have a highly dynamic ratio and an overall 
proportionality. This interaction between excitation and inhibition and the 
activity in the seizure focus could similarly explain the observed higher amount 
of suppression index in the patients with frequent seizures. One plausible idea is 
that a seizure focus drives increased activity in the inhibitory surround. If the 
seizure focus is possible to be maintained by the increased activity in the 
surround, then the seizure remains focal, but if this breaks down or was unable 
to respond to the focal activity in the first instance, a generalised seizure could 
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occur. It is also possible to hypothesise that some global issue with inhibition 
underlies a tendency for focal seizures to generalise. 
Having demonstrated that inhibition fluctuates in controls, the question was 
whether this fluctuation is different in patients. In other words, it may be not the 
absolute level measured at a single time point, but how much it changes (for 
example goes below the threshold for triggering a seizure) that matters. Results 
of measuring standard deviation of between and within subjects indicated that 
although patients showed higher variations compared to that shown by the 
control group, the difference was not significant.  
The next question to answer was whether there is any association between the 
measured fluctuations in the suppression indices and times of seizures. To 
answer this question, we decided to compare suppression indices in defined cut 
offs (24hr, 12hr, 6hr before or after a seizure) using box plots. Boxplots did not 
show any relationship between the suppression indices and timing of seizures in 
any of the time points. The outcome is that we have not been able to find a 
strong link between timing of seizures and suppression index and considering 
the few number of samples of controls and patients we cannot use this 
information to predict the occurrence of a seizure.  
There are multiple mechanisms involved in seizure generation. Results of 
decades of experimental investigations in animals have given rise to the idea of 
an imbalance of inhibition and excitation in seizure development (Staley, 2015, 
Prince and Wilder, 1967, Wiechert and Herbst, 1966, Matsumoto and Marsan, 
1964). The idea of imbalance between excitatory and inhibitory drives might 
explain seizure generation, however it cannot always explain epilepsy, the 
chronic condition giving rise to seizures. The brain activity in patients with 
epilepsy has a great dynamic range with most of the time being normal. For 
example, the amount of time that the brain seizes is relatively small (<< less than 
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1%, typically) (Staley, 2015, Moran et al., 2004). If the whole network undergoes 
a lack of balance of excitation and inhibition, then why does that network not 
seize all the time? Perhaps, it is reasonable to think that there are further 
mechanisms associated with inducing or blocking seizure activity which leads to 
epilepsy.  
Positive feedback mechanisms, the process of enhancement of an effect, might 
be an additional influence on the system. Once a seizure was induced, given that 
there are enough positive feedback in the system, the seizure itself can produce 
enough activity to suppress inhibition or increase excitation (Abbott et al., 1997, 
Staley, 2015, Scharfman, 2007). For example according to the potassium 
accumulation hypothesis, an initial increase above a certain threshold boosts 
extracellular potassium accumulation which in turn triggers a positive feedback 
loop, with increased excitability, increased firing, and further K+ increases 
(Frohlich et al., 2008, Fertziger and Ranck Jr, 1970). As another example whilst 
PV interneurons have been shown to have inhibitory effects on epileptic activity, 
in other situations they can actually prompt seizures (Ellender et al., 2014). Cl− 
accumulation can change the role of PV+ interneurons to fire rather than 
terminate hyperexcitability in the network during the clonic phase of a seizure 
(Sessolo et al., 2015, Cohen et al., 2002, Dzhala et al., 2005). 
Although visual psychophysical tasks have been used in a variety of clinical 
disorders, there are still some discrepancies in the literature. An example is in 
studies done in schizophrenia. While a lot of studies in patients with 
schizophrenia have reported reduced surround suppression in judgements of 
relative contrast (Dakin et al., 2005, Serrano-Pedraza et al., 2014, Yoon et al., 
2010, Yoon et al., 2009) and motion (Tadin et al., 2006), a study done by Chen et 
al. (2008) indicated elevated amount of suppression in patients with 
schizophrenia compared to healthy controls in a random dot motion stimuli. 
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These dissimilarities in comparing reports for schizophrenia could be caused by 
different paradigms or patients groups that have been used. Similarly, as I 
showed in chapter 3 that motion and contrast suppression indices are not 
correlated, we cannot merge the findings of different psychophysical tasks and 
expect them to show similar results. Moreover, it is still not clear whether visual 
psychophysics (even by using the same task) have the consistency to be used as 
a tool for studying different clinical disorders. Another important factor is that 
neural suppression consists of different range of inhibitory processes and the 
relation between suppression and cortical inhibition is greatly complex 
(Friedman and Miyake, 2004, Tadin, 2015).  Therefore, it is crucial to be very 
clear on which tasks are being used and what they actually measure. 
 
7.2 General discussion of results in India cohort 
Results found at India cohort was different in several ways to participants in 
Newcastle. Firstly, there was no significant difference between controls and 
patients with frequent and infrequent seizures in India. Secondly, no patient had 
duration thresholds higher than 600ms. And finally, the mean of the motion 
suppression index in India was significantly lower in both patients and controls, 
and the mean of the contrast suppression index was significantly higher 
compared to Newcastle. These results are difficult to interpret at this stage. One 
possibility is that a long term exposed factor to participants in India might have 
a role in the observed variances, such as dietary and sun exposure and its effects 
on the contrast sensitivity. The higher incidence of infectious diseases and their 
association to epilepsy could also be a potential reason for the observed 
differences. I was not in a position to explore these any further within the time 
frame of my thesis. In the future, a more accurate design of the study should be 
carried out with enough power and sample size to find a more clear answer. 
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Running psychophysics and patients’ recruitment require careful observation 
and patience of the experimenter. 
 
7.3 Future work 
A long list of possible follow-up experiments could be envisaged in studies using 
psychophysics. For instance, one may wonder what information do high duration 
thresholds in the motion discrimination tell us and why some people had these 
long durations. A way to find possible answers for this particular question is to 
first find out how reliable these extreme results are with repeating these 
psychophysical experiments in the participants who showed these high duration 
thresholds, and then use a different experimental approach to test them. A 
method of constant stimuli is one option to test high stimulus durations 
repeatedly with randomly interleaved staircases. If this method gives similar 
results to the previous approach, then it is necessary to look at individual 
psychometric functions to extract more information. 
Moreover, we still do not have enough evidence to know what exactly these 
visual psychophysical tests measure. To find more evidence, different studies 
with combination of visual psychophysics with simultaneous EEG, Magnetic 
Resonance Spectroscopy (MRS) or Transcranial Magnetic Stimulation (TMS) 
could be defined to compare the findings and get a more clear understanding of 
the neuronal processes in the brain. Another interesting line of investigation is 
to explore the possible reasons of why Indians did not show similar results to 
participants in Newcastle. What are the differences between the two cohorts 
that Indian participants never showed high duration thresholds? Could dietary 
and contrast sensitivity be accounted as possible reasons for the observed 
differences? One way of finding answers to these questions is to use different 
psychophysical approaches. Another possible option is to use visual evoked 
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potentials to measure the contrast gain control of patients in response to 
patterns of different contrast and look for possible differences between patients 
in Newcastle and India. Park and Tadin (2015) presented an abstract at the Vision 
Sciences Society (VSS) meeting showing that people with higher amount of 
suppression index were better at segmenting motion defined figure-ground 
stimuli. They suggested that there is a trade-off and different people adopt 
different optima. Maybe the optima balance is different in India than in 
Newcastle for some reason we do not understand. 
In conclusion, results from this study revealed that the motion discrimination 
and the contrast detection tasks are not measuring the same property of the 
cortex. For the epilepsy cohort, our prior hypothesis was that people with 
epilepsy may show a reduced suppression index. However, most showed similar 
suppression indices to our control group, whilst one group of patients, those 
with exclusively focal seizures, actually showed an increase.   
In addition, I report the first instance of raised suppression index in any patient 
cohort, which appears to differentiate between patients with respect to the 
likelihood of seizure generalization. Results suggest that the motion suppression 
index may prove to be a promising candidate as a biomarker to predict the risk 
of SUDEP in patients with epilepsy. Raised motion suppression index seen in 
patients who have never previously had a generalised seizure can indicate a 
lower risk of SUDEP, whereas a normal motion suppression index in patients with 
a history of generalised seizures can indicate a higher risk.  
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Appendices 
 
Patients’ information: 
 
Patients’ aetiology of epilepsy is shown in the pie chart Appendix 1 (Fisher et 
al., 2014). 
 
Appendix 1. Patients’ classification of aetiology. 
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Appendix 2. Table of patients’ information.   Including patients ID, duration of epilepsy (EP duration), PMH (Past Medical 
History), imaging results, types of seizures, presumed aetiology, presumed location, information regarding their grading 
and whether they belong to defined frequent and infrequent groups and their grade,  details of the frequency of 
seizures, anti-epileptic drugs (AEDs), and  the number of AEDs. 
 
ID Age onset Ep duration PMH Imaging 
Seizure 
type 
Presumed 
aetiology 
Presumed 
location Grading A Grading B GRADE 
Detail of 
frequency AED 
Number 
of AEDs 
EP1 Not known 
Not 
knows - R MTS 
Focal 
dyscog 
Structural-
metabolic Temporal Infrequent Frequent 3 2-3/month 
VPA- 
Epanutin 
(PHT)-CLB-
PGB 
4 
EP2 13 40 Meningitis/encephalitis as child L MTS 
Focal 
dyscog 
Structural-
metabolic Temporal Infrequent Infrequent 1 
None since Aug 
2010- seizure 
free for 4 years 
CBZ/CLOB 2 
EP3 12 40 Intracranial tuberculoma 
Left 
temporal 
lobe 
atrophy 
Focal 
dyscog 
Structural-
metabolic Temporal Infrequent Infrequent 1 
None since Oct 
2005 
CBZ/KEP/LA
M 3 
EP4 64 8 Aortic valve replacement 
Normal 
(CT) 
Focal 
dyscog Unknown Temporal Frequent Frequent 4 1/week LAM 1 
EP5 34 0.5 Head injury/frontal lobectomy 
Bilateral 
Frontal 
encephal
omalacia 
Focal motor Structural-metabolic Frontal Infrequent Infrequent 2 
None for 2 
months, 
previously 
1/month 
CBZ 1 
EP6 11 months  >20  
Amygdalo-
hippocampectomy 
2012 
L MTS Focal dyscog 
Structural-
metabolic Temporal Infrequent Infrequent 2 
None for 5 
months,  
previously 
2/month 
VAL/LAM/PR
EGAB/CLOB 4 
EP7 6 >50 Skull fracture R MTS Focal dyscog 
Structural-
metabolic Temporal Infrequent Frequent 3 1/month 
PHE/LAM/LE
V 3 
EP8 childhood 30 - n/a GTCS Genetic Generalised Frequent Frequent 5 Daily none 0 
EP9 12 5 - Normal GTCS Genetic Generalised Infrequent Infrequent 1 Single seizure VAL 1 
EP10 16 0.5 - n/a GTCS Genetic Generalised Infrequent Infrequent 2 0.5/month- 3 in 6 months VAL 1 
188 
 
ID Age onset Ep duration PMH Imaging 
Seizure 
type 
Presumed 
aetiology 
Presumed 
location Grading A Grading B GRADE 
Detail of 
frequency AED 
Number 
of AEDs 
EP11 54 <1 year - Normal GTCS Unknown Unknown infrequent infrequent 2 
2 since Sep 
2012- 2 in 6 
months 
VA 400mg 
started 
16/01/13 
1 
EP12 18 Single seizure - Normal 
Bilateral 
convulsive Unknown Occipital infrequent infrequent 1 
only 1 since 
Aug 2012 none 0 
EP13 27 >30  - Normal Unknown Unknown Unknown infrequent frequent 3 
usually more 
than once a 
week but none 
since 6 weeks 
ago 
LTG 1 
EP14 57 <1 head injury 2001  Normal Focal dyscog Unknown temporal  infrequent infrequent 1 
none since Sep 
2012 None 0 
EP15 22 <1 - Normal GTCS Genetic Generalised infrequent infrequent 2 2 since diagnosis None 0 
EP16 17 1 - Normal (CT) GTCS Genetic Generalised infrequent infrequent 1 single seizure none 0 
EP17 6 or 7  years old 30 - 
Temporal 
lobe 
resection 
Focal 
dyscog 
Structural-
metabolic Temporal infrequent frequent 3 1 every ~2  CBZ/KEP 2 
EP18 41 14 - - GTCS Unknown Temporal infrequent infrequent 2 1 every 6-8 weeks none 0 
EP19 3  years  old >20  
VNS in situ- recent 
head injury-  Normal 
Focal 
dyscog Unknown 
Possible 
frontal frequent frequent 4 
every other 
night-  
approximately 
12 per week 
VPA- CLB- 
PER- PHT 4 
EP20 1991 22 - MRI- Normal  Focal motor Unknown 
Presumed 
left frontal frequent frequent 5 2-3 per day 
RTG-CLB-
CBZ-LEV 4 
EP21 21   >30 
cryptogenic focal 
epilepsy onset left 
frontotemporal 
region 
Normal Focal dyscog Unknown 
left 
frontotemp
oral 
infrequent frequent 3 2-3 per month CBZ- LEV 2 
EP22 2005  8  - Normal GTCS Genetic Generalised infrequent frequent 3 2 per month LEV 1 
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ID Age onset Ep duration PMH Imaging 
Seizure 
type 
Presumed 
aetiology 
Presumed 
location Grading A Grading B GRADE 
Detail of 
frequency AED 
Number 
of AEDs 
EP23 13 30 Meningitis L MTS Focal dyscog 
Structural-
metabolic Temporal Frequent Frequent 4 
3 clusters per 
month or 9-10 
per month 
CBZ-ZNS 2 
EP24 7 15 - Normal Tonic-clonic Unknown Presumed left occipital Infrequent Frequent 3 2-3 per month TPM-ZNS 2 
EP25 7 30 Tumour (pituitary macro adenoma) L MTS 
Focal 
dyscog 
Structural-
metabolic Temporal Infrequent Infrequent 2 
Last one 
29/08/13 
before that 2 
on 22/08/13 
and before that 
January 
ZNS 1 
EP26 54 15 Depression Normal Focal dyscog Unknown Unknown Infrequent Infrequent 1 
None in 2.5 
years  VPA 1 
EP27 58 10 - Unknown Bilateral convulsive Unknown Unknown Infrequent Infrequent 1 
None since age 
60 LTG 1 
EP28 childhood 30 - Normal GTCS Genetic Generalised Infrequent Frequent 3 
1 TC/Month 
every 6-7 
days/month 
VPA-LEV-
CBZ 3 
EP29 11-12   10 - - Generalised; myoclonic Genetic Generalised Frequent Frequent 4 
4/month 
sometimes 
several 
ZNS 1 
EP30 11-12  30 - Unknown - Unknown Unknown Infrequent Frequent 3 1/month LEV- PER 2 
EP31 28 20 
Suspected 
meningitis as a 
child 
R MTS Focal dyscog 
Structural-
metabolic Temporal Frequent Frequent 4 
8 or 10/month 
in clusters LTG-PGB 2 
EP32 40 10 - Normal Focal dyscog Unknown 
Presumed 
temporal Frequent Frequent 4 2 to 4/week LEV-RTG 2 
EP33 around 51 30 Recent severe head injury Normal 
Focal 
dyscog Unknown 
Presumed 
temporal Infrequent Frequent 3 1/month LTG 1 
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ID Age onset Ep duration PMH Imaging 
Seizure 
type 
Presumed 
aetiology 
Presumed 
location Grading A Grading B GRADE 
Detail of 
frequency AED 
Number 
of AEDs 
EP34 2000 13 - Normal Focal dyscog Unknown 
Presumed 
temporal Frequent Frequent 4 Refractory 
PER-LEV-
PGB 3 
EP35 16  6 - Normal Focal dyscog Unknown 
Presumed 
temporal Infrequent Frequent 3 
3-7 complex 
partial a 
month- last one 
3/4/12 
CBZ- TPM-
CLB 3 
EP36 2001 >30   Cerebral abscess 
L parietal 
cortical 
resection 
in 2014- 
Hydrocep
halous 
post 
operation 
Focal 
dyscog 
Structural-
metabolic Parietal infrequent infrequent 2 
Every one to 
three months PHT-LTG-LEV 3 
EP37 23 4 
PET: extensive 
right temporal lobe 
hypo metabolism  
Normal focal dyscog Unknown 
Presumed 
temporal Frequent Frequent 4 
1 every other 
day- max 4-
5/week 
PER 1 
EP38 1 >20   Tuberous sclerosis  Multiple tubers 
Focal 
dyscog 
Structural-
metabolic Multifocal Frequent Frequent 4 1/week 
LEV- LTG-
CLB 3 
EP39 31   3 - R MTS Focal dyscog 
Structural-
metabolic Temporal Frequent Frequent 5 0 to 5 a day 
TPM-OXC-
LTG 3 
EP40 2014 <1  - Normal 
Primary 
generalised 
epilepsy 
Genetic Generalised Frequent Frequent 5 Daily or every other day LEV 1 
EP41 16 >10   - Normal Focal dyscog Unknown 
Presumed 
temporal Frequent Frequent 5 
Minor seizures 
daily, major 
ones 1/week 
CLB-LCM -
LEV-ZNS 4 
EP42 6 >20   
sclerosis in the 
amygdala on right 
temporal lobe 
astrocytoma, 
partial resection 
96, 97, right 
temporal 
lobectomy 99 
Right 
mesial 
temporal 
sclerosis 
Focal 
dyscog 
Structural-
metabolic Temporal Infrequent Frequent 3 
Clusters over 3-
4 days and free 
seizures in 
between 
LTG-PGB 2 
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ID Age onset Ep duration PMH Imaging 
Seizure 
type 
Presumed 
aetiology 
Presumed 
location Grading A Grading B GRADE 
Detail of 
frequency AED 
Number 
of AEDs 
EP43 14 or 15 >30 - Normal 
Bilateral  
convulsive   
with 
absence 
seizures 
Genetic Generalised Infrequent Infrequent 2 Estimate: 1-2 every 2 months PRM - PGB 2 
EP44 14 28-29 Head injury MRI normal 
absence 
and focal 
dyscog 
Unknown 
Presumed 
fronto-
temporal 
Frequent Frequent 4 every 2-3 days VPA-LTG 2 
EP45 11 >20 Depression 
Cystic 
encephal
omalacia 
of right 
temporo-
occipital 
Focal 
dyscog and 
occasional 
tonic-clonic 
Unknown 
initial onset  
in frontal 
lobe with 
propagation 
to temporal 
lobe 
Frequent Frequent 4 
More than 1 
per week/ 
clusters 
VPA- PGB- 
ESL-PB 4 
EP46 ~5 >25 - 
Possible 
abnormal
ity in left 
hippocam
pus 
Nocturnal Structural-metabolic 
Left 
temporal 
lobe 
Frequent Frequent 4 More than 15 per month 
PGB-LEV- 
CBZ- PHT- 
CLB 
5 
EP47 2009 ~6 Head injury as a child 
Small left 
hippocam
pal tail 
Focal 
dyscog Unknown 
Presumed 
left anterior 
temporal 
Frequent Frequent 4 3 per week 
ZNS, 
changed to 
CLB 
1 
EP48 1999 > 40 Asthma 
left 
mesial 
temporal 
sclerosis 
Focal 
dyscog 
 
Structural-
metabolic 
Presumed 
temporal Frequent Frequent 4 
More than 8 
per week 
CLB -VPA- 
CBZ 3 
EP49 4-5 >25 - Normal Focal Unknown 
Presumed 
left 
temporal 
Frequent Frequent 4 once a week OXC 1 
EP50 22 ~4 - Normal 
Possible 
focal 
dyscog 
Unknown 
Possible 
temporal 
lobe 
Infrequent Infrequent 2 
used to have 
once or twice 
per week- now 
controlled 
none 0 
EP51 17-18 10 Encephalitis at ~10 Normal 
Generalised 
seizures 
and focal 
dyscog 
Structural-
metabolic Unknown Infrequent Infrequent 2 
1 every 6 
weeks/ but 
increased with 
start of the test 
LTG, TPM 2 
EP53 13-14 >10 - Normal 
Bilateral 
convulsive 
and 
absences 
Unknown Presumed frontal Infrequent Frequent 3 every 2 weeks VPA- LEV 2 
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ID Age onset Ep duration PMH Imaging 
Seizure 
type 
Presumed 
aetiology 
Presumed 
location Grading A Grading B GRADE 
Detail of 
frequency AED 
Number 
of AEDs 
EP55 49-50   1-2  Ventricular tachycardia 
Basal 
ganglia 
calcificati
on 
Focal 
dyscog Unknown 
Temporal 
lobe Infrequent Frequent 3 1-2 week LEV 1 
EP56 64 2006 - 
Possible 
calcificati
on or 
hemoside
rin 
Possible 
auto motor 
seizures 
Unknown Temporal lobe Infrequent Infrequent 2 
2-3/month- 
now is 
decreased after 
increasing AED 
LEV- it is 
decreasing 
to be 
replaced by 
ESL 
1 
EP57 9 >30   - MRI normal 
Simple 
partial 
seizures- 
occasional 
generalised 
tonic-clonic 
Unknown Right hemisphere Infrequent Infrequent 3 
More than 
1/month 
ZNS- LEV-
VPA 3 
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Appendix 3. Table of patients’ information from India. Including patients ID, age of onset, type of seizure, date of last 
known seizure, details of seizure frequency, information regarding their grading and whether they belong to defined 
frequent and infrequent groups and their grade, anti-epileptic drugs (AEDs), the number of AEDs and presumed 
aetiology. The seizure classification is based on the old classification system. 
 
ID Age of onset Type of seizure date of last seizure Seizure Frequency Grading A Grading B Grade AED Number of AEDs Presumed aetiology 
KP1 59 Generalized Tonic Clonic Seizure March 2011 23 times from 2009 to 2011 Infrequent Infrequent 2 VPA - CLB 2 Genetic 
KP2 16 Partial seizure Jul-11 Once since 2011 Infrequent Infrequent 1 VPA 1 Unknown 
KP3 16 Generalized Tonic Clonic Seizure 11/09/2013 4 times per year infrequent infrequent 2 OXC, LEV 2 Genetic 
KP4 11 Generalized Tonic Clonic Seizure 2011 2010-3 times, 2011-once infrequent infrequent 2 VPA 1 Genetic 
KP5 14 
Generalized Tonic Clonic 
Seizure, Absence seizure, 
myoclonic jerks 
05/01/2013 3-4 times a year infrequent infrequent 2 LEV 1 Genetic 
KP6 14 Complex Partial Seizure 19/11//2013 1-2 times per month infrequent frequent 3 LEV, VPA, CBZ 3 Unknown 
KP7 16 Generalized Tonic Clonic Seizure 30/11/2013 5-6 times per week frequent frequent 4 VPA, LEV, CLB 3 Unknown 
KP8 4 Complex partial seizure Jul-13-2013 2-3 times a year infrequent infrequent 2 LEV 1 Unknown 
KP9 17 Secondary seizures Aug-13-2013 once in last 1 year infrequent infrequent 1 VPA 1 Structural/metabolic 
KP10 18 Idiopathic Generalized epilepsy Sep-13-2013 3-4 times a year infrequent infrequent 2 LEV 1 
 
KP11 5 Idiopathic Generalized epilepsy Aug-12-2012 once in every month till 2012 infrequent infrequent 2 VPA, PHT 2 Genetic 
KP12 17 
Secondary seizure 
Followed by Herpes 
Simplex Encephalitis 
Oct-13-2013 4 times per year infrequent infrequent 2 OXC, CLB  2 Structural/metabolic 
KP13 23 Complex Partial Seizure Nov-13-2013 2 times a year infrequent infrequent 2 OXC 1 Unknown 
KP14 54 Complex Partial Seizure Dec-11-2011 7-8 times in a year from 2010-2011. infrequent infrequent 2 OXC, LEV 2 Unknown 
KP15 26 Generalized Toni Clonic seizure 12/04/2013 2-3 times every day frequent frequent 5 VPA, CLB 2 Unknown 
KP16 1 Complex Partial Seizure 12/04/2013 2-3 times every day frequent frequent 5 LEV, CBZ, CLB, LCM 4 Unknown 
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ID Date of onset Type of seizure date of last seizure Seizure Frequency Grading A Grading B Grade AED Number of AEDs Presumed aetiology 
KP17 14 Partial seizure with secondary generalised 2012 once in every month till 2012 infrequent infrequent 2 OXC, LEV 2 Structural/metabolic 
KP18 35 Partial seizure 2012 once in 4 months till 2012 infrequent infrequent 2 OXC 1 Unknown 
KP19 16 
complex Partial Seizure 
with secondary 
generalization 
Nov-13-2013 4 times per year infrequent infrequent 2 LEV  1 Unknown 
KP20 22 Generalized Epilepsy Nov-13-2013 5 times in one year infrequent infrequent 2 LEV 1 Unknown 
KP21 15 Complex Partial Seizure Aug-13-2013 once in a year infrequent infrequent 1 OXC 1 Unknown 
KP22 16 Complex Partial Seizure 12/05/2013 5/6 times a month frequent frequent 4 OXC, CLB 2 Unknown 
KP23 26 Idiopathic Generalized epilepsy 30/11/2013 missing missing missing missing  LEV, CLB 2 Genetic 
KP24 55 Partial seizure with secondary generalization 2011 once in a year infrequent infrequent 1 
LEV 
 1 Unknown 
KP25 3 Partial seizure with secondary generalization 12/06/2013 1-2 times per week frequent frequent 4 
LEV, OXC, VPA, 
CLB 4 Unknown 
KP26 19 Idiopathic Generalized epilepsy Oct-13-2013 3-4 times a year infrequent infrequent 2 OXC, CLB 2 Genetic 
KP27 19 Idiopathic Generalized epilepsy Feb-13-2013 once in a year infrequent infrequent 1 LEV 1 Genetic 
KP28 40 Generalized Tonic Clonic seizure Sep-12-2012 once since 2012 infrequent infrequent 1 VPA 1 Unknown 
KP29 55 Idiopathic Generalized epilepsy 13/12/2012 1/2  times a month infrequent frequent 3 VPA, OXC, LEV 3 Genetic 
KP30 4 Complex Partial Seizure 12/12/2013 3/4 times a year infrequent infrequent 2 Missing Missing Unknown 
KP31 18 Generalized Tonic Clonic Seizure 22/11/2013 
Twice on the first day, no attack after 
that infrequent infrequent 1 PHT, CLB 2 Unknown 
KP32 35 Generalized Tonic Clonic Seizure Jul-13-2013 4 times in last one year infrequent infrequent 2 VPA PB 2 Unknown 
KP33 15 Complex Partial Seizure 31/12/2013 5-6 times in last 0ne year infrequent infrequent 2 LEV, CBZ, CLB 3 Unknown 
KP34 1 Generalized Tonic Clonic Seizure April,2014 2-3 times every month infrequent frequent 3 OXC, LEV, CLB 3 Unknown 
KP35 31 Generalized Tonic Clonic Seizure February ,2012 total 2 episodes so far infrequent infrequent 2 VPA, CLB 2 Unknown 
KP36 25 Generalized Tonic Clonic Seizure 03/11/2013 2 seizures only infrequent infrequent 2 OXC 1 Unknown 
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ID Date of onset Type of seizure date of last seizure Seizure Frequency Grading A Grading B Grade AED Number of AEDs Presumed aetiology 
KP37 60 Generalized Tonic Clonic Seizure ONE episode so far Single seizure infrequent infrequent 1 VPA, LEV, CLB 3 Unknown 
KP38 29 Generalized Tonic Clonic Seizure Mar-14-2014 3 episodes in last three year infrequent infrequent 1 OXC 1 Unknown 
KP39 16 Partial seizure with secondary generalization 15/05/2014 1-2 episodes per month infrequent frequent 3 
OXC, VPA 
 2 Unknown 
KP40 23 Lt Focal motor seizure with secondary generalization Jun-14-2014 2 episodes in last 1 year infrequent infrequent 2 PHT, OXC , CLB 3 Unknown 
KP41 12 Juvenile Myoclonic Epilepsy 14/01/2011 No Episode in the last 3 years infrequent infrequent 1 VPA 1 Genetic 
KP42 24 Generalized Tonic Clonic Seizure 20/04/2014 1-2 ties every month infrequent frequent 3 CBZ, VPA 2 Unknown 
KP43 57 Post head injury GTCS 17/05/2014 once in two month infrequent infrequent 2 PHT, CLB 2 Structural/metabolic 
KP44 52 Post Stroke seizure February ,2014 2 attacks in last one year infrequent infrequent 2 none 0 Structural/metabolic 
KP45 29 Generalized Tonic Clonic Seizure Mar-14-2014 once in two month infrequent infrequent 2 
PHT, , LTG,  
CLB 3 Unknown 
KP46 11 Generalized Tonic Clonic Seizure Jan-13-2013 once in six month infrequent infrequent 2 LEV, OXC 2 Unknown 
KP47 58 Post Stroke seizure April,2014 Once in last one year infrequent infrequent 1 PHT  1 Structural/metabolic 
KP48 27 Complex Partial Seizure April,2014 Once in a week frequent frequent 4 CBZ, CLB 2 Unknown 
KP49 Since birth Idiopathic Generalized Epilepsy 3 years ago missing info missing missing 
missing 
info VPA 1 Genetic 
KP50 21 Generalized Tonic Clonic Seizure 20/5/2014 5 times in last 15 days frequent frequent 4 OXC, CLB 2 Unknown 
KP51 21 Generalized Tonic Clonic Seizure 22/5/2014 4 episodes so far (in 2 months) frequent frequent 4 OXC 1 Unknown 
KP52 9 Generalized Tonic Clonic Seizure 17th may 2014 2-3 times every month infrequent frequent 3 
LEV, VPA, OXC, 
ZNS, CLB 4 Unknown 
KP53 16 Occipital Lobe seizure Dec-12 4 attacks in  4 months infrequent frequent 3 OXC 1 Unknown 
KP54 29 Complex Partial Seizure 27/05/204 Once in a week frequent frequent 4 OXC, LEV, LCM, CLB 4 Unknown 
KP55 12 Juvenile Myoclonic Epilepsy 3 weeks age 2 attacks in last 3 months infrequent infrequent 2 VPA 1 Genetic 
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ID Date of onset Type of seizure date of last seizure Seizure Frequency Grading A Grading B Grade AED Number of AEDs Presumed aetiology 
KP56 19 Juvenile Myoclonic Epilepsy two weeks ago once in a month infrequent frequent 3 VPA 1 Genetic 
KP57 17 Generalized Tonic Clonic Seizure Oct-13-2013 
>20 attacks in 2013 , No attack in 2014 
so far infrequent infrequent 2 VPA, LCM 2 Unknown 
KP58 6 Absence Seizure May-14-2014 one-two attacks/ month infrequent frequent 3 OXC, LEV 2 Genetic 
KP59 12 Generalized Tonic Clonic Seizure 2010 missing info missing missing 
missing 
info CBZ 1 Unknown 
KP60 20 Generalized Tonic Clonic Seizure 27/05/2014 4 attacks in  last 1 year infrequent infrequent 2 LEV, CLB 2 Unknown 
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Appendix 4. Patients’ information sheet
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Appendix 5. The Addenbrooke’s cognitive examination (ACE-R) (Mioshi et 
al., 2006). 
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Appendix 6. Patient information sheet regarding seizures 
 
Subject ID    _________ 
 
Date of study    _________ 
 
 
VA     R________ L_______ 
 
 
ACE     _________ 
 
 
 
Age at first seizure   _________ 
 
 
Current seizure type  ___________________________ 
 
 
     ___________________________ 
 
 
     ___________________________ 
 
 
Current seizure frequency  _________ 
 
 
Current AEDS   ___________________________ 
 
 
Comments     
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Healthy participant information: 
Appendix 7. Control information sheet
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Appendix 8. Consent from for control participants. 
 
    
 
                                                                                                                                          
 
REC no: 09/H0906/90 
 
CONSENT FORM for controls 
 
Title of Study:  
 
Assessing seizure susceptibility using psychophysical tests 
 
Name of Researcher: 
Dr Roger G Whittaker 
Consultant Clinical Neurophysiologist, 
Department of Clinical Neurophysiology, 
Royal Victoria Infirmary, 
Queen Victoria Road, 
Newcastle upon Tyne, 
NE1 4LP. 
                   Please write your initials in the box 
 
1. I confirm that I have read and understand the information sheet dated  
February 2013 (version 1.4) for the above study.  
I have had the opportunity to consider the information, ask questions and  
have had these answered satisfactorily. 
 
2.  I understand that my participation is voluntary and that I am free to withdraw 
 at any time, without giving any reason, without  my medical care or legal   
rights being affected.          
 
3.  By signing this document, I understand that I give consent for the research 
team to perform tests which assess the function of my visual and auditory 
systems. 
 
4.  I understand that the anonymised results of these tests will be passed to 
researchers in Newcastle University for analysis. 
 
5.    I understand that the results from this or from future research may not have any direct  
       benefits for myself or my family. 
 
6. I understand that relevant sections of my medical notes and data collected during the study,  
may be looked at by individuals from regulatory  authorities or from the NHS Trust, where  
it is relevant to my taking part in this research. I give permission for these individuals to  
have access to my records. 
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______________________ ________________ ____________________ 
Name of subject Date Signature 
 
_________________________ ________________ ____________________ 
Name of Person taking consent Date Signature 
(if different from researcher) 
 
_________________________ ________________ ____________________ 
Researcher Date Signature 
 
 
1 for patient; 1 for researcher; 1 to be kept with hospital notes 
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